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AIMS AND SUMMARY 
The phenomenon of autorosette formation whereby lymphoid 
cells adhere to autologous erythrocytes has been known for several 
years. However, the mode of interaction and the functional significance 
of autorosetting has remained a mystery. The ma j or aim of the 
experiments described in this thesis was to establi sh the molecular 
basis of autorosetting and determine whether the interaction is under 
maJor histocompatibility complex (MHC) control. 
In chapter J, the role of t he H- 2 complex in murine 
thymocyte autorosetting was analysed. Autorosetting was mapped 
precisely to the H-2L/H-2D region of the murine MHC using three 
experimental approaches, namely (i) inhibition of autoros etting with 
erythrocyte sonicates from different congenic and r ecombinant strains 
of mice; (ii) analysis of the autorosetting abi lity of the l ymphoid 
cells from H-2L/H-2D mutant strains of mice; and (iii) blocki ng 
the inhibitory activity of the erythrocyte sonicates with anti- H-2 
sera. This chapter also described experiments that demons t r ated 
the autorosetting of murine peripheral T and B lymphocytes was also 
H-2L/H-2D controlled. In addition, B lymphocytes were shown to be 
the major cell type which autorosetted in t he peripheral lymphoid 
organs, the autorosetting receptors on B cells not being immunoglobulin 
(Ig) or lg-associated. Both the role of t he thymic epithelium in 
selecting receptor specificity and the expression of autorosetting 
receptors on the l ymphoid cells of Fl hybr id mice were also 
investigated . It was found that t he thymic epithelium did not play 
a role in sel ecting the H-2 specifici t y of the au'torosetting receptors, 
and t here was no allel ic exclusion i n the expression of the receptors 
on Fl hybrid l ymphocytes. 
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Chapter 4 described preliminary attempts to biochemically 
characterize the receptors and acceptors involved in autorosetting. 
Using sugar inhibition assays, and treating lymphoid cells and 
erythrocytes with proteases and exoglycosidases and then testing 
for their autorosetting abilities, it was concluded that the 
autorosetting receptor on lymphocytes was a protein and the acceptor 
on erythrocytes the carbohydrate portion of a glycoprotein. 
Chapter 5 describes further attempts to chemically 
characterize the receptors and acceptors mediating autorosetting. 
A procedure was devised for extracting from murine thymocytes 
an agglutinin of mouse thymocytes that appeared to represent the 
autorosetting receptor(s). This conclusion was based on (i) the 
observation that the same sugar inhibited the haemagglutinin as 
blocked autorosetting, (ii) genetic analysis of sugar inhibition 
patterns that suggested the haemagglutinin was under H-2L/H-2D 
region control, (iii) the detection of substantially less haemagglutinin 
in thymocyte lysates of the H-2L deletion mutant mouse strain dm2, 
a strain that lacks autorosetting receptors and (iv) the ability of 
purified autorosette inhibition factor (AIF) (see chapter 6) to 
inhibit the haemagglutinin . This chapter also describes absorption and 
sugar elution procedures for isolating autorosetting receptors from 
. 1251 thymocytes and acceptor molecules from erythrocytes. By_ running -
labelled material on SDS-PAGE the thymocyte receptor was found to 
have a mol. wt. of 6J,OOO daltons and possibly consisted of _two 
subunits whereas the erythrocyte acceptor molecule was a single 
polypeptide of mol. wt. 62,000 daltons. 
In chapter 6, the biological properties of an autorosette 
inhibition factor (AIF) in nonnal se:rurn were investigated. Blocking 
experiments revealed that the inhibitory factor was neither 
viii 
strain nor species specific. Furthennore, AIF appeared to be 
secreted by a comparatively radiosensitive macrophage or monocyte as 
in vivo administration of ca:r:Tageenan or silica markedly depressed 
AIF levels in serum and in vitro studies demonstrated that AIF was 
secreted by adherent peritoneal cells. Finally, a one step procedure 
for isolating pure AIF from human serum was devised. The factor was 
shown to be a single polypeptide chain of mol. wt. 81 ,000 daltons and 
was present in human serum at a concentration of 50-100 µg/ml. 
Finally , in chapter 7, the general significance of 
the experimental results presented in this thesis, and the theoretical 
implication of the finding that autorosetting representing a MHC-
co~trolled carbohydrate-protein interaction between cells are 
discussed. 
Whatever you do, 
do it well. 
My father 
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1. MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) OF THE MOUSE 
1.1 Historical Background 
5 
The original discovery of the Major Histocompatibility 
Complex (MHC) was made by Gorer (1936) in his analysis of blood 
group antigens in mice. In an attempt to identify the blood group 
antigens in inbred mouse strains, he immunised rabbits with erythrocytes 
from different strains of mice . When the resulting antisera were tested 
for their abilities to agglutinate red cells of these inbred mouse 
strains, Gorer was able to identify four different red cell antigens. 
One of these antigens, denoted as antigen II, was found to be present 
in some mouse strains and inherited in a simple Mendelian manner. In 
addition, the antigen II negative Fl mice derived from breeding between 
antigen II positive and antigen II negative parents were found to be 
able to reject tumour grafts derived from antigen II positive strains. 
In contrast, antigen II positive Fl mice failed to reject a tumour 
from antigen II positive parents (Gorer 1937), For this reason, Gorer 
designated antigen II a histocompatibility antigen. 
In a joint study over the next few years, Gorer, Lyman 
and Snell (1948) showed that the gene(s) that code for antigen II 
mapped to chromosome 17, Antigen II and its controlling gene(s) were 
then named histocompatibility-2-hence abbreviated as H-2. Subsequent 
work carried out by Snell and co-workers using inbred mouse strains to 
+ 
analyse H-2 further demonstrated that it did not consist of II and 
II alleles alone , but a series of closely linked loci. These loci 
were unique in that they controlled separate transplantation antigens. 
These findings led to the concept of the Major Histocompatibility 
Complex , or MHC. 
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1 .2 Genetic Map of t he H- 2 Complex 
The H- 2 complex is located on the IX l i nkage group of 
the murine 17th chromosome, is O.J - 1 .5 cM long and contains 10 - 15 
known loci . Linked to the H- 2 are the mi nor histocompatibility loci 
(H-Jl , H- 32 , H- JJ and H- 39) , loci coding for various isoenzymes (Pgk- 2, 
Ce- 2 , Ap- 1 , Glo- 1 , Map- 2) , an immune response locus (Ir-5) and blood 
group locus (Ea- 2) , and a T complex which is known to affect embryonic 
differentiation , chromosome segregation, and sperm behavi our (Klein 
and Hammerling , 1977). The cUITent map of the H-2 compl ex is shown 
in Fig . 1 .1 . The complex can be divided into a t l east six regions 
(K , I , .§. , U, D and T) , with the 1 region further divided into six 
subr egions (N , A, B, l. , E and Q). With the exception of the S region , 
the gene products of all these regions are expre ssed on cell surfaces. 
Although the T region is frequently presented i n maps of the H- 2 complex, 
its function is obscure and will not be discussed f urther. 
Since its original definition by Gorer the H- 2 complex 
has been shown to contr ol a wide range of immunological and non-
inununological phenomena, Thus , at the immunological level , the H- 2 
complex controls transplantation antigens , l ymphocyt e activating 
determinants (Lad) involved in mixed lymphocyte reactions (MLR) and 
graft- versus- host reactions (GVHR) , target antigens for cell- mediated 
lympholysis (CML) , alloantigens of restricted cellular distribution and 
immune responsiveness to various antigens (Ir genes ) . A summary of the 
various genes in the H- 2 complex that control these different 
inununological eff ects is presented i n Table 1 . 1 . 
On t he other hand , nwnerous non- immunological effects 
are controll ed by t he MHC, such as cyclic AMP levels in the liver , 
testosterone levels, cortisone- i nduced cleft palate and mating 
L'-
Regions 
Subregions 
Gene Products 
Figure 1.1 
Genetic Map of the Murine MHC (Modified from Klein 1981) 
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A genetic map of the MHC complex of the mouse (H-2 gene complex) 
The gene products of the loci designed are as follows: H: Histocompatibility antigens; 
Ia: I-region-associated antigens; Ss: Serum serological; Slp: sex-linked protein; 
Tla: Thymus-leukaemia antigen 
CX) 
Table 1.1 
The Mapping of Different Genes and Functions within the H-2 Complex 
Traits associated with H-2 H-2 regions and subregions 
H-2K I-A I-B I-J I-E I-C H-2D 
Transplantation antigens + + - ? ? + + 
Lad (MLR, GVHR) + + - + + + + 
CML detenninants + + ? ? ? ? + 
H-2 (class I) antigens + - - - - - + 
Ia (class II) antigens - + - - + + 
Ia on B cells - + - - + + 
Ia on T cells - + - + + + 
Ir genes ? + + ? (+)a + 
? 
a As Ir genes were initially mapped to the I-C subregion which also included I-Ethe precise 
mapping of these Ir genes is uncertain. 
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preference. In fact , almost 60 different traits have been found to be 
associated with H- 2 (Klein, 1978 ). These observation have generated 
great interest in the H-2 complex and, in particular, have stimulated 
researchers to determine the role played by the serologically defined 
antigens in these phenomena. 
1.3 The Kand D Regions 
The gene products of these regions were originally 
described by Gorer (1936) as blood group antigens. The antigens of these 
regions are known to play an important role in the rejection of trans-
plantable tumours and normal tissues (Gorer 1937) (Table 1.1). 
The H-2K and H-2D antigens are expressed on virtually 
all tissues and exhibit a number of distinct antigenic determinants 
or "specificities". These specificities can be detected serologically 
by conventional or monoclonal antibodies, and they can be assigned 
as public or private specificities. Public specificities are defined 
as those shared by two or more alleles and they are carried by the 
H-2K and H-2D molecules of different inbred mouse strains or of 
different H-2 ;haplotypes. Private specificities, on the other hand, 
are unique antigenic determinants restricted to a single allele and thus 
are found on the H- 2K or H- 2D molecules of a particular inbred mouse 
strain. To date , over 100 public and private specificities have been 
detected on the H- 2K and H- 2D antigens. 
The direct evidence for K/D polymorphism has come 
from studies of wild mouse populations (Klein and Zalesk.a-Rutcznsk.a 
1977; Wakeland and Klein 1979a , b ; Duncan and Klein 1980). Most of the 
wild mice were found to be heterozygous at the Kand D loci. The 
phenotypic frequencies of the public specificities of the H-2K and 
H-2D antigens were much higher than those of their private specificities 
(0 . 5 compared to 0 .01 - 0 . 05) . Based on these frequencies and other 
relevant considerations, at least 100 alleles could be estimated at 
the Kor D locus of wild mice . The high degree of polymorphism of 
the K or D locus has been suggested to reflect varying selective 
pressure on the wild mouse population (Klein 1980). 
Despite the clear distinction between the H- 2K and 
H-2D regions, based on genetic, capping and sequential immunopre-
' I 
cipitation studies (Cullen et al.1972; Neauport-Sautes et al . 1973) 
there are striking similarities in the properties of the H- 2K and 
H-2D molecules. Firstly, some public H-2 antigenic specificities 
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are expressed on both the H- 2K and H- 2D molecules (Shreffler et al . 
1971). Second, both molecules are glycoproteins with a very similar 
molecular stIUcture (see section 1.3.2) and, thirdly, peptide mapping 
and limited amino-acid sequence data have demonstrated considerable 
sequence homology between the two molecules (Vitella and Capr a 1978). 
These findings clearly support the postulate that these two loci arose 
by gene duplication, a point which will be discussed later (see section 
1.3.2). 
Although the H-2K/D regions were originally described 
as single loci, recent evidence has demonst rated a greater genetic 
complexity in these regions, new loci associated with both H- 2K and 
H-2D being identified (Fig. 1.1). The most clearly established locus 
is H-2L, which is associated with t he H-2D region and will be discussed 
in detail below (section 1. 4). However, in addition to this locus, 
recent studies using cocapping techniques have identified another 
serologically distinct H- 2Dd region associated antigen which has 
been designated H-2M (Ivanyi and Demant 1979). Futhermore, serological 
analysis of Dk region products with antisera to public and private 
~ 
specificities has revealed the existence of two separate molecules , 
designated H- 2Dlk and H- 2D2k (Demant et al . 1981) . Finally , Hansen et aL. 
11 
(1981) have identified another molecule under D-region control, termed 
H- 2R , which could be serologically distinguished from H-2L. However, 
it is uncertain whether this molecule is coded for by a third H-2D 
locus or merely represents a precursor or confonnational variant of 
the Dor L molecule . 
Monoclonal anti- H- 2 antibodies have also revealed 
genetic complexity in the K region . O' Neill et al. (1981) reported hetero-
k geneity in K molecules , as the antigens detected by different monoclonal 
ant ibodies redistributed independently on the cell surface and differed 
in their chemical properties, one being a protein and the other a gly-
colipi d. molecule . Support for K region heterogeneity was reported 
by Eskinazi et al . (1981) who found two H- 2K molecules that had a 
differential expression on subpopulations of spleen cells and could be 
separ ated by seQuential immunoprecipitation. In addition, a new 
genetic region designated H- 2U , that maps between the Sand D regions 
has been recently defined by O' Neill and Parish (1981). Serological 
and biochemical studies revealed that the antigens of this region 
resembled Ia antigens in that they were expressed predominantly on B 
cells , and were made up of two different molecular weight structures, 
one of 36 , 000 and the other 60 , 000 daltons resembling the dimeric 
characteristics of Ia antigens . 
1 . J . l Cellular Distribution of H- 2K and H- 2D Antigens 
The H-2K and H- 2D antigens are expressed in most tissues 
or organs. The plasma membranes of cells of the immune system, such as 
lymphocytes and macrophages, as well as liver cells are particularly 
rich in these molecules. Most somatic cells such as muscle cells, 
fibroblasts, red cells and nerve cells, on the other hand, have low 
contents of these antigens. Very low amounts of H-2K and H-2D molecules 
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are also detected on t he membr anes of ear ly di fferentiating cells 
such as germ cells and early embryos (Kl ei n 1975) . Recently , O' Neill 
and Blanden (1979) have reported that t he quantitati ve expression 
of H- 2K and H- 2D antigens on lymphoid cells may have i mmunological 
significance . Thus , the expression of lower amounts of H- 2K and H- 2D 
anti gens on the spleen cells is paralleled by t he lower efficiency of 
the Fl cells both to be recognized as target and to a ct as sti mulators 
for cytotoxic T cells against the parental H- 2K and H- 2D antigens. 
1 . J . 2 Molecular Structure of the H- 2K and H- 2D Ant igens 
Chemical studies have revealed that the H- 2K and 
H- 2D antigens are glycoprotein molecules of molecualr we i ght 45 , 000 
daltons (Silver and Hood 1976 ; Cullen et al . 1976). This gl ycopr otein 
molecule is made up of a polypeptide chain of molecul ar weight 39 , 000 
daltons with two carbohydrate units each of J, 000 daltons covalently 
attached to it. Noncovalently associated with t his pol ypeptide 
is S2- microglobulin of molecular weight 12, 000 dalt ons which i s 
coded for by the non- MHC linked genes and has a s t riking sequence 
homology with the heavy chain constant region of immunoglobulins. 
The antigenic determinants of the H- 2K and H- 2D 
antigens appear to be determined by variations in the amino- acid 
sequence of the 45 , 000 dalton chain (Cull en et al. 1976 ; Vitetta 
and Capra 1978) . However , recent studies with monoclonal antibodies 
suggest that some antigenic determinants are dependent upon the 45 , 000 
dalton chain being associated with S2- microglobulin (I . F. C. 
McKenzie, personal communication). Although there is no evidence that 
the carbohydrat e portion of t he H- 2 glycopr oteins are antigenic , 
it was recently reported that t he K-region may control a second class 
~ 
of H- 2 antigens that are carbohydr ate in nature and are expressed as 
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glycolipids on cell surface (O ' Neill et al . 1981). These glycolipid 
H-2 antigens appear analogous to the carbohydrate-defined Ia antigens 
discussed later (section 1.5.6). 
The large polypeptide chain of the H-2 molecule 
contains four-half cysteines which combine to form two disulphide 
bridges; each bridge forming a loop with a molecular weight of 
approx. 12,000 daltons . The possible structure of the H-2K and H-2D 
antigens is depicted in Fig. 1.2. The 45 , 000 dalton glycoprotein 
can be divided into four regions. The first region is a hydrophilic 
amino-terminal region consisting of a 8 , 000 dalton protein moiety 
with one of the carbohydrate chain covalently attached to it. The second 
region corresponds to the 12,000 dalton fragment containing the 
first cysteine disulphide loop (Cl) and has the second carbohydrate 
chain covalently attached to it. With its presumed sequence homology 
to immunoglobulin, it is proposed that this Cl fragment could non-
covalently assoc1ate with S2-microglobulin. The third region is very 
similar to the second region and has the second cysteine disulphide 
loop (C2). The fourth region is hydrophobic; half of its 8, 000 dalton 
fragment is transmembrane, the other half being intracellular. The 
intra-cellular segment is believed to served as a mediator of interact ions 
with the cytoplasm (Silver and Hood 1976). 
Direct amino acid sequencing studies of t he H-2K and 
H- 2D gene products of different mouse strains revealed that allelic 
products of either gene display approximately the same degree of 
instance, Kk 
b k Db 
homology among themselves . For versus.!. , and D versus 
-
-
molecules were found to differ at some 40 - 50 amino acids. The K and D 
b b k k ) 
antigens of the same H- 2 haplotype e.g. , (lS_ , R_ ; K , 12. ; etc. , on 
the other hand, were found to differ at about the same number of 
positions (Hehning et al. 1976; Evenstein et al. 1976, 1978 ; Coligan et 
Fig . 1 . 2 
et.2 
a J c2 
NH2 
CHO 
s 
s 
s 
s 
CHO 
s 
s 
__ papain 
8 
J08 
J46 
COOH 
lymphocyte 
membrane 
cytoplasm 
B2-microglobulin 
A schematic representation of the murine membrane-bound 
H- 2K (D) molecule as deduced from different analysis. The 
molecule is comprised of four domains: a 1, a 2 and a J , while 
B2-microglobulin forms the 4th domain. 
The numbers designate the amino acid positions. 
S S: cys-cys bonds; CHO: carbohydrate; Cl: first cysteine 
disulphide loop ; C2 : second cysteine disulphide loop. 
(adapted from Klein 1979 ; Owen 1981) 
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al . 1978 ; Maizels et al. 1978 ). The 82-microglobulin polypeptide showed 
significant homology with the constant region of certain immunoglobulin 
molecules (Paulik 1975) . The sequence homology of the H- 2K and H- 2D 
gene products strongly supports the view that the genes that code for 
the molecules have evolved from a common primordial gene. 
l . J . J Biosynthesis of the H- 2K and H-2D Antigens 
Both the H- 2K/H- 2D antigens and S2-microglobulin are 
synthesized in their precursor forms of molecular weights 39,000 -
40 , 000 daltons , and 15 , 000 daltons respectively (Dobberstein et al. 
1979) . The precursor H- 2 molecule contains a signal peptide of about 
1 , 000 daltons , and this serves to insert the precursor H- 2 polypeptide 
into the microsomal membrane , this peptide being cleaved off after 
the insertion process is completed. Core oligosaccharides are then added 
to the polypeptide chain , and further glycosylation probably occurs in 
the Golgi apparatus . The precursor S2- microglobulin also contains a signal 
peptide of about J ,000 daltons , and this is cleaved off before the 
12 , 000 dalton chain combines with the H-2 polypeptide . 
1.4 The H- 21 Locus 
The H- 2L locus was initially defined serologically. In an 
attempt to establish the relationship between the private (H-2.4) and 
the public specificities (H- 2 . 28) of the H-2D region molecules, antisera 
against these two specificities were used in co-capping experiments 
(Lemmonnier et al. 1975) . Using several different antisera containing 
antibodies against the H-2.28 family of specificities it was found that 
not all the molecules with these public specificities co-capped with 
molecules bearing the private specificities (H-2.4). These findings , 
therefore, implied that in addition to the H-2D region-associated molecules 
bearing private and public specificities, another category of H- 2D-
region molecules existed that only carried public specificities. 
Subsequently , this finding was confirmed by Hansen et al . (1977) 
by immuno- precipitation of murine spleen cell lysates with D- region 
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specific allo-antisera . It was found that an antiserum which removed 
all the H- 2D region molecules carrying the private specificity did 
not remove all molecules reactive with an antiserum to the public 
specificities . The existence of a new gene product coded by the D-
region was further supported by peptide mapping studies that revealed 
peptide differences in the molecule recognized by anti-H-2 . 28 and anti-H-2.4 
sera although these molecules had similar molecular weights and 
' ' ' 
were associated with B2- microglobulin (Demant and Neauport-Sautes 1978). 
Support for the new locus was also gained from studies with the H-2d 
' loss ' mutant BALB- H- 2dm2 in which (i) a loss (deletion) of some 
H- 2 . 28 was detected, whereas the H- 2.4 molecule remained intact, and 
(ii) antisera detecting the ' H- 2 . 28 family' of antigens could be raised 
between mutant and parent (McKenzie et al. 1977 ; Morgan et al. 1978). 
In accordance with the standing rules of H-2 nomenclature , the new locus 
' in the D- region of H- 2 was then named H-21 (Demant et al. 1977 ; 
' ' Neauport- Sautes et al. 1978) 
Subsequent serological studies have shown that the 
anti- H- 2 . 28 sera detecting H- 21 in fact detect a family of specificities: 
H- 2 . 28 which is shared between H- 2K, H-2D anf H- 21 molecules , and 
' H- 2.64 and H- 2 . 65 that are only found on the H- 21 molecule (Demant et al. 
' ' 1978; Neauport- Sautes et al 1978). Furthermore, a serological examination 
of twenty- one D- end recombinant mouse strains for their H- 21 
specificities revealed that H-21 antigens correlated with H- 2D antigens, 
thus implying that the H-2D and H-21 loci are tightly linked (Huang 
et al. 1979) . This study also demonstrated a high polymorphism for the 
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H- 2L locus, and it is possible that this will be increased further 
when more anti- H- 21 antisera become available. 
The cell surface expression of H- 2L molecules 
has recently been examined by Potter et al. (1981). By employing 
monoclonal anti - H- 2L antibodies in a flow microflurometry analysis, 
it was found that the cellular distribution of H-2L molecules was 
the same as that of the H- 2K and H- 2D antigens. However, there 
was about 2 - 3 fold less H- 2L molecules expressed on lymphocytes 
than H- 2K and H- 2D antigens . In addition, as with the H-2K and 
H- 2D molecules , the expression of H- 2L antigens on Fl lymphoid 
cells did not show allelic exclusion. 
The primary structure of the H-2L molecule has 
been compared to that of H- 2K and H- 2D gene products in different 
mouse strains . Peptide maps of. H- 2Ld antigen immuno-precipitated 
from H- 2d tumour cells by specific allo- antisera have revealed 
~
amino acid sequence homology with the H- 2Kb and H-2Dd gene products 
(Coligan et al . 1979) . On the other hand , the differences between 
the H- 2Ld molecule and these other transplantation antigens appear 
to be distributed throughout their polypeptide chains. Thus the 
pr imary structure of the H- 2Ld molecule substantiates its classi-
fication as a classical transplantation antigen, but indicates it 
is distinct from the H- 2K and H- 2.D molecules. 
Analysis of the tryptic peptide maps of the H-2Lq 
and H- 2Ld molecules isolated from spleen cells has revealed remarkable 
similarities (Rose et al. 1980). On the other hand , some differences 
in amino acid sequence between the two molecules were observed, 
despite no serological differences being detected between these 
molecules . These findings imply that the serological determinants 
of these molecules were not affected by the changes in sequence, 
although whether T cells can recognize such changes remains to be 
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determined . 
At the functional level, s t udi es of the H- 2dm2 
mutant , which lacks H- 2L, have s hown that t he H- 2L molecules can 
act as strong transplantation antigens, stimulator anti gens for 
mixed lymphocyte cultures and target antigens for alloreact i ve 
cytotoxic T (Tc) cells (Melvold and Kohn 1976 ; McKenzi e et al . 1977a , 
b ; Hansen and Levy 1978 ) . Furthermore , in studies of the H- 2-
restricted Tc response to ectromelia virus-infected cell s, Blanden 
and co- workers (Blanden et al . 1977 ; Blanden and Kees 1978 ) have 
shown that for D- region restricted lysis, t he H-2L molecule , which 
is lost in the mutant , is required for t he i nduction of Tc to virus-
infected cells but is not necessary for t he l ysis of tar gets. On the 
other hand , blocking studies with anti- H-2L antibodies have demonstrated 
that some influenza virus-specific Tc probably recogni ze virus plus 
H- 2L (Biddison et al. 1978). The H-2L molecule ther efore appears to be 
able to act as a restriction element in both t he inductive and 
effective phases of the Tc responses, as can the H- 2K and H- 2D molecules~ 
1 .5 ToeI~~oo 
The central region of the H- 2 complex (I-region) , which 
codes for t he Ia antigen, was originally def ined as result of the 
analysis of H- 2 recombinant mice for t hei r ant i body responses to 
synthetic polypeptide antigens (Shreffler and Davi d 1975 ; Klein 1975). 
Subsequently , an immune response gene, designat ed Ir- 1 , occupying a 
chromosome segment between t he H-2K and S r egi ons (i . e ., the I (immune 
response)region) was shown t o genetically cont r ol and primarily 
determine t he responsiveness t o t hese anti gens . Further analysis of the 
ability of various i nbred and congenic mous e strains t o respond (i . e., 
high responsiveness a s opposed t o l ow or non- responsiveness) to many 
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different synthetic polypeptide antigens led to the sub:livision of the 
.I-region into two subregions, Ir-IA (originally termed Ir- 1) and 
Ir-IB. 
With the use of H- 2 recombinant mice a greater 
genetic complexity in the I-region has become apparent. The I -region 
is currently sub:livided into six subregions namely N, A, B, J, E and 
C arranged in this order from the centromeric to the telomeric 
ends. Each of these subregions may contain one or more loci controlling 
different traits such as serologically detectable antigens (Ia), 
immune response (Ir) genes, lymphocyte activating determinants (Lad) 
and histocompatibility antigens (H) (Table 1.1). 
1.5.1 The I-N Subregion 
The I-N subregion was recently identified by Hayes 
and Bach (1980). By absorbing an (ATL x Bl0.D2)Fl anti-BlO.BR antiserum 
with Bl0.T(6R) lymphocytes, the antiserum was still found to retain 
activity on AQ,R lymphocytes. Based on this observation and additional 
functional studies the I-N subregion has been proposed to exist between 
the K region and the I-A subregion. 
- -
1 .5 .2 The I-A and I -E Subregions 
1.5.2.1 Cellular Distribution 
The I-A subregion contains the Ia-1 locus which 
codes for Ia specificities which are predominantly found on B cells. 
In addition, Ia antigens encoded by the I-A subregion are expressed 
on epidermal cells, Langerhan cells in the skin (Frelinger et al. 
1978), splenic macrophages (Cowing et al. 1978) , T cell blasts, 
Fe receptor (FcR+) T cells (Stout et al. 1977) and cytotoxic T cells 
against some syngeneic tumours (Fujimoto et al. 1978). Allogeneic 
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effect factor (AEF) which acts on B cells has also been reported to 
bear I - A subregion coded determinants (Annerding et al . 1974) . So far, 
I - A subregion encoded antigens have not been reproducibly detected 
on helper and suppressor T cells (Murphy et al . 1976). Serological 
analysis has so far revealed that the Ia specificities detected on 
B cells are distinct from those on T cells, or T cell derived factors 
(Tohyhisa et al . 1978; Oi et al. 1978; Hammerling et al. 1979). The 
Ia- 1 B specificities like the H-2K and H- 2D region coded specificities, 
can also be classified as public and private. For example, Ia.2 is the 
' private ' Iak specificity whereas Ia.l, J, 5 and 18 are public 
specificities (Shreffler and David 1975). To date , over 40 Ia 
specificities within the I-A/I-E subregions have been defined sero-
logically (Shreffler and David 1975; Muller 1976). The I - A subregion 
also contains a histocompatibility locus, H- 2IA (Klein et al. 1976). 
The I-E subregion was originally defined by the 
detection of the Ia.22 specificity encoded by the Ia-5 locus present 
in the H- 2k haplotype (Shreffler et al. 1977) . Recently , Ia.23 specificity 
of H- 2d and Ia.7 which is a public specificity of H- 2k and H- 2d 
have also been mapped to the I-E subregion (Okuda and David 1978; 
Murphy et al. 1976). These specificities are predominantly present 
on B cells. Co- precipitation studies also have shown that they are 
present on one Ia molecule, thus implying that they are all controlled 
by one locus in the I-E subregion (Shreffler et al. 1977 ; David and 
Cullen 1978; Cullen et a1.1980). Other cell types which express these 
Ia specificites include a proportion of splenic macrophages (Cowing 
1978) and epidermal cells (Frelinger 1978). Also, I - E specificites 
reacting with antisera rci.ised against Con- A induced T cell blasts 
have been demonstrated on T cells, but not on B cells, thus suggesting 
that a new locus exists within the I - E subregion (Hayes and Bach 1978). 
The I - E subregion also contains a Lad locus, but it is not clear 
whether this is i dentical with the Ia-5 l ocus (Peek et al . 1977 ; 
Okuda and David 1978). 
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1 .5 . 2 . 2 Molecular Structure of the I-A and I-E Subregion ~ene Products 
Based on the potential importance of the I-A 
and I - E subregion antigens in immuno-regulation, work has been stimulated 
towards the serological and biochemical characterization of these 
gene products . 
Like the isolation of the H-2K and H-2D antigens, 
murine Ia antigens coded for by the I-A and I-E subregions on B 
lymphocytes are usually obtained from detergent extracts of radio-
labelled lymphocytes by immuno-precipitation with specific allo-antisera. 
Immuno- precipitates of these antigens from both these subregions 
usually yield molecules ranging in molecular weights from 57,000 -
6J , OOO daltons (Schwartz and Cullen 1978) that are dissociated into 
two- identical polypeptide chains, termed a andB, one of about JJ , 000 
daltons , and the other of 28 , 000 daltons. Thesea andB polypeptides 
are glycoproteins with the carbohydrate moiety constituting some 
10 - 15% of each chain (Freed and Nathenson 1977). In some cases, the 
a and B polypeptides can be precipitated independently by monospecific 
anti- Ia antibodies, thus implying they are likely to be noncovalently 
associated . The antigenic activity of these glycoprotein molecules 
appears to reside in their protein portion ( Cullen et al. 1975), but 
there is evidence for a second family of Ia antigens that are 
carbohydrate in nature (see section 1.5.7). It is not clear at present 
which specificities are associated with the a and B chains of the 
molecule. Recently, Mckean et al. (1981) have detected an alteration 
in the B chain of the Ia molecule in the I - A subregion mutant 
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B6 . C-H- 2bml~ However , it may also be that an intact a - S complex is 
required for the detection of the Ia specificities. 
Biochemical analysis has indicated that the I - E 
subregion products are similar to the Ia-1 locus products , having an 
a (JJ , 000 daltons) and a B (28 , 000 daltons) chain structure (Schwartz 
and Cullen 1978) . Subsequent studies by Jones et al. (1977, 1978, 
1978b) using two dimensional gel electrophoresis analysis have 
revealed that I - A and I - E subregion molecules are three chain 
structures composed of two highly polymorphic chains ( a.and S) , and 
one non- polymorphic chain , the Ia associated invariant chain (Ii) 
of molecular weight about Jl , 000 daltons. A point of particular 
interest arising from these studies is that one chain (S) of the I-E 
molecule is coded for by the I-A subregion, whereas the other (a) 
is coded for by the I - E subregion (Jones et al. 1978). The a and S 
chains of the I - A antigens are, however, both encoded by the I - A 
subregion . In ad.di tion , the~ coded product appears to regulate 
the cell surface expression of the I-A subregion product (David and 
Cullen 1978). More recently, it has also been s hown that an Ia locus 
mapping in I - A/ I - J regulates the quantitative expression of the I -E 
subregion controlled a chain (Murphy et al. 1980) . Analysis of the Ia 
antigen immuno- precipitated from tunicamycin-treated murine spleen 
cells has so far revealed that Ii contains two N-linked carbohydrate 
units (Sung and Jones 1981). So far, Ii has been found to be absent 
from Ia preparations from plasma membranes. Thus Ii seems to associate 
specifically with the a and S chains inside the cells, and is unlikely 
to be a structural component of the Ia antigens on plasma membranes. 
Genetic and biochemical studies have revealed that 
Ia antigens may vary diversely in their structures and expression on 
cell membranes of different mouse strainss Many mouse strains express 
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two distinct complexes of Ia antigens, Aa; AB and AS: Ea on their 
cell membranes . Cells from Fl animals can express mixed haplotype 
Aa : A6 and AS :Ea complexes in addition to the parental forms (Jones 
et al . 1981 ; McNicholas et al . 1982) . As a result, individual cells 
from an I - region heterozygote can express as many as eight different 
sets of Ia complexes . 
The significance of these findings lie not only 
in the fact that these interactions between different I-subregion 
products can generate ~_new ' Ia antigneic specificities, but also 
as they may provide the basis for an understanding of the dual 
Ir gene control of immune responses, e.g., Ir gene complementation 
in Fl hybrids between non- responder parents. At this point it should 
be noted that although complementing : Ir genes were initially mapped 
to I - A and I - C subregions (Benacerraf and Germain 1978), the I-C 
Ir genes could be in the I - E subregion, since the original I-C 
- -
subregion contained both I - E and I-C. 
Peptide mapping and amino-acid seQuencing studies 
of the N- terminal ends of the murine Ia antigens revealed that the 
a and B chains of the I - A or I - E subregion molecules are not homologous 
to each other or to the H- 2K and H-2D antigens (Silver et al. 1977; 
Freed et al. 1978 ; Cook et al. 1979a, b). Considerable homology, 
however , has been found among the a chain of various mouse haplotypes. 
On the other hand , substantial seQuence variations were seen among 
the 6 chains , thus suggesting that the B chain is predominantly 
involved in defining the serological Ia specificities. 
Studies on wild mice so far have revealed that I-A 
subregion polymorphism is high- approaching close to that of the Kand 
D loci (Wakeland and Klein 1979b). Another degree of genetic polymorphism 
is also revealed in the primary structure of the Ia polypeptide chains, 
namely Aa., AB and AB, Ea; in addition , as discussed above, they 
combine in diverse forms to form different Ia complexes (Cook et al. 
1979; McMillan et al . 1981) . The I-E subregion is less polymorphic. 
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The number of I-E alleles has been estimated to be about 10 (Klein 1981). 
1.5.J The I-B Subregion 
The I-B subregion was originally defined by the 
presence of Ir genes which control the response to an IgC myeloma protein 
(Lieberman and Humphrey 1971) . In addition, Ir genes regulating respon-
siveness to other antigens , such as lactate dehydrogenase B (Melchers 
et al. 1973),and Staphylococcal nuclease (Lozner et al. 1974; Sachs 
et al 1977) were also mapped to the I-B subregion. So far, no Ia antigens 
associated with I-B subregion have been defined, and in fact the existence 
of the the I-B subregion has been Questioned (BenaceITaf and Germain 1978). 
However, an Ir gene controlling responsiveness to the male specific 
H-Y antigen for the delayed-type hypersensitivity reaction (DTH) and 
graft rejection, but not for the Tc response to H-Y has recently been 
mapped to the I-B subregion (Hurme et al. 1978; Liew and Simpson 1980). 
1 .5 . 4 The I -J Subregion 
The I-J subregion is marked by the Ia-4 locus. It 
was originally defined by functional criteria, where allo-antisera, by 
cytotoxicity, were shown to remove T cells which suppress the prod.uction 
of immunoglobulin of the Ig- 1 allotype (MlJI1)hY et al. 1976). The I-J 
subregion antigenic determinants have also been detected on other 
suppressor T cells, including caITier specific, idiotype specific and 
tumour specific suppressor cells (Murphy 1979). Besides being present 
on suppressor cells, I - J subregion antigenic determinants are also 
detectable on : a) cells bearing the acceptor sites for suppressor 
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factors (Tada et al . 1977) ; b) T cell derived antigen specific suppressor 
factors (Tsf), which are involved in suppressing both humoral (Tada et 
al 1976) and cellular immunity (Greene et al 1977); c) a macrophage sub-
population required in the generation of a primary in vitro antibody 
response (this reaction is only blocked by anti-I-J serum (Niederhuber 
and Allen 1980); d) Con A promotor T cells required for responsiveness 
of I-J T cells to Con A (Frelinger 1977); e) T cells which stimulate in 
the MLR (anti-I-J serum blocks this reaction) (Okuda et al 1977). Whether 
these determinants are coded for by the Ia-4 locus, or are encoded by 
another locus in the I-J subregion is still unclear. There is a recent 
report suggesting that the I-J determinants expressed on accessory cells 
(non-T/non-B) are different from those f ound on suppressor T cells 
(Murphy et al. 1981). 
In more recent studies, I-J subregion determinants 
have been detected on other immuno-regulatory T cells. Thus , at least 
two I-J+ T cell subsets have been reported to operate in the generation 
of suppressor inhibitory activity, referred to as contrasuppression. The 
+ 
first subset, the inducer of contrasuppression, secrets an I-J soluble 
mediator which acts on the second subset (i.e., the contrasuppressor cells) 
which in turn inhibits suppressor T cell eff.ector function (Gershon et-al. 
19Bl). Whether the I-J determinants expressed on these two I-J+ subs~ts of 
T cells are distinct from those detected on other cell types is still unclear. 
Studies from Tada et al. (1978b) have demonstrated 
the presence of another locus in the I-J subregion, which codes for 
determinants on a subpopulation of helper T cells (Th2) . By cross-
absorption analysis of an anti- I-J serum it was shown that the I-J 
determinants of I-J+ helper T cells (Th2) were distinct from those 
expressed on suppressor T cells. 
/ 
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In contrast to the I - A and I-E subregion coded antigens, 
+ the I-J cells have been hard to detect, only 8- 1C% of normal spleen 
T cells being found to be I-J-positive as detected by a rosetting 
technique (Parish and McKenzie 1977) , while following enrichment for 
antigen-binding T cells JC% I-J+ T cells could be detected by 
cytotoxicity (Okumura et al. 1977). So far, I-J antigens have not been 
detected on B cells. 
The polymorphism of the I-J subregion is unclear , and 
so far there have been no chemical studies on I-J subregion products. 
1.5.5 The I-C Subregion 
The I-C subregion is defined by the Ia . 6 specificity, 
which is only found in two haplotypes (S:,,.E,) (Shreffler and David 1975). 
The antisera which led to the original definition of this subregion 
contained an IgM antibody that was only found in early bleeds of the 
immunised mice (David 1976). Since then, there have been difficulties 
in producing anti-Ia.6 antibody, and hence demonstrating the existence 
of the I-C subregion. The I-C and I-E subregions have, therefore, been 
- - -
considered for some time by many investigators as a single subregion, 
I-E/I-C (Murphy 1980). Recently , Sandrin et al. (1981) have been able 
to make an antiserum which detects the Ia. 6 specificity and hence 
have confirmed I - Casa distinct subregion in the H- 2 complex. 
- -
Based on the reactivity of antisera to the Ia . 6 specificity, 
I-C subregion coded determinants have been detected on T cell blasts 
and FcR+ T cells (Frelinger et al. 1976; Stout et al. 1977). So far, · 
the Ia. 6 s~ecificity has been reported to be absent from B cells (David 
et al. 1976 ; McKenzie et al. 1980). On the other hand, using xenogeneic 
antisera, carbohydrate-defined Ia s~ecificities controlled by a gene 
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within the I - C subregion have been detected 
- ' 
these antigens being pre-
dominantly expressed on B cells (McKenzie et al .1980) . This result, 
therefore , implies that there is a second locus in the I - C. Also 
encoded within I - Care lymphocyte activating determinants expressed on 
a suppressor factor generated in a MLR ( Rich et al. 1979), and 
transplantation antigens (McKenzie and Henning 1976). 
1 . 5 . 6 Carbohydrate-defined Ia Antigens 
The cell surface Ia alloantigens described in the 
previous sections have been clearly shown by biochemical analysis to 
be glycoprotein molecules whose antigenic determinants reside in 
their protein portion (Schwartz and Cullen 1978). In contrast, a second 
class of Ia antigens have been described whose antigenic determinants 
appear to be carbohydrate in nature. These Ia antigens were initially 
detected in mouse serum, as shown by t he ability of mouse serum 
to specifically inhibit the binding of cytotoxic anti-Ia sera to spleen 
cells (Parish et al . 1976). This second class of Ia antigens can be 
distinguished from the classical glycoprotein Ia antigens , 
as they appear to be glycosphingolipid molecules of low molecular 
weight, i . e. , 2000- 5000 daltons (Parish and McKenzie 1980). Further 
evidence for these antigens comes from the ability of sugars to 
inhibit the binding of certain glycosidases, such as neuraminidase, 
expose Ia antigens of foreign haplotype on cells (Parish et al. 
1981) and from the characterisation of monoclonal anti-Ia antibodies 
that recognize carbohydrate determinants (Higgins et al . 1980). A 
particularly interesting aspect of the monoclonal antibody studies 
is that some of the specificities detected by the monoclonals were 
indistinguishable on the basis of genetiQanalysis (and, therefore, have 
been assigned the same numerical specificity) , yet differed 
in chemical composition , i . e . , carbohydrate-defined and protein-
defined Ia . 2 and Ia .17 specificities were detected . 
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The two systems of Ia antigens, although chemically 
different , have several features in common . Both systems are highly 
polymorphic , have a similar cellular distribution and are controlled 
by genes in the I - A, I - E and I - C subregions of the H-2 complex (Parish 
and McKenzie 1980) . On the other hand, these two systems of antigens 
do differ in their biological properties . For example, the carbohydrate-
defined Ia antigens are found in high concentrations in serum and tissue 
fluids whereas the protein-defined Ia antigens are not. Furthermore, 
+ -these soluble Ia antigens are secreted by Ly-1 2 T cells, the rate 
of secretion increasing rapidly during certain immune responses (Parish 
and McKenzie 1980) . Recently , it has been shown that carbohydrate Ia 
antigens are carried on certain immune- regulatory factors. 
It should be noted, however, that in spite of the 
evidence for the presence of Ia glycolipid molecules, there has been 
some controversy as to the existence of these molecules (Schwartz 
and Cullen 1978). These studies , therefore, clearly require confirmation 
in other laboratories . 
1 .6 The S Region 
The S region , situated in the centre of the H- 2 
complex , was originally defined by variations in the levels of a sero-
logically detectable serum protein , termed Ss (Shreffler and Owen 1963) , 
and Slp, a sex linked variant of this protein (Passmore and Shreffler 
1970) . Subsequently, the Ss protein was identified as the fourth 
component of complement (c4) (lachmann et al., 1975 ; Curman et al ., 1975; 
Meo et al. , 1975) . 
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The Ss locus codes for a 185,000 dalton single chain 
molecule , which is post- transcriptionally split into the a , Sand y 
chains (Roos et al . 1978) . The Slp locus apparently is distinct from 
the Ss locus . The Slp protein lacks C4 activity, and its function is 
unknown (FeITeira et al . 1978) . 
2 . H- 2 Restriction of T cell Functions 
Earlier studies clearly showed that the K, D and I-
regions of the murine MHC coded for lymphocyte surface alloantigens 
(see Table 1 .1) , but the biological significance of these gene products 
was obscure . The finding which had provided the clue as to the normal 
biological function of these alloantigens was the demonstration 
that the H- 2K and H- 2D antigens impose constraints on the recognition 
of foreign antigens (e.g., vi:ruses) by cytotoxic T (Tc) cells 
(Zinke:rnagel and Doherty 1974). In essence, Tc cells can only 
recognize and lyse target cells sharing the H-2K or H-2D antigens 
(plus foreign antigen) of the stimulator cells-a phenomenon refeITed 
to as "H- 2- restriction". These findings imply that the H-2K and H- 2D 
antigens play a critical role in the differentiation of self from 
non- self. Subsequent to the studies with Tc cells it has been shown 
that delayed- type hypersensitivity and T helper cell responses are 
also "H- 2- restricted", although these responses usually entail the 
recognition of Ia , rather than H- 2K and H-2D molecules and foreign 
antigens. The role of the H-2 restriction phenomena in T cell 
cytotoxicity, delayed-type hypersensitivity and T-B collaboration will 
be briefly outlined below. 
2.1 T cell Cytotoxicity 
The H-2-restriction phenomenon was originally described 
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by Zinkernagel and Doherty in their analysis of the destruction of 
virus infected target cells by Tc cells (Zinkernagel and Doherty 
1974). In their system, they demonstrated that CBA/H (H-2k) mice 
infected with lymphochoriomeningitis (LCM) virus generated Tc cells 
which only killed LCM-infected target cells, but not uninfected H-2k 
cells, or target cells of non-H-2k haplotypes infected with LCM . 
It therefore appeared that H-2 -~omp~tibility between Tc and target 
cells was reQuired for lysis to occur. Further analysis of H-2-
restricted Tc cells using inbred, congenic and recombinant mouse 
strains revealed that Tc cells generated during viral infections 
only recognized syngeneic Kand D gene products in association 
- -
with viral antigens (Zinkernagel and Doherty 1979). SubseQuently, 
Tc cells s~ecific for minor histocompatibility antigens (Bevan 
1975) such as H-Y (Gordon et al. 1975; Schrader et al. 1975), 
chemically modified self antigens (Shearer et al. 1975), virus 
transformed tumours (Black et al. 1976) and a wide range of 
viruses (Zinkernagel and Doherty 1979) have been shown to be H-2 
restricted, only lysing target cells bearing the H-2K and H- 2D 
antigens (plus foreign antigen) of the stimulator cells. 
Although the I-region was initially thought to 
play little, if any role in the H-2 restricted Tc res~onses, other 
studies have shown that Tc cells can recognize TNP plus self I-
region products on target cells. However, these Tc responses are 
much weaker than that directed against TNP plus H-2K or H-2D 
antigens (Wagner et al. 1977). Thus, the H-2K H-2D and Ia antigens 
ap~ear to share some functional properties and, in fact, Ia antigens 
appear to act as "restriction structures" for delayed-type hyper-
sensitivity and helper T cells (see below). 
From extensive studies it is now clear that the 
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H- 2K and H- 2D antigens play a key role in the recognition of antigen 
on cell surfaces by Tc cells. In explaining the significance of the 
requirement for MHC antigens in the Tc response to virus- infected 
cells it has been suggested that the presence of MHC antigens in 
close association with virus specific molecules enables Tc cells 
to identify and kill virus-infected cells while ignoring an excess 
(and blocking of virus receptors by) free virus (Howard 1980). 
On the other hand, the recognition structures 
used by Tc cells to discriminate between MHC antigens alone and MHC 
antigens plus foreign antigen (termed antigen X) have not been 
characterised , and remain a major area of speculation. The two most 
widely discussed models are (i) the 'altered self' model where MHC 
molecules and foreign antigen interact to form a new antigenic 
determinant recognized by Tc cells and (ii) the 'two receptor' model 
where Tc cells carry two receptors, one that recognizes self MHC 
and the other the foreign antigen. There is experimental evidence 
and theoretical arguement both for and against these two models 
(reviewed by Zinkernagel and Doherty 1979), and the issue is far 
from being resolved . The molecular basis of H- 2 restriction is 
further complicated by the fact that any model should explain the 
high proportion of lymphoid cells that can respond to MHC antigens 
(Lindahl and Wilson 1977 ) and the profound effect of MHC structures 
both inside and outside the thymus on the specificity of MHC-restricted 
recognition (Zinkernagel and Doherty 1979; Blanden 1980). 
2 . 2 Delayed- type Hypersensitivity 
The first evidence for a H- 2 restricted DTH response 
was reported by Miller et al.(1975). In order to achieve successful 
transfer of DTH , they found that there was always a requirement for 
J2 
H~2 compatibility between the donors of sensitised T cells and the 
naive recipients . In the case of soluble protein antigens such as 
fowl gammaglobulin , keyhole limpet haemocyanin, and synthetic poly-
peptides such as GAT , this H- 2 compatibility was mapped to the I-A 
subregion of the H- 2 complex . However, when contact chemicals such as 
dinitroflurobenzene (DNFB) were used as the sensitising agent, sharing 
of the K, Dor I region between the donor T cells and the naive 
- - -
recipient was found to be sufficient for DTH transfer (Vadas et al. 
1977) . In all these systems it was thought that the restriction 
required H- 2 compatibility between the sensitised DTH cells and the 
antigen presenting cells , probably an Ia bearing macrophages or 
epidermal cells. 
Evidence has accumulated during recent years to 
suggest that , depending on the antigen used, K, Dor I-region molecules 
can act as the restriction st:ructures for DTH responses. Thus DTH T 
cells generated to a variety of non-replicating antigens such as 
proteins and synthetic polypeptides (Miller 1978a), haptens such as 
azobenzene- arsonate (Bach et al. 1978), and 4-hydroxyl-J nitrophenyl 
acety (NP) (Weinberger et al . 1979) and H-Y antigens (Liew and 
Simpson 1980) were found to be I-region restricted. However, I-region 
restricted DTH was generated when NP was coupled to a protein 
carrier , whereas NP- coupled to syngeneic cells preferentially elicited 
D- region restricted DTH (Sunday and Dorf 1981). 
In the case of replicating antigens such as vi:ruses, 
it appears that the ability to integrate into cell membranes in an 
appropriate manner may determine whether the DTH response is K, 
Dor I-region restricted. Thus, DTH to LCM was K, D but not I-region 
restricted (Zinkernagel 1976) whereas Leung and Ada (1980) have 
demonstrated that DTH to UV-irradiated (non-infectious) influenza 
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virus was analogous to DTH to a protein antigen in being I - region 
restricted . On the other hand, Leung and Ada (1980) observed that when 
infectious influenza virus was used for both sensitization and 
elicitation of DTH , two populations of DTH cells could be generated 
and detected : one was K, D- region restricted , the other I-region 
restricted . These findings were subsequently supported by the 
findings of Ertl (1981) who showed that fusion-positive (infectious 
or UV- irradiated) Sendai viruses generated DTH T cells that were 
either K, Dor I - region restricted , whereas fusion-negative Sendai 
viruses only stimulated I - region restricted DTH T cells. Two 
additional reports further support the concept that DTH T cells 
can be K, Dor I - region restricted. Thus, Weiner et al. (1980) 
have shown that cells mediating DTH to infectious reoviruses were 
K, Dor I - A- subregion restricted whereas Nash et al. (1981b) have 
reported that DTH responses to Herpes Simplex virus were only I-A 
subregion restricted. 
Thus , it appears that the MJ-!C-restriction of DTH 
responses to viruses very much depends upon the nature of the 
virus used . Although the significance of these findings is not 
entirely clear , it appears likely that non-infectious viruses, like 
UV- irradiated influenza virus and fusion-negative Sendai virus, 
were processed like soluble protein antigens by macrophages so that 
an I - region restricted DTH response was elicited whereas infectious 
viruses produce virion components integrated into cell membranes 
and consequently generate li_ and D-region restricted DTH responses. 
The interesti ng aspect from these studies is the degree of functional 
heterogeneity of the different T cell subsets generated in response 
to viruses. Thus an immediate question raised is wheth er a K, 12,-
region restricted T cell mediating DTH activity could also have CML 
function. The most unequivocal answer to this possibility has 
been reported by Lin and Askonase (1980) in that a cloned Tc 
cell line mediating a DTH reaction is also active against 
J4 
influenza virus-infected target cells. In addition, a T cell clone 
which has lost its DTH function is also found to be unable to act 
as an effector cell in CML (Lin and Askonase 1981). These findings 
thus suggest that a single T cell can mediate two functions --
DTHand CML. 
2.J T-B Collaboration 
One of the earliest thoroughly studied examples of 
genetic restrictions was the demonstration that helper T cells 
(TH) and B cells must be compatible at the I-A . subregion for 
successful co-operation in antibody responses (Katz and Benacerraf 
1972; Katz 1976; Sprent et al. 1980). In this system the restriction 
appeared to occur at the TH cell-macrophage level as when syngeneic 
but not allogeneic, macrophages and T cells were cocultured, TH 
cells were activated. The H-2 region involved in this interaction 
was subsequently shown to be the I-A subregion. Such a macrophage-
lymphocyte interaction may be mediated by soluble factors such as 
genetically restricted factor (GRF), a complex of I-region associated 
(Ia) antigen and the exogenous antigen (Erb and Feldmann 1975 b, c) 
or through direct cell contact. In either case TH cells ap~ear to 
recognize a complex of self Ia antigens and foreign antigen, analogous 
to the H-2K and H-2D restricted behaviour of Tc cells. 
Although it is generally agreed that TH cells exhibit 
H-2 restricted recognition in their inductive phase, whether a similar 
H-2 restriction pattern exists in the delivery of help from T cells 
to B cells is still unclear. Many investigators argue that the 
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delivery of the helper signal from T cells to B cells depend upon 
cell- to- cell contact , and is H-2 restricted (Sprent 1978 ; Yamashita 
and Shevach 1978), whereas others have reported that the delivery of 
T cell help is not H- 2 restricted (McDougal and Cort ; Singer et al. 
1979) and is mediated by soluble factors. 
More recently, I-A subregion restricted T cells 
- H 
have been demonstrated to be involved both in the in vivo (Zinkernagel 
et al . 1978) and in vitro generation of anti-viral Tc cells (Pang 
et al . 1976 ; Kreeb and Zinkernagel 1980 ). In these systems, H- 2 
restriction appears to occur at the TH-macrophage interaction rather 
than in the activation of Tc cell precursors by TH cells (Ashman and 
" Mullbacher 1979) 
J . THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX (HLA) 
The human equivalent of the mouse H- 2 complex 
is the HLA system. Like the search for H-2, the search for histo-
compatibility antigens in man started as an analysis of blood group 
antigens on leucocytes. Early studies by Dausset (19.58) revealed that 
human peripheral blood leucocytes could be agglutinated by serum of 
polytransfused individuals, and this led him to define an antigen 
called MAC . Soon after its discovery, independent findings were made 
by van Rood and Payne (van Rood, Ernisse and van Leeuwen 1958, 
Payne and Rolfs 19_58) that leucocyte agglutinins were produced by 
foetal-maternal stimulation. Using such sera together with a statistical 
approach based on the 2x2 associations of serum reactions on a random 
panel of cells, van Rood (1962) defined a two allele system which he 
called group 4 . Following further development of these statistical 
methods by Bodmer, Payne and colleagues (Payne et al. 1964), an 
independent allelic system of antigens called LA (L for leucocytes 
J6 
and A for the first locus) was defined . later , more antigens associated 
with the LA and 4 groups were defined and it became clear that they 
fell into two series of alleles at two closely linked loci , the 
LA and 4 loci respectively (Curtoni, Mattiuz and Tozi 1967 ; Terasaki 
1970) . The combined system , by international agreement under a 
WHO committee , was given the name HLA meaning H for human , L for 
leucocyte and A for the first system . Subsequently, the system 
became more complex because many more constituent loci of the 
HLA were defined : the LA and 4 loci were renamed A and B respectively 
with the prefix reserved to describe the whole system . 
J . l The Genetic Ma~ of HLA 
Based on the fact that the HLA-D locus in HLA 
corresponds to the I-region of the H- 2 complex , which controls the 
in vitro mixed lymphocyte culture (MLC) , it is customarily thought 
that the H- 2K locus corresponds to the HLA- B locus , while H- 2D 
corresponds to HLA- A. The mapping of several complement (C ' ) 
controlling regions in both the H- 2 and HLA complexes has assisted 
in the assignment of these two systems . Thus the S- region of H- 2 
and C4 of HLA represent corresponding loci, each ccx:ling for the 
fourth component of complement , and should be aligned. The H- 2D 
and the I - region of the H- 2 complex would then align \·'7i th the HLA- B 
- -
and the HLA- D of the HLA , respectively (Fig . l . J) . This new analogy 
was extended recently by Bodmer (1980a) to include the parallel 
between H- 2L and HLA- C. It was also suggested that the gap between 
HLA- A and HLA- C might contain the equivalent of the Qj1 and Tl sets 
of loci (Bodemer 1981). 
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J .1 .1 The HLA- A and B Loci 
The original definition of HLA- A and B loci came from 
studies based on leukoagglutination assays using a range of antisera 
(Dausset , 1958 , van Rood , E:rnisse and van Leuwen 1958; Payne et al. 
1964 ; Curtoni , Mattinz and Tozi 1967 ; Terasaki 1970). Subsequently, 
with the development of the microcytotoxicity assay by Terasaki and 
McClelland (1964) , and employing sera both from foetal-maternal 
stimulation and those produced by pl an..ned immu..nization of human 
volunteers , all later defi nitions of the all eles of these two loci 
were made . The number of antigens and corresponding alleles of the 
HLA- A and B l oci defined in the 1980 Histocompatibility Testing ~ork-
shop were 20 and 42 respectively . 
Most of the alleles at these loci have gene 
frequencies of between 1 and 10- 15% in Caucasoid populations. These 
two loci have the highest known polymorphism of any human gene , more 
than 75% of typical Caucasoid individuals being doubly heterozygous 
at the A and B loci . The recombination frequency between the HLA- A 
and B loci was shown to be about 0 .8% by family studies ( Bodmer 
1978) . Thus the genetic region between these two loci is about 
1/ J ,OOOth of the total hu..man genome , and is likely to include at 
least several hu..ndred genes . 
Like the H- 2K and H- 2D antigens , the HLA and B 
antigens are strong transplantation antigens, directly controlling 
the rejection of skin and kidney grafts exchanged between sibs. Thus 
the graft survival time between HLA matched sibs is much longer 
than between unmatched sibs. In the case of kidney grafts , patients 
kept under suppressive- immunotherapy often have their grafts surviving 
as long as if the kidney donor was an i dentical twin (Singal , Mickey 
and Terasaki 1969) . By contrast, matching of the HLA- A and b antigens 
39 
between unrelated donors and recipients has had little e::ect 
on graft survival , although recent studies suggest HLA- DR matching 
does significantly improve survival of kidney allografts (Ting and 
Morris 1980 ; Svejgaard 1982) . 
J .1 .2 The HLA- D(R) Locus 
The HLA- D locus codes for two types of cell 
surface determinants , namely : D determinants which are involved 
in inducing T cell proliferative responses, and the D-related , 
or DR determinants that induce alloantibody production . At present, 
it is still lLnclear whether there is more than one locus in the 
HLA- D region coding for the DR antigens (Dick 1980). The :relation-
ship between D and DR antigens is lLnclear, although most current 
evidence tends to suggest that they are present on the same gene 
product (Thorsby 1979) . The 1980 International Histocompatibility 
Workshop formally defined 12 alleles for the HLA-D gene, and 10 
alleles for the HLA- DR gene . 
Due to experimental limitations, HLA has not 
-
been explored in as much detail as the mu:rine m-IC . Genetic loci 
other than HLA- A, B, Q and DR which are assigned with certainty in 
the HLA system are the gene for prope:rdine factor B (Bf)' a component 
of the alternative complement pathway (Allen 1974), and genes 
control_ing the second complement (C2) and fourth (c4) components 
(Alper 1976 ; Teisberg et al. 1976). 
J .2 Propert1es of the HLA- A7 B, C and DR Antigens 
J.2.1 Tissue Distr1bution of HLA Antigens 
HLA-A, Band C antigens are expressed in most 
tissues except on red blood cells, sperm, tronhoblasts and certain 
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tumour cell lines such as Daudi , Burkitt ' s lymphoma (Jilsson et al . 
1974; Goodfellow et al . 1975) , colon carcinoma (Lovo) (Br0ds~y et al . 
1979) , and some breast epithelial cell lines (Bodmer 1981) . 
The lack of HLA- A, Band C antigens on sperm presu_mably 
protects them from cellular attack in the female after fertilization 
(Law and Bod.mer 1978 , Bradsky et al . 1979) . The lack of HLA antigens 
on the trophoblast , on the other hand , may protect the trouhoblast 
from cellular attack so that the foetus can survive as an allograft 
(Goodfell ow et al . 1976 ; Barnstable and Bodmer 1978; Faulk and McIntyre 
1981) . Similarly , the lack of expression of HLA-A, Band C antigens on 
tumour cell lines may enable these tu_mours to escape from immune attack 
by effector T lymphocytes (Arce-Gomez et al 1978). 
Like the Ia antigens in mice , HLA- DR antigens 
show a restricted cellular distribution , being present on macrophages, 
B lymphocytes , epidermal cells and possibly sperm, but usually lacking 
f r om T cells , and not being detected on erythrocytes and platelets 
(Thorsby et al . 1977 , 1978 ; Albrechtsen and Lied 1978; Sandrin 
et al . 1979) . Under certain circumstances , however , HLA-DR determinants 
are expressed on T lymphocytes , such as Con AT blasts (Albrenchtsen 
et al . 1977a) and on suppressor T cells generated in mixed lymphocyte 
cultures (Hirschberg and Thorsby 1977). It should also be noted that, 
like murine Ia antigens , there is probably a carbohydrate-defined 
family of HLA- DR antigens that are expressed as glycolipids in serum 
and on cells (Sandrin et al . 1981) . 
J . 2 .2 Methods of Isolation 
Initial attempts to purify HLA- A antigens from 
human splenic lymphocytes were made by Sanderson and Batchelor (1968). 
Their method , however , has subsequently been shown to be impractical, 
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only ver:y small amounts of these antigens being obtained . Currently 
the preferred source of HLA antigens is from l ymphoblastoid B cell 
lines such as BR18 which expresses HLA- Al , A2 , B8 , BlJ , CN2 and DRW2 
specificities (McCune et a l 1975) . 
Similar to the solubilization of H- 2 antigens , the 
principle methods for extracting HLA anti gens are 1) the use of papain 
to cleave off the membrane proteins (Shi mada and Nathenson 1967 ; 
Parham et al . 1977 ; Terhost et al . 1977 ); or 2) the solubilization 
of membrane antigens by weakly ionic or non-ionic detergents. The 
former methodology yields HLA fragments retaining their allo-anti -
genicity whereas the latter gives intact HLA antigens (Snary et al . 
1974; Strominger et al . 1975) . 
A simple and efficient method for purifying intact 
HLA- A, B, C and DR antigens had been described by Bridgen et al . 
(1976). Briefly , the plasma membrane of BR18 cells were solubilized 
in sodium deoxycholate , and the detergent lysate fractionated by 
gel filtration . The glycoproteins from the gel filtration colu.mn 
were then selectively absorbed onto Lens culinaris lectin-Se~harose 
in sodium deoxycholate and eluted off using methyl- a-D-mannopy-Lano-
side . Possibly due to the heterogeneity of the HLA- C anti.gens , half 
of it was weakly bound to the lectin-Sepharose and di d not require 
sugar elution . Such a scheme gave about a lJOO- fold purification 
in each of their antigenic activities . 
The isolation of HLA- DR antigens is essentially 
identical to that of the murine Ia antigens in that it also i nvolves 
the immune - precipitation of lZ5I - labelled detergent-solubilized B 
cell lymphoblastoid p1asma membrane with specific allo- antisera . 
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J . 2 . J Basic Structure of the HLA- A, B, C and DR Antigens 
The HLA- A and B antigens are structurally 
similar to the H- 2K and H- 2D molecules in tnat each has a molecular 
weight of about 44 , 000 daltons , and is non- covalently associated 
with S2- microglobulin on the cell surface (Tanigaki and Pressman 
1974; Strominger et a _. 1976; Barnstable et al . 1978) . A hypothetical 
model of the HLA- A and B anti gens with regard to their arrangement 
in the cell membrane is shown i n Fi g . 1.4 (a). The 44 , 000 dalton 
heavy chain is comprised of three domains , a 1, a 2 and a J while S 2-
microglobulin constitutes the fourth domain . The heavy chain transverses 
the cell membrane once with about thirty amino acids forming a 
hydrophilic carboxyl - terminus facing the cytoplasm (Walsh and Crumpton 
1977) . This C- terminal portion bears one (may be two) - SH group(s) 
and it has been postulated t hat the opening and closing of these 
disulphide bridges under physiological conditions may provide the 
necessary signal from the outside to the inside of the cell 
( Strominger et al . 1976) . The second domain of the heavy chain 
possesses a single as:paragine- linked oligosaccharide unit of about 
J , 000 dalton molecular weight about 100 residues from its N- terminus 
(Parham et al . 1977) . Both the first and second domai ns of the heavy 
chain probably carry the all otypic determi nants (Strominger et al. 
1976 ) . 
Comparison of the N- terminal awi no acid seQuence 
of HLA- A and B antigens revealed that their J domains are highly 
homologous to each other (Bridgen et al . 1976; Terhost et al . 
1976 ) , as well as to both the 62- microglobulin and the iTill~unoglobulin 
(Ig) constant region domains . SeQuence variation in the HLA- A and B 
antigens are found predominantly i n their al and a2 domains . These 
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results suggest that the HLA a_nd the lg genes have arisen from a conunon 
~rimordial gene which then evolved in dif:erent directions to 
function as distinct recognition molecules (Bocimer 1972). 
Comparison of the known primary structures of the 
HLA- B7 (Orr et al . 1976) and H- 2Kb (Coligan et al . 1978 , 1979) 
antigens have revealed that they share several general structural 
features including their overall chain length , location of a 
carbohydrate chain at Asn-86 of their heavy chains , and the size of 
their second disulphide loops . It is evident that they also share 
homology at 70/a of their amino acid positions (Ploegh et al. 1978). 
There are , however , interesting differences between the two molecules. 
In HLA- B7 , the first disulphide loop extends from Cys -101 to Cys-164, 
while H- 2Kb has cysteines at residues 101, 121 and 164. Also, in 
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cm.trast to HLA- B7 , H- 2K has two carbohydrate side chains. The amino 
acid sequence difference in these molecules is found between residues 
65- 80 ; the remaining portions show only scattered differences . It is 
probable that these variations contribute to the extensive serological 
polymor~hism of these antigens . 
The HLA- C antigens , analogous to the H-2L molecules 
in mouse , have so far not been well characterized. They are believed 
to have a structure similar to the HLA- A and B antigens in that they 
contain S2-microglobulin non- covalently associated with 45,000 dalton 
pol~eptide (Crumpton et al . 1978) . 
Similar to the murine Ia antigens, the HLA- DR antigens 
are also made up of two pol~e~tide chains designated a(p.J4) and B 
(p .28) ; the numbers signifying their molecular weights. Both chains 
contain Asn- linked oligosaccharide units and three or four cysteines 
(Springer et al . 1977) , are tightly associated with each otner non-
covalently , s~an the lipid bilayer of the plasma membrane , and the 
chain is phosphor1lated at the carboxyl - terminus . The molecule, as 
viewed in the membrane is sho~m in Fig . 1 .4 (b) . Chemical analysis of DR 
antigens from several B- cell lines and a chronic lymphocytic leukaemia 
(Ikeman et al . 1978) revealed that the 8 chains varied markedly among 
these cell lines , thus suggesting that they are structurally polymorphic. 
The a chains , on the other hand , were identical in all the cell lines 
tested; so have limited , if any polymorphism . At present , there is 
some evidence suggesting that an invariant chain (Ii) of molecular 
weight Jl , 000 daltons (analogous to the Ii associated with the 
murine I -E/ C subregion antigens) may be associated with the DR 
antigens (Owen and Crumpton 1980) . 
J . 2 .4 Biosynthesis of the HLA- A and B Ant1gens 
The biosynthesis of the HLA- A and B antigens has been 
examined both in vitro and in vivo (Ploegh et al . 1979 ; Krangel et al. 
1979 ; Owen and Kissonerghis 1980), and it has been shown that their 
biosynthesis closely resembles that of the H- 2K and H- 2D antigens . 
Studies carried out in v1vo using the human B lymphoblastoid cell lines 
T5-l (Krangel et al .1979) and BR18 ( Owen and Kissonergb1s 1980) have 
shown that the heavy chain of the HLA- A and B antigens was first 
synthesized as a precursor molecule car..cying high mannose oligo-
saccharides in the microsomal membrane . Association of the heavy chain 
with 82- microglobulin then occurred , and this was followed by the 
conversion of the high mannos e sugar to the complex form involving 
the stepwise removal of glucose and mannose residues and the addition 
of the terminal sugars of the complex oligosaccharides (Tabas et al. 
1978 ; Kornfield et al . 1978) . The matured HLA- A and B antigens were 
then intracellularly transported from the endoplasmic reticulum of 
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the microsome and finally expressed as membrane dete::cminants. 
3 .2 .5 HLA Restriction of Hwnan T Cell Functions 
Similar to the H- 2 restriction nhenomena studied 
extensively in mice, HLA- restriction has been described for a variety 
of T cell responses in man . Thus , the proliferative response of BCG 
sensitised T cells to PPD requires that the soluble antigen be processed 
and presented by macrophages sharing HLA- DR determinants with the 
T cells (Bergholtz and Thorsby 1977) . In th1s system, anti - DR 
antisera were sho~m to inhibit the PPD induced proliferative response 
provided they recognized HLA- DR antigens shared by the macrophages 
and the T cells . No inhibition was observed when the antisera 
recognized DR antigens carried by the T cells and not the macrophages, 
while the inhibition was significantly less if the antisera only 
recognized DR determinants expressed on the macrophages but not on 
the T cells (Bergholtz and Thorsby 1977 ; Berholtz and Thorsby 1978). In 
contrast , HLA- DR restriction between T and B cells , in the absence 
of macrophages , in inducing PPD T cell proliferation has not been 
demonstrated (Bergholtz anf Thorsby 1979b) . 
The first demonstration that hwnan Tc cells exhibit 
HLA- restriction was reported by Goulemy et al . (1977) for anti - H-Y 
Tc cells . In a female patient who had received a bone marrow transplant 
f r om her HLA- identical brother , her lymphocytes were found to kill 
............... 
male target cells if they shared the HLA - A2 antigen . Subsequently , 
HLA- A2 has been implicated as the restriction antigen in the killing 
of DNP - coupled cells by DNP - specific Tc cells (Dickmeiss et al . 1977), 
Of the HLA- restricted anti - viral Tc cell responses 
reported , studies on influenza virus- specific Tc cells have been 
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the most extensive . It was found that the sharing of either HLA- A 
or HLA- B locus antigens between the effector and target cells 
was sufficient for lysis to occur (McMichael and Askonase 1978 ). This 
finding was , therefore , consistent with the murine studies where com-
patibility in the H- 2K..and/or H- 2D region(s) was sufficient for lysis 
of targets by virus - specific Tc cells (Zinkernagel and Doherty 1980) . 
Unlike the murine influenza virus specific Tc cells , however, HLA- C 
locus antigens (H- 2L like) were found to be not involved (MoMichael 
1978 , 1980 ; Shaw and Biddison .1979) . 
So far , HLA- restricted Tc cells specific for 
other viruses have not been well documented . In fact, T cells 
obtained from patients with acute infectious mononucleosis were 
found to lyse E];)stein- Barr virus (EBV) infected target cells in a 
non- HLA- rest:r:icted manner (Royston et al . 1975 ; Svedmy-~ and Jondal 
1979 ; Tursz et al . 1977) . However , if T cells from previously 
EBV infected individuals were stimulated in vitro with EBV , the 
Tc cells generated were shown to only lyse HLA- A or B antigen 
compatible autologous target cells infected with EBV (Moss et al. 
1979) . Similarly , HLA- A or B antigen compatibility was reQuired 
for peripheral blood leucocytes (PBL) taken from children with 
acute measles to lyse measles virus infected PHA stimulated 
lymphocytes (Kreth et al . 1979) . On the other hand , in studies 
where PBL from normal donors were sensitised with measles virus 
infected stimulators , the killing of virus infected targets by the 
effector T cells generated has so far been reported to be non-
HLA restricted (Ewan and Lachmar1n 1977 ; Wright and Levy 1979). 
Coll ectively these data suggest that , like the 
mouse , MHC antigens in man also play a key role in the recognition 
of foreign antigens . The apparent lack of r1HC - restriction 
in several systems in man probably represents defects in the 
eXJ)erimental systems used (e .g., lack of good surface markers for 
Tc cells , difficulties in controlling genetic differences , etc.) 
rather than a flLndamental difference in antigen recognition by 
human and murine T cells . 
3 .2 .6 HLA and Disease 
With the clear evidence in the mouse that the 
H- 2 complex controls a range of immune response (Ir) genes and 
can determine susceptibility to viral lelL~aemogenesis and other 
diseases (Klein 1978) , attempts have been made to correlate certain 
HLA antigens with disease susceptibility . At present , a number of 
studies have associated certain HLA- B locus specificities with 
disease incidence . The best known example of this analysis is the 
demonstration that HLA- B27 is associated with a rheumatological 
disorder called ankylosing spondylitis (Brewerton et al 1973 ; 
Schlosstein et al . 1973) . In addition , B27 has been reported to be 
associated with Reiter ' s disease and susceptibility to bacterial 
i nfect i ons (Svejgaard and Ryder 1976) . Certain HLA- B locus antigens 
have also been described as being associated with various immune 
hyperreactivity states . For example , certain HLA- B antigens are 
l i nked to Ragweed bay fever (Blumenthal et al . 1974) while HLA- B8 
positive individuals have been reported to have a higher incidence 
of autoimmune diseases (Ryder and Svejgaard 1976; Cudworth and 
Wooddrow 1976 ; Rubinstein 1977) . There is also some evidence that 
HLA- B8 positive patients have a better prognosis in Hodgkin' .s 
disease (Falk and Osoba 1974) , and leukaemic diseases (Rogentine 
et al . 1973 ; Oliver et al. 1977) . There are some reports of HLA 
being linked to malignancy , such as the association between HLA- BWJ5 
and Hodgkin ' s disease (Amiel 1967), but the only accepted significant 
association of a HLA antigen with a malignant disease is HLA- BW46 
with nasopharngeal carcinoma (Simons et al . 1974) where a herpes -
like virus may be implicated . 
There are a limited number of reports associating 
disease susceptibility with the HLA- A and HLA- C loci . For example, 
HLA- CW6 was reported to be associated with paranoid schizophrenia 
(Ivanyi et al . 1976) , whereas HLA- CW6 was linked with psoriasis, 
a disease with no known immu..nological basis (Histocompatibility 
Testing 1977) , The HLA- A locus has been associated with idiopathic 
haemachromatosis (Histocompatibili ty Testing 1977) and a deficiency 
i n the second component of complement (C2) has been frequently 
associated with HLA- AlO . Other HLA antigens such as DW2 , BW21 and 
BW40 , however , were also linked to this disorder (Cukrova et al. 
1977) . 
Finally , there are two disease susceptibilities 
that have been linked to the HLA- D locus , namely rheumatoid 
arthritis with the HLA- DR4 specificity (Stastny 1975) and multiple 
sclerosis with HLA- DR2 (Bodmer et al . 1977) . 
One problem with this approach is that many of 
the associations between HLA and disease have not been highly 
significant . In fact , the possibility exists that an unrelated 
gene , which is in linkage disequilibrium with a particular HLA 
gene , produces disease susceptibility (Cudworth and Wooddrow 1976; 
Rubinstein 1977) . 
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4 . THE AUTOROSETTIHG PHENOMENON 
Before embarking on the experimental chapters of 
this thesis it is appropriate , at this stage , to review the cur£ent 
knowledge of the phenomenon analysed in the thesis , namely autorosetting . 
The binding of autologous erythrocytes by murine 
lymphoid cells was first described by Mi cklem and Asfi (1971) in their 
attempts to detect B cell clones t hat carried I g receptors for self 
antigens . Subsequently , numerous reports appeared demonstrating that 
murine lymphocytes could rosette with both autologous and allogeneic 
erythrocytes (Sandilands et al . 1974; Charriere and Bach 1975 ; Br aganza 
et al . 1975; Kolb 1977) . However , different research groups detected 
markedly different proportions of autorosetting lymphocytes. Such 
differences certainly reflect the conditions of autorosetting , a point 
which will be discussed in detail later in this chapter. 
In this section , I will review our cur£ent knowledge 
of the autorosetting system . Whether binding of xenogeneic erythrocytes 
by lymphoid cells represents a similar system of recognition is unkno~m 
and , consequently will not be discussed in this review. 
4.1 Condit ions for Autorosetting 
As mentioned above , the conditions of autorose tting 
are cri t ically important and can markedly affect the proportion of 
autorosett ing cells detected . For example , estimates of the percentage 
of autorosetting cells in adult mouse thymus have ranged from O. J% 
(Micklem and Asfi 1971) to JO'/o (Kolb 1977) . 
Three different factors have been s hown to have a 
profound effect on autorosetting . First , the erythrocyte:lymphoid cell 
ratio is important . Thus using an erythrocyte : lymphoid cell ratio 
I 6 6 of 2.5:1 , about 400 10 lyrnpn node cells , and J000/10 thymocytes 
in normal 6 montn- old CBA/ H mice autorosetted (Micklem and Asfi 
1971) . Using a much higher ratio of erythrocyte to lymphocytes 
(128 :1) , a higher number of autorosetting cells was detected in 
murine thymus (2 .6%) and spleen (1%) (Charriere and Bach 1975) . 
Subsequently , erythrocyte : thymocyte and erythrocyte : spleen cell 
ratios of at least 20 :1 and 50 :1 respectively were found to be 
required for optimal autorosetting (Steele and CU11.ningham 1980) . 
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The second factor affecting the number of 
autorosettes recorded h~s been the method used to resuspend the 
lymphoi d cell - erythrocyte pell et prior to examination for auto-
rosettes . Low percentages of autorosettes were detected when the cell 
pellets are resuspended by me chanical rotation at 10-20 rom on a 
roller for 2 min at room temperature (Micklem and Asfi 1971; Charriere 
and Bach 1975; Braganza et al . 1975 ; Primi et al . 1979) . Subsequently, 
the number of autorosetting cells was found to decrease as the 
vigour of resuspension i ncreased (Kol b 1978 ; Steele and Cunningham 
1980) . For resuspending autorosettes , gentle methods such as 
using short pasteur pipetttes (Kolb 1978 ) or gentle tapping (Steele 
and Cunningham 1980 ) were recommended . 
The third variable that influence aotorosetting 
is the presence of factor(s) in serwn that strongly inhibit 
autorose t te formation (Kolb 1977 ) . Many studies have not taken 
this vari able into account . 
On the other hand , autorosetting was shown to 
be independent of metabolic activity and cytoskeleton function as 
it was not influenced by metabolic inhibitors such as sodium azide , 
and sodium cyanide or by the cytoskeleton inhibitors colchicine and 
vinblastine (Kolb 1978). Furthermore, dead cells autorosetted (Kolb 
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1977) . Autorosetting was also found to be i ndependent of the 
+t +t divalent cations Ca and Mg , could be fo:nned within the pH 
range of 5,5-7.5 (Kolb 1978) and could occur at 4- J7°C . (Kolb 1978) . 
However , the electrostatic force between lymphocytes and 
erythrocytes appears to influence autorosette fo:nnation as the 
inclusion of the polyanion heparin ( 20 units/ml) i n serum free 
medium completely abolished autorosetting , presumably by i ncreasing 
the electrostatic repulsion between cells (Kolb 1978 ). 
4 . 2 Nature of Autorosetting Cells 
There have been contradictory reports on the nature 
of the autorosetting cells . Originally, Micklem and Asfi (1971) 
suggested that autorosetting cells were immature T cells, although 
this suggestion was based simply on the observation that thymus had 
a higher incidence of autorosetting cells than lymph node . In sub-
se~uent studies Charriere and Bach (1974 , 1975) obtained additional 
evidence supporting the claim that autorosetting cells were i mmature 
T cells . They found that autorosetting cells were blocked by anti-
Thy- 1 .2 sera , adhered to nylon wool columns, had a low density , and 
were sensitive to steroids , all characteristics of immature T cells. 
Furthe:nnore , higher levels of autorosetting cells were reported 
in thymectomised mice which could be corrected to normal values 
by administration of thymic ho:nnones , treatments that presumably 
influenced T cell differentiation . In addition, recent moriihological 
studies have shown rosetting cells to be large with clear and well 
developed euchromatin , abundant cytoplasm with many free ribosomes 
and mitochondria which were characteristics of immature T rather 
than mature T cells (Charriere and Bach 1979). These autorosetting 
T cells also have been shown to proliferate when cultured with 
Con A (Fournier and Charriere 1978) . 
A major criticism of the studies described above 
is that autorosetting conditions ~ere em~loyed that were far from 
optimal , usually 2% of spleen , thymus and lymph node being shown 
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to autorosette . Using more superior autorosetting conditions Kolb (1977) 
demonstrated that murine thymus and spleen contained a similar 
proportion of autorosetting cells , i.e. , ap~roxirnBtely JO% of the 
cells autorosetted . In addition , cells from the spleen of athymic 
nude mice autorosetted , thus suggesting for the first time that B 
lymphocytes could also autorosette. SubseQuent immunofluorescence 
studies by Primi et al . (1979) demonstrated that 70- 80% of autorosetting 
+ 
cells in mouse spleen were Ig . 
The simplest explanation of these contradictory 
findings is that immature T lymphocytes autorosette more avidly than 
mature T lymphocytes and B lymphocytes , hence their preferential 
detection when autorosetting conditions are suboptimal. The 
experimental data presented in this thesis is completely consistent 
with this explanation. 
4 .J Ontogeny of Autorosetting Cells 
Murine autorosetting cells have been detected in 
the yolk sac as early as 10- 11 days of gestation , and their number 
could be reduced by exogenous thymic factor (Charriere and Pyke 1980). 
As the embryo developed , autorosetting cells were detected at 14-days 
of gestation in the foetal liver , then in the same numbers in the 
15- 16 day old foetal thymus , and in the 17-18 day old foetal spleen 
(Steele and CUILDingham 1980) . Foetal thymus autorosettes reached adult 
levels at 17-18 days of gestation , and spleen autorosettes at 2 weeks 
after birth (Steele and Cunningham 1980) . 
4.4 Autorosetting 1n Different Snec1es 
There are a limited numbers of studies demonstrating 
autorosetting lymphoid cells in species other than the mouse . For 
example , it has been shown that rabbit snleen has the same number 
of autorosetting cells as the mouse spleen (Kolb 1977), Surprisingly, 
no autorosetting cells were found in the spleen of rats (Kolb 1977). 
On the other band , human thymus contains from 40- 75% of autorosetting 
cells (Baxley et al . 1973) . 
A thorough study into the autorosetting ability of the 
peripheral blood leucocytes (PBL) of a variety of species revealed 
that the cells from hamster , guinea pig , rabbit , rat, mouse and 
dog lacked autorosetting ability . However , about 7% and 2CY/o of 
autorosetting cells were found in human and sheep PBL respectively 
(Braganza et al. 1975) . This study was marred, however , by suboptimal 
autorosetting conditions being used . 
4.5 Serum Inhibition of Autorosetting 
Several studies have demonstrated that autorosette 
formation can be blocked by seru.m (Micklem and Asfi 1971; Charri~re 
and Bach 1974 , 1975) . By employing seru.m free Hank ' s balanced salt 
solution (HBSS) for autorosetting , Kolb (1977) was able to detect at 
least twice the number of autorosetting cells in murine thymus and 
spleen compared to that obtained by other workers . Similarly, the 
number of autorosetting cells detected in nu.man PBL could be 
increased 4-9 fold when FCS was replaced by BSA in the rosetting illediu.m 
(Braganza et al . 1975) . Serum inhibitory material was preliminary 
characterised by Kolb (1977) in that it was non- dialysable , ~as not 
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precipitated by 18% sodium sulphate suggesting that it was not an 
immunoglobulin , and was found to fractionate with serum a - globulins. 
Recently , the inhibitory material in mouse serum (tenned "auto-
rosette innibition factor" or AIF) was demonstrated to be associated 
with serum high density lipoproteins (Hsu et al . 1980 ) . 
4 .6 Nature of the Autorosetting Receptor and Acceptor 
Little is known about the membrane structures 
mediating autorosetting . There is some controversy, however , as 
to whether the autorosetting receptors on murine lymphoid cells are 
associated with immlLnoglobulin (Ig) . Among the evidence in support 
of the receptor being Igor lg- associated is the report that lymph 
node cell autorosettes can be inhibited by pretreating the lymph ncde 
cells with anti - Ig sera (Micklem and Asfi 1971) . In addition, the 
autorosetting ability of adult and new- born spleen cells was 
abolished by anti-Ig capping using a sheep anti - mouse Ig serum 
(Steele and Cunningham 1980) . Autorosettes in thymus, however , 
were not affected by anti - Ig capping treatment (Steele and Cunningham 
1980). In direct contradiction to these findings , anti -Ig capped 
spleen cells were shown to autorosette , even though the majority 
of autorosetting spleen cells were demonstrated to be Ig+ by 
immunofluorescence (Primi et al . 1979) . It seems likely , however , 
that autorosetting receptors are not lg- associated and the earlier 
contradictory results are due to the use of anti-Ig reagents 
containing autorosette inhibitory factor . When immunoabsorbent 
purified anti - Ig was used (Primi et al. 1979, chapter J) the 
autorosetting receptors were clearly shown not to be Ig. 
There has been only one preliminary attempt to 
characterize the membrane structures involved in autorosetting , 
namely the effect of different enzymic treatments on the auto-
rosetting behaviour of thymocytes and erythrocytes (Kolb 1978) . 
The autorosetting ability of thymocytes or spleen cells was abolished 
by trypsin , while erythrocytes were found to lose their autorosetting 
ability when treated with tDJPSin , papain or bromelin . Treatment 
of erythrocytes or lymphocytes with neuraminidase was found to 
increase the proportion of lymphocytes autorosetting . This effect 
was probably due to the reduction of electrostatic repulsion between 
cells when sialic acid residues where removed (Kolb 1978) . From 
these studies it was concluded that autorosetting represented a 
protein- protein interaction between lymphocytes and erythrocytes . 
4 . 7 Role of Ma. · or Histocompa ti bili t, Comnlex MHC in Autorosettin 
The role of the murine H- 2 complex in autorosetting 
has been recently investigated by two research grou~s. By rosetting 
BDFl spleen cells , after 24 hrs culture , with erythrocytes from 
di fferent congenic and recombinant strains of mice , Primi et a_ . 
(1979) found that lymphocytes and erythrocytes differing in the H-2 
complex failed to autorosette . By examining intra- H- 2 recombinant 
strains of mice , it was found that compatibility at the D region 
was required for autorosetting . There was also a suggestion from 
the behaviour of some recombinants that autorosetting was controlled 
by a separate locus (H- 2R) mapping just to the left of the D region. 
Charriere et al . (1980) employed two annroaches 
to determine the role of the H- 2 comnlex in autorosetting . First, 
- -
like Primi et al. (1979) , they observed that lymphocytes preferential_y 
bound H- 2 compatible erythrocytes . The second a~proach was to 
- -
measure Lhe ability of H- 2 compatible or incompatible erJthrocyte 
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ghosts to inhibit autorosetting , a study wh1ch revealed that 
~- 2 compatible ghosts were the most efficient innibitors . :5urther-
more , based on their results from one H-2 recombinant mouse strain 
they concluded , u..nlike Pri_ i et al . (1979) , that both Kand D 
regions of the H- 2 complex were involved in autorosetting . 
It should be noted that studies reported in 
tnis thesis , that were carried out at the same time as those 
described above , demonstrated H- 2 involvement in autorosetting 
and directly mapped the gene(s) involved to the H- 2L region 
(see chapter J) . 
Thus , tnree independent studies have clearly 
demonstrated that the autorosetting receptors on lymphocytes 
preferentially recognize H- 2 compatible structures on er1throcytes. 
Th O d O I l t h 
O h O r, .J..h ere is some isagreemen-c, , nowever , as o w __ ic _ regions or L, __ e 
H- 2 complex are involved , a uoint which will be discussed in more 
- -
detail in chBpter J and 7 of this thesis . 
4 .8 Fur1ctional S1gnificance of Autorosetting Receptors 
The functional significance of the autorosetting 
receptors on lymphoid cells is uriJ<:nown . There are only two reports 
that nave attempted to cor£elate autorosetting cells with immune 
function . The first -rTas by Cari aud e.1.. al . (1977) , who observed 
that spleen cells from adult tnymectomised mice induced a..n 
enlargement of the draining yopliteal _ymph node following inocu-
lation into t_e hind :ootpad of synge eic recipients (termed 
"syngeneic graft versus : ost reaction 11 ). riowever, -rThen the eel_ 
inoculu.m was ep_eted of autorosetting ce_ls on a J~col_/Hypaque 
r ~;:i • ' +1n_ere i,i;::>S • • ..,. • d ' · · .Lhe s- nP-ene1 c G '! H g a...i.::.en- .., ,,....., a sign_= ic2 . rn:, re uc- _on _:1. l.,1_ --o _ _ 1 
reac.1..~on , a result sugges.L~~..g .Lhat autorose.L.Ling _ynp~_ocytes could 
mediate this response . 
In the second study by Tomari et al . (1980), it 
was shown tnat tnose T lymphocytes that responded in an autologous 
mixed lymphocyte reaction (MLR) were present in the autorosetting 
subpopulation of T cells . Furthe:rmore , when the T cells that 
responded in a primary autologous MLR were restimulated it ~as 
found that compatibility of the whole HLA com3?lex was required 
to generate the secondary response . These findings, however, do 
not prove that the autorosetting receptors actually initiate 
syngeneic G /Hor autologous MLR . Furthe:rmore , the functional 
significance of tne syngeneic GI H reaction and autologous ML] 
is unknown . 
At a more speculative level it has been proposed 
that the autorosetting cells may mediate autoimmunity in thymus 
deficient states (CharLiere and Bach 1974) . The supportive evidences 
for this proposal inc_ude : (i) tne observation that the percentage 
of autorosetting cells in the spleen was increased from 6 days and 
attained a 20- 30 fold increase 3 montns fol_owing adult thymectomy 
and (ii) increased le1els of autorosetti:g cells ~ere fou_nd ~n 
adul+ 6 T·fePk-- ol_d n __ ude · 11 - -1- , d 1TZB · aY"ld 15 mon' h v 1 ~ _ice , .-monvn o_ _ mice .u ___ 1:,_ -
old mice which showed thymic atro3?hy as we_l as spontaneous auto-
antibody formation . Fur+her.nore , Lhese aonormally high autorosetting 
_evels could be retur1ed to :orma_ by tne injection of ?u.rified 
thymic hormone bou_nd to carboxy- _ethyl ce __ ulose to increase its 
half life . ~owever , as ~en-1-ioned earl~er , in their studies Char~ere 
d 3 , 1 - -1- ' - ,-. ' · ( 1rat) -=- L'ne au-1-oroset-1-.! no-an ac_ on y e ec1:,eu a sma__ = rac1:,ion v;o o_ t.,__ L, t., ___ o 
ce_ls -ue to subo~ti al autoroset-1-ing cond~tions . ~his akes tneir 
n • d . , . ~n· ul I I • I I rin _ngs ui==ic' 1:, 1:,0 in1:,eryre- . 
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2 .1 Ax1imals 
Table 2 .1 lists the mouse strains used in this study together Nith 
the haplotype origin of their H- 2 regions. The ~ice and ~ewis rats were bred 
at the John Curtin School o~ ed~cal Research , the majority under specific 
pathogen free conditions . Fl hybrid mice were obtained from six different 
matings over a 4 month period . Mice were used as donors of en1throcytes and/ 
or thymocytes from 8- 20 weeks of age . 
Congenitally athymic BALB/c nude (nu/nu) mice were obtained from 
the John Curtin School of_ edical Research . ~ude mice used for experiments 
were always supplied with antibiotics (Kanamycin sulfate and tetracycline 
hydrochloride bought from Bristol - yers Co . , . S . W) in their drin.."k.ing tTa ter. 
The beige mutant mice C57BL/6J bgJ/bgJ (bg/bg) and their heterozygous (bg/+) 
littermates were a gift from Dr . G. R. Shellam , University of Western 
Australia . 
Chimeras were produced as described ~n detail elsewhere (Sprent et a_ 
1975) . The mice were irradiated with a supra- lethal dose of 900 - 1000 Rads 
from a cobalt source , and on the same day or 24 hours later were recon-
stituted w~th 1 .5 - 2.5 x 107 foetal (14- 16 days) liver cells injected intra-
venously (i .v . ) . All chimeras were analysed individually 6- 12 Neeks later 
and were shown via complement mediated lysis with anti - H-2 sera, to be 
9CP/o repopulated Nith donor lym~hocytes . 
2 .2 Sera and Antisera 
Blood of mice , rats , Guinea Pigs and African C_awed Toad was 
collected by cardiac _uncture . Blood :rom geese and chickens Nere ootained 
by bleeding their wing veins . ?er~phera 8_ooci of humans and sheeu Nas 
collected by venous pu_ncture . 3lood samp_es Nere al_owed to cl tat room 
temperature for JO min at 10 c. Sera were stored at - 20°C unti_ use . The serum of 
ittle Brown 3at was =-<~ndly donated by :_r . ~ ~·d- z t:rj Je~_uart~ent, • .:.c. _ =- eman, oo_ o~ 
As ra_ian ~ational -nivers~ty. 
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Table 2 .1 
HaplotY.9e Origin of H- 2 Regions Carried 
by Mouse Strains sed in this Study 
Strain Haplotype Region a) 
K I s L/D 
A B J E C 
C57BL/ 6 , C57BL/ 10 b b b b b b b b b 
BALE/ c , DBA/ 2 d d d d d d d d d 
Bl0 .D2 (M504) dml d d d d d d d 
db) 
BlO . A (2R) h2 k k k k k d d b 
BlO . A (4R) h4 k k b b b b b b 
BlO . A (JR) iJ b b b b k d d d 
CBA/H , BlO . BR k k k k k k k k k 
DBA/1 , BlO .G q q q q q q q q q 
SJ L/ J , A. SW s s s s s s s s s 
A.TH t2 s s s s s s s d 
BlO . AQ,R yl q k k k k d d d 
Bl0 .T(6R) y2 q q q q q q q q 
a) Haplotype origin of regions according to Klein et al . (1978) 
' b) The dml mutant carries modified H- 21 and H- 2D (Demant and 
' Neauport - Sautes 1978) . 
6J 
Anti - H- 2Ld serum which was raised in (BALB/c - H- 2dm2 x A.SW)Fl mice 
against BALB/c lymphoid cells (AS 207) was a gift from Dr . I . ~ . C. McKenzie. 
Monoclonal anti - H- 2 . 25 antibody (H100- 27 .R9) was provided by G. Hammerling. 
By microcytotoxicity the anti -H- 2Ld serum had a titire of between 1/16- 1/32 
on BALB/ c spleen cells whereas the anti - H- 2 . 25 antibody gave a titre of 
1/20 ,000 on CBA/H spleen cells . 
Monoclonal anti- T~y 1 .2 IgM antibody (F7D5) was kindly supplied by 
Dr . P . Lake . The antibody had a microcytotoxicity titre on CBA/H spleen cells 
of 1/ 5000 . 
2 .J Sugars 
The sugars used in the inhibi tion studies and the suppliers are listed 
in Tabl e 2 . 2 . These sugars we r e usual l y di ssolved in phosphate - buffered 
saline (PBS ) at a concentrati on of 20 mg/ ml . The pH of N- acetylneuraminic 
acid , D- glucosamine , D- glucuroni c a cid , D- galactosamine , D- mannosamine and 
D- gala cturonic aci d was adjusted t o 7 . 2 wi th O. l N NaOH bef ore use . 
2.4 Enzyme s and Periodate 
Papain , a - galactosidase (Green Coffee Bean ) , s-galactosidase (E . coli , 
grade 111 ) , and a - mannosidase (Jack Bean , T-ype 111) were purchased from Sigma 
Chemical Co ., St Loui s , Mo . , U.S .A . Neuramini dase (Vi bro cholera , B grade) , 
pr onase and Bromelin were supplied by Calbiochem , San Diego , U.S .A. Trypsin-
TPCK was purchased from Worthi ngton Bi ochem . Corp . , New Jersey , U.S .A. 
Sodi um metaperiodate was suppli ed by BDH , Poole , England. 
2.5 Anti - macronhage Agents 
Carrageenan Type 1 f r om I r i sh Moss was purchased from Sigma Chemical 
Co., St Louis , Mo . , U.S . A. Si lica particles of average size distribution 
5µ were obtained from Whi ttaker , Cl ark & Daniels Inc ., New Jersey . Carrageenan 
was dissolved in physiological saline (10 mg/ml) before 0 . 2 ml (i . e . 2 mg) 
being injected intravenously (i .v . ) into each mouse . To make up varying dilutions 
Table 2 . 2 
Sugars Used for Inhibition Stu d i e s 
Monosaccharides : 
a) 
D- glucose 
N- acetyl - D- glucosamine 
b) 
D- glucosamine 
D- glucuronic acid 
b) 
D- galactose 
b) 
N- acetyl-D - galactosamine 
D- galactosamine 
D- galacturonic acid 
C) 
D- mannose 
b) 
Glycosides: 
me thyl - a - D- glucopyranoside 
b) 
me t hyl - a - D- g a lactopyranoside 
methy l- S - D- galactopyranoside 
methyl - a - D- mannopyranoside 
Oligosaccharides : 
b) 
me libiose 
b) 
raf f inose 
s tachyos e 
d) 
lactose 
b) 
L - mannose 
N- acetyl-D - mannosamine 
D- mannosamine 
D- mannitol 
L- fucose 
b) 
D- fucose 
L - rhamnose 
c) 
D- ribose 
N- acetylneuraminic acid 
b) 
maltose 
mannan 
cellobiose 
d) 
sucrose 
b) 
a) Ajax Chemicals Ltd ., Sydney, Australia 
b) Calbiochem , San Die g o, California, U.S.A. 
c) Fluka AG , Buchs, Switzerland 
d) BDH, London, England 
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Remaining sugars suppied by Sigma Chemical Co., St. Louis, 
Mo . , U.S.A. 
of carrageenan , the lOmg/ml stock solution was serially diluted in hot 
physiological saline . Silica was suspended in phys iological saline (10 mg/ ml), 
sonicated for JO sec using a Branson (Danburg , Conn . ) probe - type sonicator 
(Sonifier Bl2 model) and immediately 0 . 2 ml (i . e . 2 mg) injected into each 
mouse . 
2 .6 Cell Ponulations 
2 .6 . l Preparation of Cell Susuensions 
Thymocyte , lymph node and spleen cell suspensions were prepared 
by gently pressing thymus , lymph node or spleen fragments through wire sieves 
into cold Hank ' s balanced salt solution (HBSS) containing 0.5% (v/v) foetal 
calf serum (FCS) . Peritoneal cells were harvested by lavage of the mouse 
peritoneal cavity with 5 ml of Fl5 medium lacking FCS . For the collection of 
bone marrow cells , both ends of the femur bones were cut, and the marrows 
' blown- out ' with Fl5 medium lacking FCS using a hypodermic syringes with a 
18g needle . All cell suspensions were gently pelleted , cell clumps removed 
by low speed centrifugation (100g , JO sec) , and the dispersed cells washed 
twice with cold mediu_m . The thymocytes and spleen cells were then counted 
and cell viability assessed by trypan blue exclusion. Cells were then 
L 
diluted to a concentration of 2 x 10°/ml in medium . 
Blood was collected in Alsever ' s solution. Erytnrocytes were 
wasned three times with saline for J ~-n at 2000 mm and 22°c and di_uted 
to 0.5% or 1% in HBSS containing 0.5% res . 
2 .6 .2 Separation of Lymnhocyte Populations 
Cells bear~ng surface Ig were removed from lymphoid eel_ 
susuensions by forming Ig roset.Les and separating .Lhe rosetting and non -
rosetting cells by centri~ugation on Iso:paque/Ficol_ (?ar~sh et a_ 197L). 
Briefly, sheep red cel_s (SRBC) were coated , via cre13, with sheep anti - IG sdecific 
for ouse Ig and Nere m~xed ·,nth lymphoid cell suspensions. mhe ~ixture of 
SR-oc d 1 11 1 ' d , .L · ,.., ' · ' h 1 ' rPsus ended ~ an sp een ce s Nas pe __ e~e 8Y cen~n..:uga-_on , ~-e pe __ e~ -
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in its supernatant and the rosette - forming cells then sedimented on IsopaQue/ 
+ Ficoll - medium interface . To separate lg- , Thy- 1 . 2 spleen cells , the 
splenocytes were first incubated with monoclonal anti -Thy- 1 .2 antibody 
8 (JO µ1/ 10 lymphocytes) . Cells carrying the Thy- 1 . 2 antigen thus became 
coated with mouse antibody and therefore both Thy- 1 . 2+ and Ig+ cells now 
rosetted for surface Ig . Using this procedure 92% of BlO . BR spleen cells 
rosetted and the rosettes were depleted in the usual manner on IsopaQue/ 
Ficoll (Parish et al 1974) . In some cases , spleen cells were depleted of Thy-1+ 
cells by being treated with monoclonal anti - Thy-1 . 2 antibody and guinea 
pig complement (McKenzie and Parish 1976) and the resulting dead cells 
removed by IsopaQue/Ficoll centrifugation (Davidson and Parish 1975) . 
2 . 6 . 3 Blocking and Capping Surface I mmunoglobulin (Ig) on Spleen Cells 
Spleen cells were made to a concentration of 107 cells/ml in 
ice- cold balanced salt solution containing 0.5% FCS . Immunoabsorbent 
I 
purified sheep (Fab ) 2 specific for mouse Ig was added to a concentration of 
50 µg/ml and the mixture incubated for 75 min at either 4°c for blocking , 
or 37°c for capping . Previous studies have demonstrated this procedure to 
completely block and clear surface Ig from mouse spleen cells (Parish and 
McKenzie 1980) . Following incubation t he cell suspensions were washed twice 
with ice- cold medium and used for autorosetting (see section 2 .10 .1). 
2 . 7 Preparation of Subcellular Fracti ons of Cells 
2 . 7 .1 Preparation of Erythrocyte Sonicates 
Blood was collected from mice or Lewis Rat in Alsever's solution 
and washed four times in normal saline . Packed or 5CY/o suspension of 
erythrocytes in medium were then disrupted by sonication for 10 sec at 
JO watts using a Branson (Danburg , Conn.) probe- type sonicator (Sonifier 
B 12 model) . The red cell suspensions were completely transparent after 
this treatment . Sonicates ~ere usually prepared on the day of use 
or stored for no longer than 24 hr . at 4°c . 
2 . 7 . 2 Preparation of Detergent Lysates of Lymphocytes and 
Erythrocytes 
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Spleen and bone marrow cell suspensions were first 
sedimented on Isopaque- ?icoll to remove erythrocytes (Davidson and 
Parish 1975) . Thymocyte and lymph node cell suspensions were not 
treated in this manner if they were freed of red cells . The lymphoid 
cells were then washed twice in cold PBS and used for lysate 
preparations . 
To 1 x 108 lymphoid cells suspended in 0.5 ml of cold 
PBS containing 10- J M phenylmethylsulphonylfluoride (?MSF) was added 
0.5 ml of a 1% (v/v) Nonidet P- 40 ( NP - 40) solution. The mixture 
was i ncubated for JO mi n on ice witn occasional shaking . The cell 
nuclei were then pelleted at 4000 g for 5 min at 4°c and the 
supernatant SDlLn at 28 , 000 g for _5 min at 0 c to remove any remaining 
membrane fragments . The lysate was deuleted of NP - 40 by adding an 
equal volume of acked XAD- 8 resin beads (Rohm and Hass Co ., 
Philade _phia , Pa) and agitating the _ysate-resin mixtu~e for 2 hr at 
0
c (Parish et al _980) . mhe detergent -depleted lysate Mas then used 
for haemaggl ·:nating assays . 
In the case of erythrocyte _ysaLes , b_ood Mas col_ecLed 
~rom . ice and other ani. a_s in Alsever ' s so _ut:on and the red cells 
washed four ti .es in cold PBS oefore use . 200 µl of ]ac~ed erJthrocytes 
Mere _ysed ~ ~ d • ' ' d ·.r 1 ~ m_ o_ co_ is~ ___ e ~a~er _or_ ~:non ice . ~ne 
erythrocyte g .os's trere ~el_eted by spinning Lhe. ixtu~e at 2 , 00 
C. The uel_et Mas Lhen resusuendea ~~ 50 J of 
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cold PBS containing 10- J M PMSF , 500 µl of 1% NP -40 added and lysis 
allowed for JO min on ice . The lysate was then spun at 28 ,000 g 
for JO min at 4°c , the supernatant treated with XAD- 8 and used 
for the inhibition of haemagglutination . 
2 . 7.J Preparation of Cytoplasmic and Microsomal Fract1ons 
of Thymocytes 
Thymocytes were susnended at a concentration of 1 x 108 
cells/ml in PBS containing 10- J M PMSF and subjected to sonication, 
in an ice bath , at JO watts for 5 min using a Branson (Danbury, Conn.) 
probe- type sonicator . Cell debris was pelleted by centrifugation 
at 4000 g for 60 min to give a microsomal pellet and freely soluble 
/ 
cytoplasmic components . The microsomal pellet was then solubilised 
in 0.5% NP -40 as described above (108 cell equivalents/ ml) . 
2 .8 Enzymic and Chemi cal Treatments of Cells 
2.8 .1 Enzymic Treatment of Thymocytes and Erythrocytes 
In all treatments thymocytes were used at 8 x 106 cells/ml 
and erythrocytes as a 1% (v/v) solution . Thymocytes or erythrocytes 
in HBSS were incubated separately with 0 .2 mg/ml of pronase (pH 7,5) , 
1 mg/ml of trypsin (pH 8 .0) or lmg/ml of bromelin (pH 7.5) . The 
HESS was adjusted to the appropriate pH with lN NaOH prior to use . 
11 · bat d ·'ht · b 1 · ~ JO mi' n at J7°c Ce_ s were incu e wi~ :r.f1)Sln or rome in or 
whereas , in order to minimize cell lysis, pronase digestion was 
limited to 10 min at J7°c . For papain treatment, cells were incubated 
at J7°c for JO min with 0 .4 mg/ml of enzyme in P3S containing 1.2% 
(w/v) 1- cysteine and 0 .186% (w/v) EDTA . 
Thymocytes and erythrocytes were incubated for JO min at 
J7°c with the following concentrations of glycosidases: S- galactosidase-
20 units/ml , a - mannosidase - 2 units/ml , neuraminidase - 10 units/ml , 
a - galactosidase - 0 ,5 units/ml and 0 . 6 mg/ ml of mi xed glycosidases 
supplemented with 10 units/ml of neuraminidase . All glycosidase 
treatments were performed in HBSS , except for the mixed glycosidases 
incubation where a 1 : 1 (v/v) mixture of PBS and calcium- magnesium 
saline was used . 
With all treatments a control was included where cells 
were incubated under identical conditions but in the absence of the 
enzyme or chemical . Controls for the a - galactosidase , S- galactosidase 
and a - mannosidase treatments also included the equivalent amount 
of ammonium sulphate added with the enzyme . 
2 .8 .2 Periodate Treatment of Lym~hocytes and Erythrocytes 
For periodate treatment , 1 x 108 lymphoid cells in 
1.0 ml of cold PBS were mixed with 4 . 0 ml of cold PBS containing 
21 . 4 mg of sodium metaperiodate (BDH, Poole , England) . The mixture 
was left on ice for JO min after which it was washed J times with 
cold PBS . Cell lysates were then prepared as described above . 
2 .8 . J Glutaraldehyde Fixation of Mouse Erythrocytes 
A stock solution of glutaraldehyde (70%) was diluted 
1:1 with distilled water , and then to a final concentration of 0,05% 
(v/v) with PBS . Equal volumes of 0.05% glutaraldehyde solution was 
then mixed with a 5% (v/v) erythrocyte suspension in PBS , and the 
mixture left for 10 min at room temperature. The erythrocytes were 
washed four times with PBS and then twice with PBS containing 0 .1% 
BSA prior to being used for the absorption of thymocyte lysates. 
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2 .9 Lactoneroxidase - Catalysed Iodination of Cells 
The method was essentially similar to that described 
by Cone and Marchalonis (1974) . A suspension of thymocytes was 
prepared , the cells were washed twice in serum- free PBS and then 
resuspended to a concentration of 2 x 108 cells/ml. For iodination, 
to 5 x 10 7 cells in 250 µ 1 of PBS containing 80 µg of lacto-
peroxidase , was added carrier- free 1251 (500 µCi) , immediately 
followed by JO µl of 12 µg/ml H2o2 in PBS . The mixture was incubated 
on ice for 1 min , another JO µl of 12 µg/ml H2o2 in PBS added, and the 
mixture further incubated on ice for 1 min. The reaction was then 
stopped by the addition of 20 volumes of ice - cold PBS . The cells were 
sedimented by centrifugation at 4°c , washed twice with ice - cold PBS, 
and finally resuspended in 250 µl of cold PBS. The preparation of 
lysate from these 1251 - labelled thymocytes was identical to that 
des cribed previously for non- labelled thymocytes . 
For the iodination of erythrocytes 20 µ1 of packed 
erythrocytes previously washed four times in serum-free PBS were 
resuspended in 180 µl of cold PBS containing 160 µg of lacto-
peroxidase , and iodination then carried out as described for thymocytes. 
Lysis of 1251- labelled erythrocytes was the same as for unlabelled 
erythrocytes except that preparation of erythrocyte ghosts was 
omitted . 
. ? . 10 Rosetting Assays 
2 . 10 .1 Standard Rosetting Assay and Important Assay Variables 
The standard autologous, allogeneic and xenogeneic 
rosetting assay was carried out in the following manner in 96 well 
U- bottomed microlitre plates (Linbro Chemical Co. , New Haven, Conn.). 
71 
6 
To 25 µl of each murine lymphoid cell suspension (2 x 10 /ml) was 
added 25 µ1 of different concentrations of a~~ropriate red cell . 
The red cell - lym~hoid cell mixture was then pelleted by centrifugation 
at 200 g for 1 min at 4°c . The cell pellets were incubated on ice 
for J0- 60 min before being very gently resuspended with a short 
pasteur pipette . Methyl violet staining solution (100 ~1) (Parish 
and McKenzie 1978) was then added to the wells , each sample 
transferred to a haemocytometer chamber and the percentage of 
rosette forming cells assessed . Usually a minimQm of 100- 200 
thymocytes were scanned for rosettes and when the rosette frequency 
was < l0% up to 500 thymocytes were examined . Any thymocyte which 
bound four or more erythrocytes was classified as a rosette. 
At this point , several important assay variables 
should be discussed . First , the erythrocyte concentration (erythrocyte: 
lymphocyte ratio) markedly affected autorosetting efficiency . It was 
found that the highest percentage of thymocyte autorosette3 was 
obtained when an erythrocyte concentration equal to or greater than 
0.5% was used , whereas a red cell concentration greater than 0 . 5-1% 
was required for optimal spleen autorosetting (Table 2 . J) 
The second vari able which influenced autorosetting 
efficiency was temperature and ~H . By performing autorosetting at 
room temperature (using 0.5% erythrocytes) , it was found that the 
percentage of BALB/c (H- 2d) thymocyte autorosettes detected was 
usually lower than if the assay was carried out at L}°C (25% vs 44%), 
On the other nand , medium in the pH range 6 .8- 7 . 2 was found to be 
required for the formation of the optimal number of autorosettes 
(Table 2 .4) . 
Table 2 . J 
Effect of Erythrocyte Concentration on the Detection of BALB/c (H- 2d) 
Autorosettes 
Erythrocyte 
Cone . (%) 
0 .1 
0 . 2 
O. J 
0 .4 
0 .5 
1. 0 
2 .0 
Erythrocyte 
Lymphocyte Ratio 
5 : 1 
10 :1 
15:1 
20 :1 
25 :1 
50:1 
100 : 1 
2 
8 
24 
37 
44 
45 
44 
% Autorosettes 
Thymus Spleen 
a) 
± O. 7 2 ± 0 .5 
± 1 . 9 2 ± o .6 
± J . l 4 + 1 .5 
+ J ,-, 
- . :) 8 + 1 . 7 
± 2 . 7 12 + 2 . 2 
± J .4 14 + 2 . 4 
± 2 . 9 14 ± J .1 
a ) Resul ts ex~ressed a s % r osetting lymphoid cells+ standa:rd error 
of mean of three detenninations . 
Tabl e 2 .4 
Ef fect of uH of HBSS on the Autorosetting of BALB/c Thymocytes 
pH of HBSS b) % Thymocyte Autorosettes 
6.o 7 ± 2 .1 
a) 
6 . 4 25 ± 2 .8 
6 .8 4J ± J . 1 
7 . 0 42 ± 4 . 0 
7 . 2 44 ± 2 . 9 
7.5 J4 ± J . 6 
8 . o 12 ± J .4 
a ) Footnote as in Table 2 . J 
b) pH of H:BSS was adjusted by adding either lN NaOH or ll HCl. 
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The third factor affecting autorosetting efficiency 
was the i ncubation time on ice before autorosettes were resuspended 
(described bel ow) for examination . By performing BALB/c (H-2d) 
thymocyte autorosetting using an erythrocyte : lymphocyte ratio of 
25 : 1 , it was fou..nd that an i ncubati on time of at least 25 min was 
required for detecting the optimal number of autorosettes ( Table 2.5) . 
Table 2.5 
Effect of Incubati on Time on the Detection of BALB/c Thymocyte 
Autorosettes 
Incubation Time % Autorosettes 
(min ) 
1 0 
5 1 + 0.5 a) 
10 7 ± 1 . 2 
15 19 ± J . 1 
20 J7 ± J . 4 
25 44 ± J . 2 
JO 4J ± J . 0 
60 44 ± 2 .8 
a ) Footnote as in Table 2 . J 
The fourth factor which was critical in determining 
the percentage of autorosettes detected was found to be the 
method employed to resuspend the rosettes . When resuspension was by 
gentle vortexing for 10 sec at room temperature , low percentages 
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of autorosettes was always obtained , i . e ., 7% vs 4J% for BALB/c 
(H- 2d) thymocyte autorosetting using an erythrocyte/lym~hocyte 
ratio of 25 : 1 . Subsequently , autorosettes were resuspended by using 
a short pasteur pipette . By gently pipetting the mixture up 
and down 8 times , the erythrocyte/lymphocyte mixture was usually 
homogeneously dispersed , and reproducible numbers of autorosettes 
were detected , these numbers being higher than reported by other 
groups who resuspended rosettes with a roller . 
As autorosetting was always reported in the 
literature to have been carried out using HBSS or PBS as medium, 
it was , therefore, important to dete:rmine whether medium had an 
effect on autorosetting efficiency . By using BALB/c (H-2d) 
thymocyte autorosetting (erythrocyte/lymphocyte ratio of 25:1), 
it was found that optimal percentages of autorosettes were 
obtained in HBSS , PBS or physiological saline (0.9%) containing 
0.5% FCS (Table 2.6). In contrast, low percentages of autorosettes 
were detected when Eagle ' s Minimal Essential Medium (F15) or RPMI-1640 
were used. The reason for autorosetting being suboptimal in Fl5 or 
RPMl - 1640 is unknown , although these media represent complex 
mixtures of amino-acids, vitamins and cofactors, some of which 
presumably inhibit autorosetting . 
Table 2 . 6 
Effect of Medium on the autorosettin of BALB c 
Medium % Thymocyte Autorosettes 
HBSS 44 ± 2. 9 a) 
PBS 4J ± J .4 
Physiological Saline 42 ± 2. 7 
Fl5 6 ± 1. 6 
RPMl- 1640 7 ± 1 .4 
a) Footnote as in Table 2 . J 
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Finally , it should be noted that normal animal sera 
contain a potent inhibitor of autorosetting , a point wb1ch will 
be discussed in detail in chapter 6 . It was , important, therefore, 
to perform autorosetting either in serum free medium or in the 
presence of proteins that did not inhibit autorosetting . It was 
found that most batches of FCS were not inhibitorJ , particularly 
at the 0.5% concentration used for the autorosetting assays 
described in this thesis . The 0.5% FCS was routinely included 
in the autorosetting medium as it minimised thymocyte losses 
during handling . 
2 .10 . 2 Inhibition of Rosetting by Erythrocyte S0n1cates 
In this assay 50 µl of serial dilutions of erythrocyte 
sonicates were placed in the wells of microlitre plates. 
Preparation of sonicates is described in section 2.7 .1. Usually 
the highest concentration of sonicates was prepared from packed 
(100%) erythrocytes . 25 µl of thymocytes (2 x 106/ml in medium) 
were then added to each well and the mixture incubated on ice 
for 60 min . The wells of the microlitre plate were filled with 
200 µl of ice cold medium , the cells sedimented by centrifugation 
at 200 g for 1 min at 4°c and the supernatant discarded by flicking 
the plate . The cells in each well were washed once more with 200 µl 
of ice cold medium and then resuspended , by gentle vortexing, in 
25 µl of ice cold medium. 25 µl of a 0.5% suspension of erythrocytes 
was added to each well and the standard rosetting assay then 
performed (see section 2 .10). 
2 .10 . J Blocking S0nicate - Inhibit1on with Antisera 
In some experiments erythrocytes were preincubated with 
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anti-H- 2 sera prior to sonication and used in the inhibition assay. 
The preincubations were as follows : to 0 . 125 ml of packed 
erythrocytes was added 0 .4 ml of either undiluted anti - H- 2Ld serum 
or a 1/200 dilution of H- 2 . 25 monoclonal antibody . The mixtures were 
left on ice for JO min and the red cells then washed three times with 
medium prior to sonication as packed eI"Jthrocytes . 
2 . 10 .4 Inhibition of Rosetting by Sugars 
This assay entailed incubating 25 µl of serial 
dilutions of the sugar with 25 µl of thymocytes (2 x 106/ml) for 
1 hr on ice in the wells of microlitre plates. 50 µl of 0.5% 
erythrocytes suspension was then added to each well , and then the 
mixture pelleted and incubated on ice for J0- 60 min. The number 
of rosetting cells was then determined as described in section 
2 .10 .1 
2 .11 Autorosette Inhibition Factor (AIF) 
2 .11 .1 Detection of AIF 
Autorosette inhibition factor was detected by mixing 
25 µl of a particular sample (usually serum or column fractions) 
6 
with 25 µl of thymocytes ( 2 x 10 /ml ) and incubating the mixture 
on ice for JO min . The thymocytes were then rosetted with 25 µ1 of 
0.5% erythrocytes in the usual manner . To eliminate anti - red cell 
antibodies , sera from sheep , geese , chicken and bat were first 
absorbed with mouse erythrocytes (90 µl of neat serum+ 10 µl of 
packed erythrocytes for 1 hr on ice before use) . 
For the absorption of AIF by thymocytes, 100 µl of 
10% fresh BALB/c serum was preincubated with 100 µl of varying 
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number of BALB/c or C55 thymocytes f or 45 min on ice . The mixture 
was spun at 400 g for 10 mi n at 4°c ., and the supernatant used 
for inhibiting BALB/c thymocyte autorosetting . 
2 . 11 . 2 Assaying Lymphoid Cells for AIF Secret1on In V1tro 
Cell suspensions from different lymphoid organs 
were washed twice with Fl5 medium lacking FCS but supplemented 
with 5 x 10- 5 M 2- mercaptoethanol . This medium was used for all 
subsequent cell washi ng and culturing. Cells were made to a 
concentration of 2 x 107/ml in a total volume of 5 ml and 
incubated at 37°c for 6 hr in a 9 cm diameter plastic petri dishes 
in a humidified atmosphere of 5% CO2 in air . 
The supernatants of the cultures were harvested by 
pelleting the cells at 2000 g. The supernatants were then 
centrifuged at J0 ,000 g for 15 min at 4°c in a Sorvall rotor , 
concentrated 10- 15 fold using vacuum dialysis , dialysed over-night 
at 4°c against PBS containing 1 mM EDTA and DTT , and assayed for 
AIF as described above . 
Adherent peritoneal cells were prepared by 
incubating peritoneal cell suspensions in 5.5 cm plastic petri 
dishes at a concentration of lx 107 cells/ml in 2 ml of Fl5 medium 
containing 5% FCS at 37°c for 2 hr in a humidified atmosphere of 
5% CO
2 
in air . Non- adherent cells were collected , washed once and 
recultured in another dish for 6 hr at 1 x 107 cells/ml. The 
adherent cell populations were washed three times with 5 ml of 
medium lacking FCS and t hen recultured for 6 hr in 2 ml medium . 
Culture supernatants were then collected and processed as described 
above. 
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2 .11 . J Purification of AIF from Human Serum 
Phosphocellulose purchased from Whatman Ltd ., Kent , 
England was first precycled by the method of Greene et al (1978). 
The resin was stored until use in a storage buffer containing 
0 . _5M sodium chloride , 1 mM EDTA , 1 mM DTT and 10 mM sodiun phosphate 
pH 7,4 . After packing , the column was washed first with one column 
volume of storage buffer containing 50 mg/ml of bovine serum 
albumin (BSA) purchased from Armour Pharmaceutical Co . Ltd ., 
Eastbourne , England . The column was then washed with five column 
volumes of the storage buffer without BSA but with the sodium 
chloride concentration raised to 2 . _5M . The column was finally 
re-equilibrated with the normal storage buffer and used immediately. 
All stages in the purification were carried out at 
o0 -4°c . Sixty ml of human blood was collected and immediately 
diluted into 200 ml of ice cold 0 . 15M sodium chloride , O.l?M 
sodium citrate solution containing 200 units of heparin. The 
citrated blood was then centrifuged at 2000 g for 20 min at 4°c . 
and the supernatant collected . 
The diluted plasma was then dialysed overnight 
against 4 litres of the storage buffer . The dialysed plasma ( 251 ml ) 
was then loaded onto a 3 x 20 cm column of precycled phospho-
cellulose equilibrated in the same buffer. Under these conditions 
the bulk of the protein does not bind and passes through the ion-
exchange column . The sodium chloride concentration in the buffer 
was increased to 0 .8M and the column was washed with a further 
one litre of this buffer . The column was then eluted with a 500 ml 
linear salt gradient in which the sodium chloride concentration 
in the buffer was increased from 0 . 8M to 2 . _5M . 
2 . 12 
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Haemagglutinin in Lymphoid Cel_ Lysates 
2 .12 . 1 Haemagglutination and Haemagglut1nation- Tnhibit1on 
Assays 
The haemagglutinating activity of lymphoid cell 
lysates prepared as descri bed in section 2 . 7 . 2, was assessed in 
96 well U- bottomed microlitre plates . 25 µl of the lym~hocyte 
lysate was serially diluted using PBS containing 0 . 1% bovine 
serum albumin (BSA) as diluent . Then 25 µl of a 1% (v/v) erythrocyte 
suspension made up in the same diluent was added to each well, and 
haemagglutination was allowed to take place at 4°c on a flat 
surface . Haemagglutination titres were recorded at least J hr later. 
The inhibitory activity of erythrocyte lysates was 
assessed by making 25 µl serial dilutions of the erythrocyte 
lysate in 0 . 1% BSA- PBS and adding 25 µl of a constant dilution 
of thymocyte lysate (haemagglutinin) to each well . After incubation 
on ice for 60 min , 25 µ1 of a 1% (v/v) suspension of erythrocytes 
was added to each well and h..demagglutination titres assessed. 
2 .12 . 2 Sugar Inhibition of Haemagglutination 
In this assay , 25 µl of sugar (at various concentrations) 
was added to each well of microtitre plates containing serial 
di lutions of the thymocyte lysate . mhe mixture was incubated on ice 
fo r 60 min , and then 25 µl of a 1% (v/v) suspension of e:rythrocytes 
added to each well and haemagglutination titres assessed J hr later. 
2 . 12 . J Inhib1t1on of Haeme,gglutination by AIF 
In this assay , 25 µl of pure human AIF was serially 
diluted using PBS containing 0 .1% BSA as diluent . Then 25 Wl of a 
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thymocyte lysate at different dilutions was added to the wells 
containing AIF . The plate was incubated on ice for JO min , 25 µl 
of a 1% (v/ ,) suspension of erythrocytes was added to each well and 
haemagglutination titres assessed . 
The human AIF in this inhibition assay was purified 
from human plasma as described in section 2 .11 . J . 
2 . lJ Isolation of Autorosetting Receutors and Acceptors 
Figure 2 . 1 depicts the experimental protocol used 
to purify and characterise the thymocyte haemagglutinin . The protocol 
consisted of binding the haemagglutinin in a 1251 - labelled lysate 
to glutaraldehyde fixed red cells , eluting the haemagglutinin from 
the red cells with D- galactosamine (20mg/ml) and analysing the 
eluate by SDS -PAGE . In all experiments a control was included 
where the red cells were eluted with D- glucose ( 20 mg/ml) 
rather than D- galactosamine . Furthermore , a fraction of each eluate 
was depleted of sugar by dialysing and tested for the recovery of 
haemagglutinin acceptor from 1251 - labelled mouse erythrocytes , 
except that the erythr ocyte lysate was bound to and eluted from 
thymocytes and recovery of haemagglutination- inhibition activity 
was determined . 
2 . 14 SDS -Polyacrylamide Gel Slectrouhoresis (SDS- PAGE) 
2 . 14 .1 SDS-PAGE of Serum Proteins 
D1fferent serum fractions and AIF samples were 
- -
analysed by gradient SDS- PAGE performed essentailly as described 
by Laemmli et al (1970) . Reduction of the sample was uerformed with 
10% 2- merca~toethanol in 1% SDS in 50 m.M Tris nH 6.8 ouffer in a 
Fig . 2 .1 
125 I-labelled Thymocytes 
' (lactoperoxidase catalysed iodination) 
t 
Solubilisation in 0 . 5% NP-40 PBS containing 
PMSF. Spin out nuclei and debris (28,000 g, 15 min) 
Absorb lysate to glutaraldehyde fixed mouse red 
0 
cells , 2\ hr., 4 C. 
l 
Wash red cells X 2 with 0.01% NP - 40 - PBS/0.1% BSA 
1 Elute re ceptor from red 
D-galactosamine in 0.01% 
t 
cells with 20 mg/ml of 
0 NP - 40 PBS, 1\ hr., 4 C. 
Collect supernatant 
Analyse on SDS-PAGE Dialyse against 0.01% 
0 NP -4 0 PBS, 4 hr., 4 C. 
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Test for haemagglutination 
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boiling water bath for 1 . 5 min and electrophoresis carried out on a 
gradient of 10- 20% polyacrylamide for 16 hr at 50V . The gel was 
stained with 0 . 25% Coomassie Blue R- 250 in le% acetic acid and 
5CP/o methanol (v/v) at 37°c for 1 hr . 
2 . 14 . 2 SDS-PAGE of Autorosetting Receptors and Accentors 
125I - labelled material eluted from glutaraldehyde 
fixed erythrocytes or thymocytes was analysed using SDS- PAGE 
essentailly as described by Maizel (1971). Gels used consisted 
of a 10 . 6 cm resolving gel and 2 ,5 cm of stacking gel of 0 .6 
cm in diameter . Final concentrations in the resolving gel were : 
le% acrylamide (Cyanamid , Australia) , 0 .266% N, N'-bis - methylene 
acrylamide (bis acrylamide , Eastman Chemicals Co) ; 0 , J7.5M Tris 
(Sigma) HCl , pH 8 . 9 ; and 0 . 1% SDS (Sigma). Polymerisation was 
catalysed with N, N, N'-tetra- methylethylenediamine (TEMED, 
Eastman Chemical Co . ) , final concentration J . JJ rnJ1 , and ammonium 
persulphate (BDH) , final concentration 2 . 2 mM. Stacking gels 
contained J% acrylamide , 0 . 08% bis- acrylamide , 0 . 062_5M Tris/HCl, 
pH 7 ,6 , and 0 . 1% SDS . Stacking gels were polymerised with J . JJmM 
TEMED and 4 .4 rnM ammonium persulphate. Prior to use , SDS was 
recrystallised from ethanol , acrylamide from chloroform , and bis -
acrylamide from acetone . The electrode buffer contained O. J84 mM 
glycine , 0 .0495 M Tris , and 0 . 1% SDS , and was the same for both upper 
and lower buffer compartments . Samples for SDS- PAGE were dissolved 
by boiling for 1- J min in appropriate volumes of a solution 
containing 2% SDS , 10% glycerol , 5% 2- mercaptoethanol, 0 .002% 
bromophenol blue , and 0 . 0625 M Tris- HCl . The pH of the dissolving 
mix was adjusted to approximately 7 ,5 with lN NaOH . 
BJ 
Electrophoresis was carried out at 60 watts u..ntil the 
dye marker entered the resolving gel and then run at 120 volts . 
Gels were cut into 2 mm fractions using a gel slicer , and counted 
in a Packard Auto- gamma Counter . 
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J .1 Introduction 
There have been numerous reports in the past that 
substantial subpopulations of murine lymphocytes can form rosettes with 
/ 
both autologous and allogeneic erythrocytes (Micklem and Asfi 1971, 
Sandilands et al 1974, Cha:r:riere and Bach 1975, Braganza et al 1975, 
Kolb 1977) . However , the nature of this interaction and its fu..nctional 
significance has remained a mystery (see chapter 1). 
In recent years it h.as become increasing apparent that 
products of the major histocompatibility complex (MHC) of the mice 
and other species play a critical role in immune induction. For example, 
self H- 2K and H- 2L/H-2D antigens play a vital part in the recognition 
of foreign antigens by cytotoxic T cells (Doherty et al 1976, Shearer 
et al 1976) . In a similar manner , it appears that self structures mapping 
to the I - region are recognized in association with foreign antigen by 
the T cells which express help (Katz and Benacerraf 1975), delayed- type 
hypersensitivity (Miller et al 1976) and antigen- specfic proliferation 
in vitro (Thomas et al 1977, Schwartz et al 1978) . Although the mechanism 
of recognition of self plus foreign antigen in these systems is still 
uncertain frequently it has been suggested that two receptors are 
involved , one recognizing foreign antigen , the other recognizing a 
self :MHC product (Janeway et al 1976 , Zinkernagel et al 1978). 
With these concepts in mind , it appeared possible that 
the interaction between lymphocytes and autologous erythrocytes might be 
mediated by an anti- self receptor on lymphocytes which had syngeneic 
preference for a MHC gene product on er,Jthrocytes . This anti - self 
receptor would probably weakly cross react with other haplotypes and 
thus multipoint binding via a low affinity receptor, would explain the 
interaction of lymphocytes with both allogeneic and syngeneic 
87 
erythrocytes . 
This chapter describes the experimental procedures under-
taken to test this hypothesis . The experimental ~rotocol was to measure 
the ability of different erythrocyte sonicates to inhibit the 
rosetting of thymocytes and peripheral l ymphocytes of different 
inbred strains of mice with autologous red cells . Using this method it 
was possible to demonstrate that autorosette formation is , indeed, 
mediated by an H- 2 controlled receptor . In fact , the receptor on murine 
thymocytes and peripheral T and B lymphocytes appeared to be primarily 
directed against an H- 21 region controlled molecule . Furthermore , with 
the recent demonstration that the H- 2 antigens on the thymic epithelium 
determine the specificity of H- 2 restricted cytotoxic T cells (Bevan 
1977 , Zinkernagel et al 1978) , the infl uence of the thymic environment 
on the specificity of H- 21 region controlled rosetting was examined . 
In addition , the specificity of the autorosetting receptors in Fl 
hybrid mice was analysed . 
J .2 Results 
J . 2 .1 Eff1 ciency of Autorosetting 
Table J . l lists the proportion of rosetting cells in the 
thymus , spleen , lymph node and bone marrow of seven strains of mice. 
Substantial subpopulations autorosette in each lymphoid organ , the 
autor osette freq_uency being thymus > spleen > lymph node ;> bone marrow . 
An additional important feature of Table J . l is that the lymphoid organs 
of athymic BALB/c nude mice contained a slightly higher proportion of 
autorosetting cells than nonnal BALB/c mice . This result implies that 
thymus - independent cells can autorosette . 
Initially when the autorosetting of lymphoid cells was 
examined it became apparent , however , that mouse strains varied in their 
Mouse 
Strain 
BlO . BR 
BALB/c 
BALB/c 
(nude) 
DBA/2 
A.SW 
BlO .G 
BlO 
Table J .1 
Proportion of Autorosett1ng Cells 1n D1fferent 
Lymnhoid Organs 
Lymphoid Oran 
Haplotype 
Thymus Spleen Lymph Node 
k 59 + 3 .1 a) 26 + 2.5 16 + 1. 0 
d 43 + 2 . 3 14 + 2 . 4 13 + 0 , 7 
d 20 + 2.5 1 .5 + 1 . 0 
d 38 + 2 .8 20 + 3,5 10 + 1. 4 
s 58 + 4 . 2 18 + 2 .6 14 + 2 . 0 
q 58 + 2 . 9 26 + 2 . 7 12 + 1.5 
b 54 + 1 .2 13 + 1 .2 8 + 1. 4 
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Bone Mar...cow 
13 + 1. 2 
6 + 1 .5 
11 + 1. 0 
8 + 1. 4 
10 + 2 . 0 
10 + 2 . 0 
7 + O. 7 
a) Results expressed as% rosette forming cells+ standard deviation 
of at least three determinations . Rosetting performed between 
autologous lymphocytes and erythrocytes in each case. 
autorosetting potential . For example , only 5% of SJL/J spleen cells 
formed autorosettes , whereas 26% of BlO .BR splenocytes autorosetted . 
By rosetting different combinations of lymphocytes and erythrocytes , 
it was found that the source of variation usually resided in the 
rosetting erythrocyte . Table J .2 presents three strain combinations 
which clearly demonstrate this point . A higher proportion (26%) of 
BlO . BR spleen cells rosetted with BlO . BR red cells , whereas a much 
lower proportion (8%) of CBA/H spleen cells formed autorosettes. 
However , the converse result was observed when BlO . BR spleen cells 
were rosetted with CBA/H red cells or CBA/H splenocytes were rosetted 
with BlO . BR erythrocytes . Similar results were obtained when the 
autologous and heterologous rosetting of two other strain combinations 
were compared , namely A. SW with SJL/J and DBA/1 with BlO .G (Table J.2). 
The same trends were observed when different combinations of thymocytes 
and erythrocytes were rosetted , although the combinations were less 
marked than with spleen cells (Table J .2) . In contrast , there was 
little difference between autologous and heterologous rosetting when 
lymph node and bone marrow cells were examined (see Table J .8) . 
Since H- 2 compatible strains were compared in Table 
J . 2 , background (non H- 2) genes must influence the ability of 
erythrocytes to bind to lymphocytes . One possibility is that these 
background genes modify rosetting efficiency by va:01ing the density 
of H- 2 molecules on the red cell surface . This seems unlikely as 
allo- antibody absorption studies demonstrated that BlO.BR e:0Jthrocytes, 
which rosetted very well , express approximately eight times less H- 2 
antigen than CBA/H red cells , which rosette poorly . A more likely 
explanation is that ai'ter specific union between lymphocyte and 
erythrocyte the complex is stabilized by non- specific interactions 
Table J . 2 
Influence of Erythrocyte Background on Rosetting 
Efficiency of Spleen Cells and Thymocytes 
Rosetting Lymphocytes 
Lymphocyte 
Source 
k 
B10.BR(H-2 ) 
B10.BR 
k CBA/H (H-2 ) 
CBA/H 
s 
A.SW(H-2 ) 
A. SW 
s 
SJL/J(H-2 ) 
DBA/1 (H-2q) 
DBA/ l 
B10.G(H-2q) 
B10.G 
Erythrocyte 
Source 
B10.BR 
CBA/H 
CBA/H 
B10.BR 
A. SW 
SJL/J 
A. SW 
DBA/1 
B10.G 
B10.G 
DBA/1 
Spleen Thymus 
a) 
26 + 2.5 57 + 3 . 2 
10 + 2. 1 34 + 2.8 
8 + 1.4 34 + 2 . 3 
28 + 2 . 1 60 + 3.5 
18 + 2 . 6 58 + 3.5 
3 + 0. 6 30 + 2.1 
20 + 1.5 58 + 2.8 
12 + 0.6 42 + 3 . 0 
26 + 2.0 49 + 4.2 
26 + 2 . 7 58 + 2.8 
12 + 1.0 44 + 2.8 
a) Results expressed as% rosette forming cells+ standard 
deviation of at least three determinations. 
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(e .g . electrostatic forces) bet~een the red ce_l and lymphocyte 
membranes . Obviously these non- snecific forces which stabilize the rose~~es 
are not under H- 2 contra_ , 
Table J . 2 presents selected examp_es of the effect of the 
J.. 1.-.~ I b T d ' 1 I ' • b I t, ' d ery L,1irocy-r,e acKgrolLn on -c,ne rose-c,-c,ing e-c,ween nymocyi:,es an 
erythrocytes from nine different strains which nave been performed , i . e . , 
BlO . BR , CBA/H , BALB/c , DBA/2 , A. SW , SJL/J , DBA/1 , BlO .G and C57BL/6 . Of 
the 8_ combinations tested , any variations in rosetting efficiency 
can be attributed to the red cell background in all except three cases , 
namely the rosetting of SJL/J thymocytes with either BALB/c or DBA/2 red 
cells and the rosetting of DBA/1 thymocytes with C57BL/6 erythrocytes . 
I th f h • f th r • .J:" I I • I h J.. l n ese -c,iree ins-c,ances _e proporGion o~ rose-c,-c,ing -c,_ymocy l,es was _ower 
than expected . Similar checker- board analysis of the rosetting of spleen 
cells , although incomplete , has given similar results to thymocytes . 
The r osette assay used has detected a higher freQuency 
of autorosettes in lymphoid organs tnan reported by some groups (Aicklem 
and Asf i 1971 , Char.cier and Bach 1975 , 3raganza et al 1975 , l abarLa and 
Charriere 1979 , Primi et al 1979) but has giveP- simi_ar resu_ts to other 
investigators (Kolb _977 , Sandilands et al 1974) . The reasons for these 
differences has been discussed earlier (cnapter 1 & 2) . It should be 
re - emphasized , _owever , J..hat the largest sources of error are the 
inhibitory effecJ..s f serum (Kolb _977 , P~rish et al 197 , Kolb _978) 
and the mec_anical d~sruption of rosetJ..es during their resuspension , i . e., 
resusne:sion of rosettes on a rol_er should oe avoided . 
J .2 . 2 
IJ.. ~swell establis _ tnat sub_opu_aJ..ions f mur~~e 
lymphocytes :orm rosettes ~ith bot s~_geneic and al_ogene~c e::c'""Jthrocytes 
(;'!~ckle an __ s:~ _971 , Sandi ands e.i. al 197L , v~a~e:-.ce and 3ac:C-: _975, 
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Braganza et al 1975 , Kolb 1977) , However , this rosetting phenomenon may be 
due to a strain- specific receptor whose specificity is mas~ed by multi -
point interaction between lymphocytes and erythrocytes . In order to test 
this hypothesis an inhibition assay was developed which entailed pre-
incubating the lymphoid cells with different erythrocyte sonicates , 
washing the lymphocytes and then rosetting the lymphocytes with autologous 
erythrocytes . Using this assay it was , indeed, possible to demonstrate 
some strain specificity in both the thymocyte and spleen cell receptors 
which recognize autologous erythrocytes . It must be emphasized that to 
increase the sensitivity of sonicate inhibition the lowest lymphocyte: 
red cell ratio reQuired for maximum autorosetting was used (see section 
2 .10 .1) . 
Table J .J summaries the results obtained with this inhibition 
assay when thymocytes from seven different mouse strains were tested, 
It was found that with C57BL/6 , SJL/J and DBA/1 thymocytes the auto-
rosette inhibition was completely strain specific. In contrast, 
inhibition was strongly cross - reactive between BALB/c, DBA/2 , CBA/H 
and BlO . BR mouse strains. This result suggested t hat in BALB/c , DBA/2, 
CBA/H and BlO . BR mice the thymocyte receptors have identical or ver:y 
similar specificity . The complete inhibition data obtained with BALB/c 
thymocytes is depicted in Fig . J.1 . Again it can be seen that BALB/c 
DBA/2 , CBA/H and BlO.BR erythrocyte sonicates show strong inhibition 
whereas C57BL/ 6, SJL/J and DBA/1 sonicates are not inhibitory. 
SubseQuently , spleen cell autorosette inhibition from 
six mouse strains and BALB/c (nude) mouse was also found to be completely 
strain specific (Tables J.4 & 3,5). Again, inhibition of autorosetting 
of these lymphoid cells was strongly cross-reactive between the (H- 2d) 
and (H- 2k) haplotypes . 
CV'\ 
CJ"\ 
Thymocytes 
Bl\LB/c 
DBA/2 
CBA/H 
BlO . BR 
C57BL/6 
SJL/ J 
DBA/1 
Erythrocyt es 
BALB/c 
DBA/2 
CBA/H 
BlO . BR 
C57BL/6 
SJL/J 
DBA/1 
Table J.J 
Strain Specificity of Autorosette Inhibition 
Nil 
4 3 ±2 . 5 
3 3 ±1 . 5 
3 4 ±2 . 3 
5 7 ±3 . 2 
4 5 ±2 . 7 
2 1 ±1 . 6 
4 2 ±3 . 0 
BALB/c 
d (H-2 ) 
b) 
19±3.ol 
1 s ±2 . o 1 
J 6 ±2 . s I 
126±2 . 1 1 
4 4 ±2 . 1 
2 0 ±2 . 4 
41 ±2 . 1 
D!3A/2 
(H-2d) 
I s ±2 . o 1 
14 ±2 .o l 
[ 6 ±2 . o 1 
[2 4 ±2 . ii 
4 5 ±1 . 5 
2 2 ±1 . 5 
4 3 ±2 . 6 
a) 
Erythrocyte Sonicate 
CBA/H 
k ( H- 2 ) 
111 ±2 . 11 
l s±2.s j 
I 6 ±1 . 21 
j 19±3 . s l 
4 5 ±2 . 1 
2 1 ±3 . 1 
4 0 ±1 . 5 
BlO.BR 
k (H-2 ) 
1 1 7 ±1. 4 j 
113 ±1.s l 
1 9 ±2 . 1 I 
I 2 9 ±0 . 7 1 
4 3 ±3 . 1 
21 ±2 . 0 
41 ±1 . 7 
C57BL/6 
b ( H -2 ) 
4 3 ±2 . 1 
3 0 ±1 . 6 
3 1 ±2 . 1 
5 5 ±3 . 5 
114±2.o j 
. 
21 ±2 . 6 
4 2 ±2 . 1 
SJL/J 
s (H-2 ) 
4 0 ±2 . 5 
31 ±2 . 1 
3 2 ±2 . 0 
5 7 ±3 . 5 
4 3 ±4 . 0 
I s ±1 . o:I 
4 3 ±3. 1 
DBA/1 
(H- 2q ) 
4 4 ±2. 0 
3 1 ±2 . 1 
31 ±1 . 5 
5 7 ±0 . 7 
4 4 ±2 . 5 
2 0 ±1. 5 
( s±3.s f 
a) Thymocytes preincubated for 60 min at 4°c with 100% erythrocyte sonicate prior to rosetting with 
autologous erythrocytes . 
b ) Results expressed as% r o setting thymocytes ± s tan d ard dev i atio n of mea n of t h ree determinations . 
significant inhibitio n are enclosed. 
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Fig. J. l Ability of erythrocyte sonicates from different 
mouse strains to inhibit the rosetting of BALB / c thymocytes 
with BALB / c erythrocytes. The erythrocyte sonicates used 
as inhibitors are listed on the figure . Thymocytes wer e 
preincubated with different concentrations of sonicates 
prior to rosetting. Vertical bars represent standard 
deviations of means. The rosetting of control thymocytes, 
which were not preincubated with sonicates, is indicate d 
in the right hand margin of the figure. 
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0 
It should be noted that the data in Tables J . J - J , 5 and 
Fi g . J . l tend to ~mplicate the H- 2 complex in autorosette-inhibition . 
Thus BlO . BR (H- 2k) and C57BL/ 6 ( _- 2b) thymocytes and BlO . BR (H- 2k) 
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and C57BL/10 (H- 2b) spleen cell exhibit strain- specific inhibition 
even though these mouse strains have very- similar genetic backgrounds . 
Conversely , both H- 2d (BALB/c and DBA/2) and H- 2k (CBA/H and BlO . BR) 
strains tested yielded comparable results even tnough these strains 
have very different genetic backgrounds . 
In subsequent experiments it was found that the erythrocyte 
sonicates used in the inhibition assays contained ver y small membrane 
vesicles which can only be sedimented by centrifugation at between 
5000 and 20 , 000g . When red cell ghosts were used as inhibitors in the 
assay non- specific inhibition of autorosetting was observed . 0n the 
other hand , detergent dissociated red cell membranes were not inhi bitory . 
J . 2 . J Genetic Mapping of Autorosett1ng of Thymocytes 
In the next series of experiments attempts were made to 
map the gene(s) responsible for t he strain specific i nhibition of 
autorosetting . Figs . J . 2 and J . J depict the complete i nhibition data 
of the thymocytes obtained with the seven strains examined in Table 
J . J . Virtually i dentical inhibition data was obtained with BALB/c 
(H- 2d) , DBA/ 2 (H- 2d) , CBA/H (H- 2k) and BlO . BR (H- 2k) thymocytes (Fig . 
J . 2) . Inhibition of rosetting was only obtained with sonicates from 
mice expressed either the d (i . e ., BALB/c , DBA/2 , A.TH) or k ( i.e., 
BlO . BR , CBA/H) haplotype in the H- 2L/ H- 2D region of the MHC . However , 
,the most striking result was that t he erythrocyte sonicate from the 
BALB/c- H- 2dm2 mutant mouse (C55) strain was not inhi bitory . This strain 
carries an H- 2Lddeletion mutation (McKenzie et a l 1977 , Hansen et al 
t t I 
1977 , Demant and Neauport- Sautes 1978) and , therefore , this finding 
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Fig. J. 2 Genetic mapping of inhibition of thymocyte autorosetting 
by erythrocyte sonicates . Each graph is headed with the 
strain and H- 2 haplotY1)e of the thymocytes considered. 
The erythrocyte sonicates used as innibitors are listed 
on the right hand side of the Figure . Vertical bars 
represent standard deviations of means . The autorosetting 
of thymocytes , in the absence of inhibitors, is indicated 
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Legends as in Fig . J .2 
I 
-J 
0 
strongly suggests that BALB/c , DBA/2 , CBA/H and BlO . BR thymocytes are 
recognizing an H- 2L region controlled structure on mouse e:rythrocytes . 
Further anal·rsis of this mutant strain will be n_resen+ed 1 ' · th " J ..., .... ai:,er in .is 
chapter (section J . 2 .5) . An additional implication of these results is 
that , in this autorosetting test , thymocytes cannot distinguish between 
the H- 2L molecules carried by d and K haplotypes . 
Inhibition results obtained 0~rith SJL/J , DBA/1 and C57BL/6 
thymocytes were a_so consistent with a_n H- 2L/ H- 2D region controlled 
molecule being recognized in autorosetting . Thus , .Lhe rose.L.Li" nrr t.,_. - L, L, --6 of 
SJL/J (H- 2s) thymocytes (Fig . J . J) was strongly inhibited by an SJL/J 
sonicate but not by an A. TH sonicate , A.TH mice differing from SJL/J 
mice at the H- 2L/rl-2D region of the .1HC . Similarly , DBA/1 (H- 2q) 
autorosettes (Fig . J . J) were inhibited with DBA/1 (H- 2q) and BlO .G 
(H- 2q) sonicates but were not blocked by BlO . AQR and Bl0 .T(6R) sonicates. 
BlO .AQ..R maps the effect to the D end of ~he ~=c (i .e., to the right 
of the S region) . Finally , with C5?BL/6 (H- 2b) rosetting (Fig . J . J) , 
significant inh1bition was obtained with C57BL/ 6 (H- 2b) , BlO .A (2R) 
and BlO .A (hR) sonica.Les . 3_0 ,A(~R) mans tne inh1bition to the right of 
I-A whereas Bl0 .A(2R) mans the effect to tne D end of tne _1HC , i . e ., 
to the right of the .§. region . Similarly the lack of inhibition by 
BlO .A(JR) and 3_0 .T(6R) sonicates __ aus t .. e effect to the right of I - J 
and to the D end of the MHC , resyec.Live_y , It shou_d be emnhasized that 
the inhib~tion of C573L/6 autorosetting was not as marked as N~.Ln 
other strains . However , the ~n_hibition obta~ned with the 100% sonicates 
o~ 310 . A(2~) and 3_0 ,A(LR) erJtnrocJ-tes ;ras statistica_ly s~gni:~cant 
(_ < . 5) . 
-=- .L-rro add~ tional mouse strains 
has also been ge:e.L~ca __ y ~a_yed (data no.L shown) , namely .Lhe 3 O.G 
( .. ? ) d A S'. 1-....- - ? s) ' · - , · · · · · .::.=.:::.- a. . t; ~ S""G~arc.s . J.:_'Lo_ -2_ :r.. .::, 3 0,, .,... .!..!..:. .,,..{J'.::, .,1 .. " 01. - , 0 - OSe _, V---o - 0 __ 0 t ed. 
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the same genetics as that obtained with DBA/1 (H- 2Q) thymocytes (Fig. 
J . J) . Similarly , A. SW autorosette - inhibition corresponded to the genetics 
observed with H- 2 compatible SJD/J thymocytes (Fig . J . J) . 
During these inhibition studies it became apparent that 
erythrocyte sonicates from mouse strains carrying the BlO background 
tended to be substantially less inhibitory than sonicates from other 
strains , e .g ., CBA/H compared with BlO . BR in Fig . J . 1 and Table J.2, 
DBA/ 1 compared with BlO .G in Fig . J . J and C57BL/6 compared with BlO 
recombinants in Fig . J . J . This effect may reflect a lower density of H-2 
molecules on the surface of erythrocytes from mice with the BlO 
background . Preliminary alloantibody absorption studies are consistent 
wi th this interpretation . 
J . 2 . 4 Genetic Mapping of Autorosetting of Suleen , Lymph Node 
and Bone Marrow Cells 
The ability of erythrocyte sonicate to inhibit the auto-
r osetting of spleen cells from seven mouse strains was assessed . The 
i nhibition assay was identical to that described above for thymocytes 
( sect i on J . 2 . J ). I niti ally the haplotype specificity of inhibition was 
exami ned (data not shown) . I t was found that , as with thymocytes , b , .9.. 
and ~ haplotypes exhibited haplotype specific inhibition , whereas d and 
k haplotypes showed cross- reactive inhibition . 
By the use of recombinant mouse strains it was , sub-
SeQuently , possi ble to map the autorosette- inhibition within the H- 2 
complex . With BlO . BR (H- 2k) , BALB/ c (H- 2d) , BALB/c nude (H- 2d) and 
DBA/ 2 (H- 2d) spleen cells , inhibition of autorosetting only occurred 
when the erythrocyte sonicates carried either the dork haplotype in the 
H- 2L/ H- 2D region of the :MHC (Table J . J) . Furthermore , erythrocyte 
sonicates from the H- 2L deletion mutant (BALB/c- H- 2dmZ) or (C55) 
strain lacked inhibitory activity , which mapped autorosette - inhibition 
to the H- 21 region . The complete inhibition data for DBA/2 , BlO.BR 
100 
and BALB/c strains is depicted in Fig . J .4 . 
Similar inhibition experiments with A.SW (H- 2s) spleen cells 
ma~ped inhibition to the H- 2L/H- 2D region , i . e ., A. TH sonicates were not 
inhibitory (Table J .4) . In a similar manner , the -inhibition of 310 .G 
, 
BlO (H- 2°) autorosettes was mapped to the D- end of the MHC , i.e., 
to the right of the S region (Table J . 5) . The key recombinant strains for t he 
genetic mapping of BlO .G inhibition were Bl0 .T(6R) and BlO . AQR, whereas BlO 
inhibition was mapped by the Bl0 .A(2R) and BlO . A(4R) recombinant strains. 
The specificity of the autorosetting receptor on lymph node 
and bone marrow cells was also examined using the inhibition assay . The 
results obtained with BlO . BR lymphoid cells are presented in Table J .6 . 
As with spleen cells , autorosette- inhibition was mapped to the H- 2L/ H- 2D 
region for the lymph node and bone marrow . In this experiment subpopulations 
of spleen cells were also examined for autorosetting potential . The Ig 
(B cell depleted) population of spleen could still autorosette but not as 
effectively as unfractionated or Thy- 1 . 2- ( T cell depleted) spleen . The 
proportion of autorosettes in T~y- 1 . 2- spleen was consistent with the results 
obtained with T cell depleted (nude) mice (Tables J .1 & J . 4) . However, the 
recovery of autorosetting cells in Thy-1. 2 spleen was slightly lower than 
ex~ected . It was subsequently shown that this loss was due to the blocking 
effects of guinea pig complement (Kolb 1977 and 1978). When BlO . BR spleen 
+ + 
was depleted of both Ig (B) and Thy- 1 . 2 (T) cells by a double resetting 
procedure (see chapter 2 , section 2 . 6 . 2) the remainLng population of null cells 
was virtually unable to for:m rosettes (approx . 1%) . From these data it can be 
calculated that approxi mately 80% of the rosetting spleen cells are B-
lymphocytes and 2CP/a T lymphocytes . Calculated in another way, if one assumes 
6CP/o B cells and JC?/o T cells in BlO . BR spleen , approximately JO% of B cells 
and 15% of T cells can rosette with autologous erythrocytes. Further:more, 
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Genetic mapping of inhibition of spleen cell autorosetting 
by erythrocyte sonicates . Each graph is headed with the 
strain and H- 2 haplotype of the spleen cells considered. 
The erythrocyte sonicates used as inhibitors are listed 
on the right hand side. of the figure. Vertical bars 
rep~esent standard deviations of means , The autorosetting 
of spleen cells, in absence of t he inhi bitors, is 
indicated in the right hand margin of each graph . 
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Table J.4 
Genetic Mapping of Inhibition of Spleen Cell Autorosetting: H-2k 
' 
H-2d 
Autorosetting 
Strain 
B10 . BR ( k) 
BALB/c ( d) 
BALB/c ( d) 
(nude) 
DBA/2 ( d) 
A. SW ( s ) 
Nil 
26±2.5 
16±1.0 
20±1 . 4 
21±1 .4 
20±1.S 
B10 .BR 
( k) b) 
I 13 ± 3 . sf) 
19 ± 1 . 4r 
19±1 . 41 
I 12 ±1 . s] 
19±3.S 
CBJ\/H 
( k) 
[ 6 ± 2 . 1} 
13 ± 1 . ol 
! s±1.4} 
13 ± 1 . 41 
19±2.l 
BALB/c 
( d) 
[7±0.71 
12±0.sj 
1 s ± 2 . 11 
l 6±0.7j 
18±2.1 
Erythrocyte Sonicate 
BALB/c 
( dm2) 
28±1.4 
14 ±0. 7 
19±1.4 
2 2 ±2. 8 
ND 
DBA/2 
( d) 
ls±l.4r 
13±2.1 1 
}7 ±2 .1) 
14 ±0.6] 
19±2.l 
a) 
A. SW 
( s ) 
2 8 ±2. l 
15 ±1. 0 
2 0 ±2 . l 
21±2.8 
14 ±0.6] 
s 
and H-2 Haplotypes 
SJL/J 
( s) 
28±1.5 
14±1.l 
22±1.4 
19 ±0 . 7 
J10 ±2.s] 
A.TH 
( t 2 ) 
16±2.3 1 
j s±1.4 ( 
13±1.4 1 
I s ±2 . s l 
20±0.6 
B10.A(2R) 
( h 2) 
28±1.5 
16 ±0 . 7 
19 ±2. 2 
2 2 ±2 . 8 
ND 
a) Spleen Cells preincubated for 60 min at 4°c with 100% erythrocyte sonicate prior to rosetting with 
autologous erthrocytes . 
b) H-2 haplotype of each mouse strain. 
c) Results expressed as% rosetting spleen cells± standard deviation of three determinations. Values 
which represent significant inhibition are enclosed. 
ND Not determined . 
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Table J.5 
• 
Genetic Mapping of Inhibition of Spleen Cell Autorosetting: H-2 
b 
and H-2q Haplotypes 
-- -
-
Erythrocyte Sonicate 
a) 
Autorosetting 
Strain R. 
Nil BlO.G BlO B10.BR B10.T(6R ) B10.AQR B10.A(2R) B10.A(3R) B10.A(\ 
( s._) b) ( b) ( k) ( y 2 ) ( y 1 ) ( h 2 ) ( i 3) ( h 4) 
-
-
-
! 11 
c) 
B10.G ( q) 26 + 2 . 7 + 2 . 1i 29 + 0 . 7 30 + 2.0 25 + 1. 4 26 + 1 . 4 ND ND ND 
B10 ( b) 13 + 1 . 2 13 + 0 . 7 [ 6 + 2 . oj 15 + 0.7 ND ND [ 2 + 1 . 1 l 14 + 0.7 1 4 + 0.7 
Footnotes as in Table J .4 
..:j 
0 
.-1 Table J .6 
Genetic Mapping of Spleen , Lymph Node and Bone Marrow Autorosetting 
Lymphoid 
Organ 
Spleen 
Ig Spleen 
Thy-1 . 2 
Spleen 
Lymph Node 
Bone Marrow 
Nil 
26 + 2 . 5 
12 ± 1 . 5 
2 2 ± 1. 7 
16 + 0 . 7 
14 + 1 . 5 
BlO . BR 
( k) b) 
C ) 
! 13 + 3 . 5 1 
I 4 ± 0 . 7 1 
[11 ± 0 . 7 ] 
[ 5 ± 1 . 4 1 
I 7 ± 1. s j 
CBA/H 
( k) 
] 6 + 2 . 11 
[ 1 + 0 . 71 
-
] 5 ± 0 . 71 
] 3 ± 1. 4 1 
1 4 ± 1. o I 
Erythrocyte Sonicate 
BALB/c 
( d) 
I 7 + 1 . sf 
[ 1 ± 1 . o I 
J 1 ± 2 . 0 1 
1 s ± 0. 71 
.I 2 + 1.0( 
SJL/J 
( s ) 
28 + 1.4 
12 ± 0.7 
2 0 ± 1.4 
15 ± 0. 7 
13 ± 1.0 
in 
a) Autorosetting is inhibited with different erythrocyte sonicates . 
Footnotes as in Table J .4 
k BlO.BR (H-2 ) 
A.TH 
( t 2 ) 
I 6 + 2 . 31 
I 1 ± 0 . 71 
I 3 ± 2 . 11 
1. 6 ± 1 . sl 
1 3 ± 1. s ( 
a) 
Mice 
Bl0.A(2R) 
( h 2) 
28 + 2 .8 
13 ± 1.4 
21 ± 2 .8 
15 ± 1.0 
14 ± 0.7 
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genetic mapping studies using the inhibition assay , revealed that both B 
(Thy- 1 . 2- )and T (Ig- ) lymphocytes autorosetted via H- 2~/H- 2D region 
restricted receptors (Table J .6) . 
The inhibition studies with spleen cells confirmed the 
observation with thymocytes described above (section J . 2 . J) that erythrocyte 
sonicates from mouse strains carrying the BlO background are less inh1bitory 
than sonicates from other strains e .g ., compare BlO . BR and CBA/H sonicates 
in Fig . J . 4 and Table J .4 . This difference is probably due to the lower 
density of H- 2 molecules carried by erythrocytes from BlO 1Bckground 
mice (see section J . 2 . 1 and Table J . 2) . Thus erythrocyte sonicates behave 
very differently from intact red cells as non- H- 2 strucuures , rather than 
H- 2 density , influence the ability of whole erythrocytes to bind to 
lymphocytes (Table J .2) . 
J . 2 . 5 Analysis of Autorosetting in H- 2L/H- 2D Region Mutant Mice 
Experiments described earlier in this chapter demonstrated that 
erythrocyte sonicates from BALB/c- H- 2dm.2mutant mice were unable to inhibit 
the autorosetting of BALB/ c thymocytes (Fig . J . 2) and spleen cells (Fig. J.4). 
Lymphoid cells of the BALB/ c- H- 2dm2 mutant mice to ~rosette with autologous, 
a l logeneic or xenogeneic red cells were then tested . The mutant thymocytes were 
almost devoid of rosetting activity (1 - 3%) with all erythrocytes tested 
(Table J , 7) , In addition , the mutant spleen , lymph node and bone marrow 
cells were also found to rosette less effectively (Table J.8) . Mutant lymph 
node , however , rosetted with mutant red cells (7%) almost as effectively 
as wild type lymph node (11%) . The specificity of the receptor on the residual 
population of rosetting cells in the BALB/c- H- 2dm2mutant is unknown. 
Attempts to inhibit these rosetting cells with erythrocyte sonicates have , 
so far , failed . In contrast , the lymphoid cells of the wild-type BALB/c 
strain strongly rosetted with all the target erythrocytes used (18% - 55%). 
\D 
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Table 3.7 
Rosetting of BALB/c Mutant 
drn2 a) d (H-2 ) and BALB/c(H-2 ) Thyrnocytes with Different Erythrocytes 
Thyrnocyte 
BALB/c(H- 2 drn2 ) 
BALB/c(H-2d) 
a) 
BALB/c 
( H _ 2 drn 2 ) 
b) 
1± 1. 7 
4 8± 4 . 2 
BALB/c 
d (H-2 ) 
2± 2 
40±2 . 1 
DBA/2 
(H-2d) 
2± 2 
3 6± 2. 1 
BlO.BR 
(H-2k) 
2± 2 
55±3.5 
Rosetting Erythrocyte 
CBA/H 
(H-2k) 
1± 1 
32±3.5 
C57BL/6 
(H-2b) 
2± 1 
47±2.1 
/ 2 drn2 . . 55 · BALB c-H- strain also designated as C strain 
SJL/J 
(H-2s) 
1± 1 
27±4.2 
DBA/1 
(H-2q) 
2± 0. 6 
4 6± 2. 8 
BlO.G 
(H-2q) 
2±1.5 
53±2.l 
b) Results expressed as% rosetting thyrnocytes ± standard deviation of at least three 
determinations . 
Lewis 
Rat 
3± 1. 4 
18± 1. 4 
['.... 
0 
r-l 
Table J.8 
Rosetting of Lymphoid Organs from Mutant (H-2dm 2 ) and Wild-type (H-2d)BALB/c mice with Different 
Erythrocytes 
BALB/c Strain Lymphoid Rosetting Erythrocyte 
Organ BALB/c BALB/c DBA/2 B10.BR A. S W BlO.G B10 Rosetted Rosetted 
mutant wild-type 
(dm2)a) ( d) ( d) ( k) ( s ) ( q) ( b) 
- - - -
Mutant Spleen l±0.8b) 3±0.7 3±1.4 3±1.4 2±0.7 4±1.7 2±1.3 
Wild type Spleen 16±1.4 14±0.7 22±2.1 28±1.4 20±2.1 30±1.4 13±1.4 
Mutant Lymph node 7±1.5 3±0.7 2±0.7 4±1.1 3±0.7 3±1.2 2±1.0 
Wild type Lymph node 11 ±1 .7 11±2.1 11 ±2 .8 13±2.1 11±0.7 13±1.4 10±1.4 
Mutant Bone marrow 2±1.0 2±1.4 3±0.7 3±0.7 2±1.4 3±0.9 2±1.4 
Wild type Bone marrow 9±1.4 10±0.7 12±1.4 14±0.7 11±1.4 12±0.7 11±2.1 
a) H-2 haplotype of each mouse strain. 
b) Results were expressed as percentage of rosetting lymphoid cells± standard deviation of 
three determinations. 
Lewis 
rat 
3±1.2 
9±1.4 
2 ±0 .7 
8±1.6 
2±1 .4 
6±0.7 
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In fact , BALB/c thymocytes rosetted ~ell with the mutant erythrocytes even 
though these erJthrocytes lack H- 2L region controlled anti gens . Presumably 
the receptors on BALB/c thymocytes primarily recognize H- 21 antigens but 
weakly cross react ~th H- 2K and H- 2D antigens . This weak cross - reaction, 
combined with multi - point binding , would allow rosette formation to occur 
with the mutant erythrocytes . 
Since the BALB/c- H- 2dmZ strain represents an H- 2L 
deletion mutant (McKenzie et al 1977 , Hansen et al 1977) , these data are 
consistent with the H- 21 region playing an important role in autorosetting. 
On the other hand , it could be argued that a mutation in some other 
unrelated gene has modified the rosetting behaviour of the H- 2dm2 
mutant . To rule out this possibility another mutant mouse strain was 
examined , namely the Bl0 . D2- H- 2dml (M504) strain . This mutant has sub-
stantially modified H- 21 and H- 2D antigens (Morgan et al 1978) . ~hen this 
mutant was tested in the rosette-inhibition assay it was found that the 
H- 2dml erythrocyte sonicate was unable to inhibit the autorosetting of 
H- 2d(BALB/ c) thymocytes (Table J~9) . Conversely , H- 2dsonicates were 
bl t . h "1 . ' 'h I t ' . n H 0 dml 'h ' s · ·1 1 i"-l.,' una e o in ioi0 0 _e au0orose 0ing or_ - c 0 ymocy0es. imi ar y , was 
d found that H- 2 erythrocyte sonicates were unable to inhibit the auto-
rosetting of H- 2dml spleen , lymph node and bone marrow cells , whereas 
H- 2dml sonicates could not inhibit the autorosettes formed by the lymphoid 
cells of the H- 2d haplotype (Table J .10) . Thus , these data are consistent 
with the notion that the lymphocyte autorosetting receptors primarily 
recognize self H- 21 antigens on erythrocytes . 
It should be noted from the experiment presented in Table 
J , 9 that the H- 2dml mutant erythrocytes rosetted more effectively with 
( . d 2dml) 'h H 2d ' hr ~ mh 1 , . thymocytes either H- 2 or H- 0 an.:....:...... ery0_ -ocy ve s. ~- -e exp ana0ion 
of this effect is unclear . Presumably it is due to the different genetic 
background of BALB/c and Bl0 .D2 mice , a point discussed in section J .2 .1, 
Thymo cyte 
H-2 d 
H- 2 dml 
H-2 d 
H- 2dml 
Table J.9 
Specificity of Autorosetting-I nh i b iti on 
dml a) 
of BlO. 02 Mutant ( H- 2 ) Thym o c y t e s 
b) 
Erythrocyte Erythrocyte Sonicate 
Nil 
H-2 d 39±3.1 
H- 2 dml 57±3.4 
H- 2 dml 55±2.9 
H-2 d 37±2.8 
d H- 2 
6±2 . 7 1 c) 
54±1 
l 21±3 . 5 j 
36±2.5 
2 dml H-
37±2 . 1 
[31 ±3 .1( 
51±2.6 
{ 5±1.7[ 
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a) dml Bl0.02-H-2 strain also designated as M504 strain (Table I) . 
In Table H-2d refers to BALB/c strain, H-2dml to Bl0.02 
mutant (H-2dml) strain . 
b) Thymocytes preincubated for 60 min at 4°c with 100% 
erythrocyte sonicates prior to rosetting with appropriate 
erythrocytes. 
c) Results expressed as% rosetting thymocytes ± standard devia tio n 
of three determina tions. Values which represent significant 
inhibition are enclosed . 
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Table J.10 
Inhibition of Autorosetting of Lymphoid Cells from BALB/c and B10.D2 Mutant 
(H- 2 dml) 
Mice 
b ) 
Erythrocyte Sonicate 
Mouse Strain 
Ros e tted a) 
Lymphoid Organ 
Rosetted 
d 
H-2 
H- 2 dml Nil 
d l 2 ± C) H-2 Spleen 14 ± 1.4 2 . s ( 13 ± 1.4 
dml II l 6 ± 0 . 71 H-2 2 3 + 1.4 21 ± 0 . 7 . 
--
d I 3 ± 1 . 41 H-2 Lymph Node 12 + 0. 7 13 + 0. 7 
dml .1 5 
H-2 II 
II 20 ± 2 . 8 19 ± 1.4 
+ 2 . 1{ 
d l 2 1 . 41 H-2 Bone Marrow 10 ± 1.4 + 9 + 2 . 1 
+ 
2 dml 
J s 
H- II II 14 + 2.1 
15 + 0.7 0. 71 
a ) 
d . dml dml H-2 refers to BALB/c mice and H-2 to B10 . D2-H-2 mutant mi ce . 
b) Lymphoid cells preincubated for 60 min at 4 °c with 100% erythrocyte sonicates 
prior to autorosetting . 
c ) Results expressed as% rosetting lymphoid cells± standard deviation of mean . 
Valu es whi c h represent significant inhibition are enclosed . 
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J .2 . 6 V - . , · 1 · t . ,, BATJ/ H 2dm2 , . ariaoi i yin Gne ./"U.JD c -.:...:.::_ _uGant Mice 
The autorosetting studies described above with the 
BAL":)/c-__ - 2dm2 t I • ._,,L> d • 1 .u mu anG mice ,rere DeL_ orme -i'7"i -ch a l 1_· ne of -v' he mu.Lan+ • L, -- lJ 
that was bred ad ~aintained at the John Curtin School of Medical Besearc~. 
In early 1981 , this l ine died out and fresh breeding stock was obtained 
from Professor I . F . C. .cKenzie and Dr . R. 1el vold . UnliKe the 
original stock the thymocytes of .Lhese mice autorosetted as wel_ as 
wild- type BA.LB/c thymocytes ( Dr . Rylatt , personal com.munication , Sept ., 
1981) . Additiona_ dm2 mice obtained from Dr . Klein and Dr . ~elief also 
autorosetted normal ly , although there were occasional mice ( 2 out of 12) 
that showed slightly lower thymocyte autorosetting percentages than the 
wild- type strain (J4% versus~) (lTov . , 1981 - April 1982) . 
The new mutant mice were then tested for their ability 
to reject wild- type skin grafts and respond to 5AL5/c splee·_ cel_s ~n 1~C 
( Dr . Blanden , personal commlLnication , Dec ., 1981) . It was ~ound that 
vari able MLC responses occurred , and out of ten mi ce skin grafted only 
two rejected the graft in 12 days , the remainder rejecting their 6.cafts 
after 20- JO days . Th1s is unlike the origi:al d .. 2 utant that consis.Lently 
r ej ected wi_d- type 6.cafts in 10- 12 days , a· _d rrhi ch was or~gianlly defined 
by i ts ability .Lo re~ect grafts in th1s anner (Melvold and Iohn 1976) . 
Thus , the d 2 utant annears to oe an uns.Lable de_etion . _utant of :-I - 2L . 
the original st:rai n in Ca _ber.ca bred.. poor_y and was usually :runted 
when c pared N~.Lh -,<l_ _d - type 3\L3/c . ?urtrermore , the mutant maintained 
bred we __ and were :_ever Till teci. . 
__ ttem ts are be~ng 1 ade to corr 0 i~ . utant ·rariabi_i ty 
-
a:0..a 
re - isolating the drn2 mutants bearing the phenotypes : :rtmted, uoor-
breeding and non- autorosetting . 
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J . 2 . 7 Genetic .apuing of ~osetting N1th Allogeneic and Xenogeneic 
Erythrocytes 
It was important to determine whether the same thymocyte 
receptor also recognized allogeneic and xenogeneic erythrocytes . In 
order to answer this question , the genetics of rosette - inhibition when either 
allogeneic or xenogeneic (rat) erythrocytes were used as rosetting targets 
was examined . When CBA/ H (H- 2k) thymocytes were reacted with allogeneic 
C57BL/ 6 (H- 2b) erythrocytes this rosetting showed the same genetics of 
inhibition as when autologous (CBA/ H) erythrocytes were used (compared 
Figs . J .2 and J .5) . Thus , CBA/H (H- 2k) , BALB/c (H- 2d) , and A. TH erythrocyte 
sonicates were inhibitory whereas C57BL/6 (H- 2b) , and c55 (H- 2dmZ) sonicate s 
did not inhibit (Fig . J .5) . In a similar manner , when CBA/H (H- 2k) 
thymocytes were rosetted with xenogeneic Lewis rat red cells the rosette 
i nhi bi tion was identical to that observed with autorosetting. Again , CBA/H, 
BALB/ c , and A. TH soni cates lacked inhibitory activity (Fig . J . 5) . 
Collectively , these results indicate that the same thymocyte 
receptor (probably H- 21 region controlled) interacts with syngeneic, 
allogeneic and xenogeneic (rat) erythrocytes . 
J . 2 . 8 Blocking of Autorosette - Tnrlib1t1on w1th Anti - H- 2 Sera 
If thymocytes and spleen cells primarily recognize H- 2L 
antigens on erythrocytes then erythrocyte sonicates should lose their ability 
to inhibit autorosetting if they are coated with anti - H- 21 antibodies. 
To test this prediction BALB/c erythrocytes were preincubated with anti - H- 2Ld 
antibodies prior to sonication and used as inhibitors of autorosetting by 
BALB/c thymocytes and spleen cells . 
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Fig. J.5 Ability of erythrocyte sonicates from different 
mouse strains to inhibit the rosetting of CBA/H thymocytes 
with allogeneic (C57BL/6) and xenogeneic ( Lewis rat) 
erythrocytes . The erythrocyte sonicates used as inhibitors 
are listed on the right hand side of the figure. Vertica l 
bars represent standard deviations of means. The rosett ing 
of control thymocytes, which were not preincubated wi th 
sonicates, is indicated in the right hand margin of each 
graph . 
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To control against antibody bound to red cells non-
specifically blocking autorosette - inhibition, a monoclonal anti - H- 2 .25 
antibody (anti - H- 2Kk) was shown to be unable to block inhibition by CBA/H 
red cell sonicates (Table J .11) . In this experiment the CBA/H 
erythrocytes were preincubated with a concentration of anti- H-2Kk anti-
body which was known , from red cell absorption experiments, to completely 
saturate the erythrocytes with monoclonal antibody. 
J . 2 , 9 Relationship Between Autorosetting Receptor and Surface Ig 
on B Lymphocytes 
Since a substantial subpopulation of B lymphocytes can form 
autorosettes it Nas of interest to see if su_rface Ig played any role 
in the rosetting phenomenon . It was found that either complete blocking 
or complete capping of surface Ig with immunoabsorbent purified sheep 
(Fab ' ) anti - mouse Ig'G had no effect on the autorosetting ability of spleen 
cells from athymic BALB/c (nude) mice (Table J .12). 
J .2 .10 Specificity of Autorosetting by Fl Lymphocytes 
The data presented in sections J .2 .2 to J.2.7 indicate that 
murine lymphocytes carry receptors that preferentially recognize self 
H- 2L/ H- 2D molecules on erythrocytes . Of particular interest is whether 
in Fl hybrid mice, both parental receptors are expressed on all lymphocytes 
or exhibit allelic ·exclusion . The next series of experiments used 
inhibition of autorosetting by erythrocyte sonicates to examine this 
question . 
Table J . lJ surmnaries the ability of different erythrocyte 
sonicates to inhibit the autorosetting of thymocytes from three Fl 
hybrid strains of mice . Fig . J . 6 depicts the complete inhibition data 
obtained with (CBA/H x C57BL/6)Fl thymocytes, It can be seen that 
autorosetting by (BALB/c x SJL/J)Fl, (BALB/c x DBA/l)Fl and (CBA/H x 
C57BL/6)Fl thymocytes was strongly ~nhibited by the corres~onding Jl 
Autorosetting 
Cells 
Thymocytes 
Thymocytes 
Thymocytes 
Spleen Cells 
Spleen Cells 
Spleen Cells 
Table J.11 
Blocking of Autorosette - Tnhibition 
by Anti - H- 2 Antibodies a) 
Antiserwn Treatment 
of Sonicate b) 
N. l l-
Anti - H- 2Ld 
Anti - H- 2Kk 
Nil 
Anti -H- 2Ld 
Anti - H- 2Kk 
EnJthrocyte Sonicate c) 
None BALB/c 
46 + 4 . 0 9 + J . O 
4J + 2 .1 
8 .5 + 1.8 
16 .5 + 0 . 7 4 .5 + 0 . 7 
15.0 + 1.4 
7.0 + 1.4 
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CBA/H 
6 + 2 .1 
20 + 2 .5 
8 + 2.J 
4.0 + 1.4 
14.5+0.7 
6.5 + 0 . 7 
a) Inhibition of autorosetting between BALB/c thymocytes or spleen cells and 
erythrocytes . 
b) Erythrocytes preincu1::ated with antisera prior to sonication and used as 
inhibitors . Anti - H- 2Ld = (BALB/c- H- 2dm2 x A.SW)Fl anti-BALB/c seru.m. 
Anti - H- 2Kk = monoclonal H- 2 . 25 antibody (Hl00-27.R9). 
c) Thymocytes or spleen cells preincubated for 60 min at 4°c with 100% 
erythrocyte sonicates prior to rosetting . Results expressed as% rosetting 
lymphocytes+ standard deviation of three detenninations . 
Table J.12 
Effect of Either Blocking or Capping Surface 
Immunoglobulin (Ig) on Autorosetting Potential 
a) 
of B lymphocytes 
b) 
Treatment 
Nil 
Surface Ig Blocked 
Surface Ig Capped 
% 
Autorosetting 
Spleen Cells 
18.S + 2.1 c) 
19.0 + 1.4 
20.S + 3.5 
a) Spleen cells from BALB/c nude mice were 
autorosetted. 
b) Spleen cells were incubated with immunoabsorbent 
purified sheep (Fab) 2 anti-mouse IgG either 
on ice (for blocking) 0 or at 37 C (for capping) 
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c) Mean autorosetting percentage+ standard deviation 
of mean. 
C"-
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Thymocyte 
Autorosetted 
(BALB/ c X SJL/J)Fl 
(BALB/ c X DBA/l)Fl 
Table J . 1 ~ 
Ability of Different Erythrocyte Sonicates to Inhibit Autorosetting of Fl 
Thymocytes 
Nil 
4 2 ±3 . 2 
(BALB/c X 
SJL/J)Fl 
[ 7 ±3 . s [ 
b ) 
a) 
Erythrocyte Sonicate 
(BALB/c X 
DBA/l ) Fl 
ND 
(CBA/H X 
C57BL/6)Fl 
ND 
BALB/c 
( d) C ) 
J 6 ±~~ ·~ ?! 
SJL/J 
( s) 
j 2s±3 . s f 
DBA/1 
(-9_) 
4 3 ±3 . 0 
CBA/H 
( k) 
j 7±3_6 , 
5 3 ±3 . 7 ND [ 16 ±2 . 9 l ND [ 12 ±3 . 7 1 5 3 ±3 . 1 I 13 ±3. 41 f 6 ±3 . 11 
C57BL/6 
( b) 
41±3.6 
5 3 ±2 . 6 
( CB A/H X C57BL/6)Fl 4 7 ±2 . 8 ND ND I s ±3 . s l I 7 ±4 . 4 r 4 4 ±3. 9 4 5 ±3 . 2 I 4 ±3 . 1 I !21 ±3. 61 
a) Thymocytes preincubated for 60 min at 4°c . with 100% erythrocyte sonicate prior to rosetting with 
autologous erythrocytes . 
b) Results expressed as% rosetting thymocytes ± standard deviation of three determinations. Values 
which represent significant inhibition are enclosed . 
c ) H- 2 haplotype of each mouse strain . 
ND Not determined . 
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Fk. _ J.6 Ability of erythrocyte sonicates from different 
mouse strains to inhibit the rosetting of ( CBA/H X C57BL/6 )Fl 
thymocytes with ( CBA/H X C57BL/6 )Fl erythrocytes. The 
erythrocyte sonicates used as inhibitors are listed on the 
figure. Thymocytes were preincubated with different 
concentrations of sonicates prior to rosetting. Vertical 
bars represent standard deviations of means. The rosetting 
of control thymocytes, which were not preincubated with 
sonicates, is indicated in the right hand margin of the figure. 
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erythrocyte sonicates . Furthermore , sonicates of the parental strain 
erythrocytes were effective inhibitors of autorosetting , although in some 
cases sonicates of one parent inhibited better than the other , e . g., 
BALB/c compared with SJL/J with (BALB/c x SJL/J)Fl thymocytes. This 
"parental bias" is probably due to differences in H- 2 antigen density 
on erythrocytes rather than a property of Fl thymocytes (see section J.2.J) . 
Subsequent experiments as shortlrl in Table J .14 , demonstrated 
that spleen cells from Fl mice exhibited identical specificity of 
inhibition as Fl thymocytes . It should be noted that spleen has a much 
lower incidence of autorosetting cells than thymus and the majority of 
these autorosetting cells are B lymphocytes . Finally , the inhibition 
data in Tables J . lJ and J .14 confirms that CBA/H (H- 2k) and BALB/c (H-2d) 
erythrocyte sonicates show completely cross reactive inhibition, i.e., 
receptors carried by thymocytes or peripheral lymphocytes from k and 
d hapl otypes are cross reactive (see sections J . 2 . 2) . 
J . 2 .11 Specificity of Rosetting by Lymphocytes from Chimeric 
Mice 
In order to establish whether the thymic epitheliu_m 
dictates the specificity of the H- 2L region restricted receptors on 
thymocytes and spleen cells , three types of chimeric mice were 
examined , namely : Fl into parent ; parent into Fl and completely allo-
geneic chimeras . The specificity of the chimeric thymocytes , as measured 
by inhibition of rosetting by erythrocyte sonicates, is presented 
in Table J .15 . In all three types of chimeras the thymocytes gave the same 
pattern of inhibition as the donor cells rather than as the X- irradiated 
recipient . Thus , with the completely allogeneic chimera, C57BL/6 ~ 
CBA/H , inhibition of rosetting was achieved only with sonicates 
derived from C5?BL/6 or (C57BL/6 x CBA/H)Fl mice . Similarly, with 
the (C57BL/6 x CBA/H)Fl ~ CBA/H chimera both parental sonicates 
' 
0 
N 
rl 
Table J .lL~ 
Ability of Different Erythrocyte Sonicates to Inhibit Autorosetting of Fl Spleen Cells 
Spleen Cell 
Autorosetted 
Nil 
(BALB/c X SJL/J ) Fl 11±2 . 2 
(BALB/ c X DB A/ 1) F 1 10±2 . 4 
( CB A/H X C57BL/6)Fl 7±2 . 1 
(BALB/ c X 
SJL/J)Fl 
.I 1 ± 1. 7 1 
b) 
ND 
ND 
(BALB/c X 
DBA/l )Fl 
ND 
I l±l.3r 
ND 
a) 
Erythrocyte Sonicate 
(CBA/H X 
C57BL/6 )Fl 
ND 
ND 
I 1±1.41 
BALB/c 
( d ) C) 
I 1±1.s l 
1 2±1 . 6 ! 
I 1±1.7 1 
SJL/J 
( s ) 
1 3 ± 2 . 21 
9±2.1 
8±1 . 5 
DBA/1 CBA/H 
(_g_) ( k) 
8± 2. 7 I 2±1 .21 
I 2±2.1 I I 1±1 . 41 
7±2.4 I 2± 1. 31 
a) Spleen cells preincubated for 60 min at 4°c. with 100% erythr ocyte sonicates prior to rosetting 
with the erythrocytes . 
Footnotes as in Table J .lJ 
C57BL/6 
( b) 
9±1.9 
11±2.3 
1 3±1 . 6 1 
, 
M 
N 
r-1 
Table J .151 
Ability of Erythrocyte Sonicates to Inhibit Rosetting of Thymocytes from Chimeric and Normal Mice 
Thymocyte 
Rosetted 
C57BL/6 ---=r CB A/H 
C57BL/6 
( C57B L/6 X CBA/H) ~ 
CBA/H 
( C57BL/6 X CB A/H)Fl 
CBl\/H ~ 
( C57B L/ 6 X CBA/H)Fl 
CBA/H 
Erythrocyte 
Nil 
CBA/H 34±2 .7 
CBA/H 33±2 . 8 
CBA/H 33 ± 2.9 
CBA/H 32±3.5 
(C57BL/6 X CBA/H)Fl 46±3.4 
(C57BL/6 X CBA/H )Fl 45±4.2 
CBA/H 
( k) c) 
27±1.7 
30±2 .4 
110 ±2.7 1 
1 9±3 .21 
I 19 ± 2. 5.1 
8±4.31 
Erythrocyte Sonicate 
C57BL/6 
( b) 
l11 ±2.8 jb) 
j 14±2 . 5 j 
11 8±3.4 1 
-
11 6±3 .61 
47±3.6 
38±3.8 
DBA/1 
( q) 
29±2.9 
31±2 .5 
31±3.0 
29±3 . 3 
45±3.8 
44±2.9 
a) 
(C57BL/ 6 X CBA/H)Fl 
j 12±2.8 1 
I 1 s + 3 . 1 ! 
1 9± 3.21 
_I 14 ±3 .4I 
17 ± 4.21 
11 ±2 . 8 1 
a) Thymo c ytes preincubated for 60 min at 4°c. with 100% erythrocyte sonicates prior to rosetting with 
the erythrocytes. 
Footnotes as in Table J .lJ 
were inhibitory whereas with the CBA/H ~ (C57BL/6 x CBA/H)Fl chimeras 
only CBA/H derived erythrocyte sonicates inhibited rosetting. It should 
be emphasized that the same specificity of sonicate inhibition was 
obtained whether chimeric thymocytes were rosetted with CBA/H , C57BL/6 
or (C57BL/6 x CBA/H) Fl erythrocytes (data not shown) . This result is 
consistent with the earlier finding that, although thymocytes can 
rosette with allogeneic erytnrocytes , inhibition of rosetting was only 
achieved with syngeneic erythrocyte sonicates (see section J .2 . 6) . 
In similar experiments, as shown in Table J .16, it was 
found that spleen cells from these chimeras showed the same specificity 
of inhibition as the thymocytes . 
J . J Discussion 
J.J . l Nature of Autorosetting Cells 
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Substantial subpopulations of murine thymocytes , spleen , 
lymph node and bone marrow cells can bind autologous , syngeneic or 
allogeneic red cells (Micklem and Asfi 1971 , Charriere and Bach 1975, 
Braganza et al 1975, Kolb 1977 , 1978 , -abarra and Charriere 1979) . 
However , the proportion of cells that autorosette in different lymphoid 
organs varies between laboratories due to important assay variables 
that have been described in detail in chapters 1 (section 4 .1 ) and 2 
(section 2 .10 .1 ) . 
Using a standa:r:tlised rosetting assay the frequency 
of autorosetting cells in different lymphoid organs was thymus ~ spleen > 
lymph node > bone marLOW (Table J .1). A comparatively high proportion 
of thymocytes formed rosettes (20 - 5Cf'/o) and up to JC!'/o of spleen cells 
autorosetted. However , autorosetting efficiency did van; between mouse 
strains, an effect that appeared to be controlled by background (non-
H-2) genes and resided in the rosetting erythrocyte . 
CV"'\ 
N 
rl 
Table J .16 
Ability of Erythrocyte Sonicates to Inhibit Rosetting of Spleen Cells from Chimeric and Normal Mice 
Spleen Cell 
Rosetted 
C57BL/6 ~ CBA/H 
C57BL/6 
(C57BL/6 X CBA/H) -..!)-
CBA/H 
(C57BL/6 X CBA/H)Fl 
CBl\/H ~ 
(C57BL/6 X CBA/H)Fl 
CBA/H 
Erythrocyte 
CBl\/H 
CBA/H 
CBA/H 
CBA/H 
(C57BL/6 X CBA/H)Fl 
(C57BL/6 X CBA/H)Fl 
Nil 
7 ±2. 2 
9 ±2 . 4 
7 ±1 . 8 
8 ±1 . 4 
7 ±2. 1 
8 ±1 . 7 
a) 
Erythrocyte Sonicate 
CBA/H 
( k) C) 
7 ±1 . 4 
8 ±1 . 8 
I 1±1 . o r 
r l ±1 . 6 t 
l ±0 . 9 I 
[ 1 ±o . 7 1 
C57BL/6 
( b) 
I 1±1.2} 
13 ±1 . 3[ 
13 ±1. 41 
.-14 ±1 . s I 
8 ±1 . 6 
7 ±1. 9 
b) 
DBA/1 
( q) 
8 ±2 . 0 
7 ±1 . 7 
8 ±1 . 7 
7 ±2 . l 
7 ±2. 2 
7 ±2 . 4 
(C57BL/6 X CBA/H)Fl 
I 2 ±1. 41 
l 1 ±1 . 1 I 
I 1 ±1 . 31 
I 1 ±o . 91 
1 ±1 . 2 I 
2 ±1. 1 I 
a) Spleen cells preincubated for 60 min at 4°c. with 100% erythrocyte sonicates prior to rosetting 
with the erythrocytes . 
Footnotes as in Table J .lJ 
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Although thymocyte autorosetting indicated that immature 
T lymphocytes carry autorosetting receptors, cell separation experiments 
demonstrated that in fact, the majority (80%) of autorosetting cells 
in spleen are B lymphocytes , whereas approx . 15% of T cells and few ( ~ 1%) 
null cells can autorosette . However , Ig capping and capping studies clearly 
demonstrated that autorosetting by B lymphocytes is mediated by 
recognition structures distinct from surface Ig (Table J.12) . Similar 
results have been reported by others (Primi et al .1979 , Kolb 1978) . 
J . J .2 Specif1city of Autorosett1ng Receutors 
In this chapter the specificity of the autorosetting 
phenomenon was analysed by an inhibition assay that entailed incubating 
lymphoid cells with different erythrocyte sonicates prior to rosetting 
the lymphocytes with autologous erythrocytes . With this assay it was 
demonstrated that autorosetting is mediated by a receptor on thymocytes, 
as well as on peripheral T and B lymphocytes which preferentially 
recognize self H- 2L/ H- 2D region controlled molecules on the red cell 
surface . 
Data in favour of this conclusion can be summarised as 
fo l lows , First , inhibition of thymocyte and spleen cell autorosetting 
in seven different mouse strains suggested H- 2 linked rather than tack-
ground genes controlled the reaction (Tables J . J - J . 5) . Second, using 
erythrocyte sonicates from a range of recombinant mouse strains it was 
pos sible to map the inhibition to the H- 2L/H-2D region of the H- 2 
complex (Fig . J .2 - J . 4) . ·· Third , the inability of the BALB/c- H- 2dmZ 
f I 
mutant , an H- 2L deletion mutant (McKenzie et al 1977 , Demant and Neauport-
Sautes 1978) , to inhibit the autorosetting of wild type (BALB/c) thymocytes 
and spleen cells directly mapped the specificity of autorosetting to the 
H- 2L region (Fig . J . 2 & J .4) . Simila~ly , the Bl0.D2- H- 2dml mutant 
(M504) , which has substantially modified H- 2L and H-2D antigens 
( organ et al 1978) , was unable to inhibit ~·rild type 2 - 2d (3LB/c) 
r osetting a..d expressed a di::erent spec~:icity receptor on 
its thymocytes (~ab_es J ,9 and J ,- ) . ?our~n , a: ~:. - ~- 2~ se~a iie~e ab_e 
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..1. • n • 11 1-.1 T 1 • • b • 1 • t.,O s:pec_:_ca y ;_; ocK - __ e in __ i _-cio __ of 3A:..._n/c autorosetting by son~cates 
of BALB/ c erythrocy-:,es (_ab_e J ,l _) . 
T e specific~ ty of autorose.1...1..ing of : :.-,e di=:feren-: 
hap_otypes , :ame_y o, d , K , ~ ar..d s , ~ere exa _ined ~n tn._:__s study . mhe 
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carried by .!..ne d and~ hap 0.1.J?eS even .!.. ho gh .!..here are serologica __ y 
de tec table d i :ferences bet,-een these rl- 2.u _o _ecules (.1cKenzie et al 1977 , 
' ' De ant and -ea port Sa utes 197 ~a: _sen ar.d Sachs 978) . 
rv;:._1 c oUirs e , d e .1. o -L,' _ _ e k ,..., · ' " " · ' u.L _ac_ 01 su_ :,ao_e reco oi:_ar.-c, "'.ilO se 
s t rai:_s , B tan.1.. ~1-ce and a __ o2-nt:.sera ~.1.. -rras no .!.. uoss~ole to direct_y 
ap t_ _e s_ ecifi c i ty f .!.. ile au.1.. roset.1.ing receutors .1.0 'he H- 2L reg~on _n 
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spleen , lymph node and bone marrow cells from the H-2L deletion mutant 
(H- 2dmZ) to rosette with any red cells (Tables J . 7 and J .8) is consistent 
with this notionl 
Collectively these results suggest that rosetting of 
murine lymphocytes with syngeneic , allogeneic and xenogeneic (rat) 
erythrocytes is mediated by an H- 2L/H- 2D region controlled receptor 
that has highest affinity for syngeneic H- 2L/H- 2D antigens on erythrocytes 
but which can cross react with other H- 2 antigens on the red cell 
surface . Inhbition studies with erythrocyte sonicates revealed this 
"self H- 2L/ H- 2D preference " probably for two reasons : (i) binding of 
intact red cells represents multi - point binding whereas the membrane 
vesicles generated by sonication would probably not bind in such a 
multi - point fashion and (ii) unbound sonicate was washed away from 
lymphocyte whereas it was impractical to remove u_nbound red cells in 
rosetting assays . The ability of sonicate- inhibition studies to reveal 
"self- preference" is probably most clearly demonstrated by t he rosetting 
behaviour of the Bl0 .D2 - H- 2dml(M504) mutant erythrocytes . Sonicates 
of these red cells are unable to inhibit wild- type (H- 2d) autorosetting 
(Fig . J . 2 and J .4) whereas when intact these mutant red cells rosette 
normally with the autologous and syngeneic (BALB/c) thymocytes (TablesJ.7&J .8 ) 
At this point it should be noted thBt two recent 
reports have appeared describing attempts to map the genes responsible 
for autor osetting . In the first report , Primi et al concluded that 
rosetting was under H- 2 control but from their data , suggested that this 
self- recognition phenomenon was associated with a new locus mapping 
between H- 2G and H- 2L/H- 2D. Data presented in this chapter are not 
completely compatible with this interpretation , although there are 
substantial differences between the assay systems used in the two 
laboratories . First , Primi et al used cultured spleen cells whereas 
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freshly prepared thymocytes and spleen cells were used in all the 
experiments described in this chapter . Even so , uncultured spleen cells 
carry H- 2L/ H- 2D r egion controlled receptors . Second , in this chapter 
the autorosetting receptors have been genetically mapped using mutant 
mice and autorosette - inhibition assays , whereas Primi et al based 
their genetic mapping on the observation that cultured spleen cells could 
only rosette with erythrocytes from certain mouse strains . Thi s is a 
surprising result as uncultured thymocytes and spleen cells rosette 
equally effectively with er"Jthrocytes from autologous, syngeneic , or allo-
geneic strains (Micklem and Asfi 1971, Sandilands et al 1974 , Charriere 
and Bach 1975 , Braganza et a l 1975 , Kol b 1977) . At present , the only 
rational explanation of these differences is that cultured spleen cells 
r ecognize different st:r:uctures on erythrocytes than their uncultured 
counterparts . 
In the second study , Charriere et al (1980) employed 
t wo approaches to detenn.ine the role of the H- 2 _complex in autorosetting. 
Fi rst , like Primi et al (1979) , they observed that l ymphocytes 
pr eferentially bound H- 2 compatible erythrocytes .The second approach 
was to measure the ability of H- 2 compatible or incompatible erythrocyte 
ghosts to inhibit autorosetting . Based on the data of one H- 2 
recombinant mouse strain BlO. A (Kk , Dd) , they concluded that both K 
and D regions were involved in autorosetti ng . However , this study only 
examined one recombinant between k and d haplotypes , and the da ta in 
thi s chapter clearly demonstrated that the autorosetting receptors of 
k and d haplotypes are completely cross- reactive, i . e . , genetic mapping 
studies cannot be attempted between these baplotypes . 
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J . J . J Exnression of Autorosetting Recentors on Fl Lymnhocytes 
Analysis of the specificity of the autorosetting receptors 
in Fl mice using the sonicate- inhibition approach, revealed that both 
the thymocytes and peripheral lymphocytes in these animals express receptors 
against both parental haplotypes . In fact, the sonicate inhibition data 
in Tables J . lJ & J .14 suggest that the majority of thymocytes and spleen 
cells simultaneously express receptors against both parents . This lack 
of allelic exclusion is clearly evident with (BALB/c x DBA/l)Fl 
lymphocytes where eT"ljthrocyte sonicates from either BALB/c or DBA/1 
mice reduced rosetting by 75 -8Cf/o . Similarly , with (CBA/H x C57BL/6)Fl 
lymphocytes CBA/H and C57BL/6 sonicates inhibited rosetting by 70 -
9Cf/o and 55 - 6Cf/o respectively . Presumably once lymphocyte receptors 
against one parental haplotype bind sonicated erythrocytes the receptors 
directed against the other parent are sterically masked. This notion 
is supported by the observation that erythrocyte sonicates are membrane 
vesicle preparations , and not solubilised membrane components , i . e. , 
the vesicles that inhibit autorosetting are sedimented by centrifugation 
at between 5000 g and 20 , 000 g . Of course , this study does not eliminate 
the possibility that small subpopulations of Fl thymocytes exist which 
carry receptors directed against onl y one of the parents .Furthermore, 
whether Fl lymphocytes exhibit allelic exclusion of their receptors 
when they become irrununocompetent or after antigenic stimulation remains 
to be determined . 
J . J.4 General Implications of MHC - Controlled Autorosetting Receptors 
Although the genetic and functional implications of the 
data presented in this chapter will be discussed in chapter 7 some of the 
more important points are worth considering here . 
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First , the data suggests that the H- 2L/ H- 2D region controls 
both the autorosetting receptors on thymocytes and the acceptor sites 
on erythrocytes . The results with the H- 2L/ H- 2D region mutant mice , 
which simultaneously express altered autorosetting receptors and 
acceptors , clearly supports this concept . There appear to be two 
possible explanations for these findings : (i) tne H- 2L/H- 2D gene product 
stimulates , possibly via somatic mutation , the generation of a receptor 
which recognizes self H- 2L/H-2D. This possibilty appears unlikely , 
however , as analysis of lymphocytes from allogeneic and semi-allogeneic 
chimeras (Tables J .15 & J .16) clearly demonstrated that radio-resistant 
elements of the irradiated recipient did not modify the haplotype 
specificity of the autorosetting receptors on donor derived lymphocytes. 
(ii) more likely interpretation is that the H- 2L/H- 2D region in some way 
directly codes for the autorosetting receptors and acceptors. How one 
genetic region can simultaneously code for these interacting structures 
will be considered in detail in chapter 7, 
Second , a surprising aspect of this study is the 
dominance of H- 2L/H-2D region controlled receptors on autorosetting 
lymphocytes . From the studies with cytotoxic T cells against foreign 
antigens , one would have expected to also detect autorosetting receptors 
on lymphocytes against self H- 2K and self H- 2D antigens (Doherty et al 
1976 , Biddison et al 1978) . This observation strongly suggests that the 
autorosetting receptors are not involved in H- 2- restricted killing of 
targets by Tc cells . Furthermore , unli ke Tc cells , the haplotype 
specificity of the autorosetting cells was not altered in allogeneic 
and semi- allogeneic chimeras (Tables J .15 & J .16) . 
The functional significance of the autorosetting 
receptors on T and B lymphocytes represents a fascinating question which 
lJO 
at present , cannot be answered . Undoubtedly these recognition structures 
appear on immature T and B lymphocytes as substantial subpopulations 
of thymocytes and bone marrow cells carry the receptors. Whether immuno-
logically competent lymphocytes also eXl)ress the receptors needs to be 
established. It should be noted, however , that any function of these 
autorosetting receptors must be tightly regulated in vivo by blocking 
factors in serwn (Kolb 1977) , a point that will be discussed in more 
detail in chapter 6. On the other hand , the autorosetting receptors may 
be involved in a range of 'odd ' iITLmu..nological phenomenon that have been 
reported in the past . For example , the species-specific attachment 
of thymocytes to macrophages in vitro may be mediated by these receptors 
(Siegel 1970 , Lipsky and Rosenthal 1973) . At a more functional level, 
it is conceivable that the phenomenon of "hybrid resistance", where 
irradiated Fl hybrid recipients reject parental bone marrow (Cudkowicz 
and Bennett 1971), involves the autorosetting receptors. Furthermore, 
the self-reactive cytotoxic T cells which freQuently appear following 
in v1tro culture (Cohen and Wekerle 1973) or after viral infections 
(Pfi zenmaier et al 1975 , Komatsu 1978) may recognize target cells via 
receptors for self H- 2L/H-2D. Finally , although only 1% null cells 
in spleen can autorosette , the general properties of natural killer 
cells (Lotzova and Mccredie 1978) suggest that they may interact 
with target cells via recognition structures which primarily recognize 
self H- 2L/H-2D antigens . 
Finally, it should be noted that previous studies have 
demonstrated autorosetting lymphocytes in a range of other species, such 
as rats , rabbits, pigs and humans (Sandilands et al 1974 , Braganza et al 
1975 , Kolb 1977 , Baxley et al 1975). It seems likely that MHC - controlled 
receptors may also mediate autorosetting in these species. Furthermore, 
lJl 
in some mammalian species the binding of xenogeneic erythrocytes by 
lymphoid cells (Braganza et al 1975 , Kolb 1977 , Jondal et al 1972, 
Stadecker et al 1973) may be mediated by MHC - controlled receptors. 
J .4 Summary 
Subpopulations of murine spleen , lymph node and bone 
marrow cells can bind autologous erythrocytes . The specificity of this 
interaction was investigated by measuring the ability of different 
erythrocyte sonicates to inhibit rosette forma tion . Using erythrocyte 
sonicates from recombinant mouse strains it was demonstrated that rosetting 
with syngeneic red cells was mediated by receptors on thymocytes and 
peripheral T and B lymphocytes which preferentially recognize self 
H- 2L/ H- 2D region controlled molecules on the red cell surface . The 
specificity of autorosetting was directly mapped to the H- 21 region by 
the inability of erythrocyte sonicates from the BALB/c- H- 2dm2mutant , 
an H- 2L deletion mutant , to inhibit the rosetting of wild type (BALB/c) 
lymphocytes . The Bl0 .D2 -H- 2dml mutant , which has substantially modified 
H- 2L and H- 2D antigens , supported this conclusion. Furthermore , anti - H- 21 
sera were able to specifically block the inhibition of rosetting by 
erythrocyte sonicates . 
The above procedures clearly implicated the H- 21 region 
in the lymphocyte rosetting of d and k haplotypes . With the s haplotype 
the rosetting was mapped to the H- 2L/H- 2D region , whereas with the band 
.9.. haplotypes rosetti ng was only mapped to the D end of the H- 2 complex . 
This study also suggested complete cross reaction between the autorosetting 
receptors carried by the k and d haplotypes , whereas the receptors of b , 
q ands haplotypes were haplotype specific . I n addition, the i nhibition 
_, -
assay indicated that the rosetting of t hymocytes and extra-thymic 
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lymphocytes with allogeneic and xenogeneic (rat) erythrocytes was mediated 
by a receptor primarily directed against self H- 2L/H- 2D molecules . 
Studies with H- 2L/H- 2D mutant mice also demonstrated 
that autorosetting is under H- 2L/H- 2D region control. 
The specificity of autorosetting also was examined in 
Fl hybrid and chimeric mice by inhibiting autorosetting with different 
erythrocyte sonicates . It was found that the majority of Fl lymphocytes 
simultaneously express receptors against both parental haplotypes . Further-
more , analysis of lymphocytes from allogeneic and semi-allogeneic chimeras 
clearly demonstrated that radioresistant elements in the irradiated 
recipient did not modify the haplotype specificity of the receptor on 
donor derived lymphocytes . 
Final ly , the expression of autorosetting receptors on 
splenic T and B cells was examined . It was found that the majority of 
autorosetting lymphocytes in spleen were B cells , fewer T cells (15%) 
and virtually no( < 1%) null cells autorosette . Futhe:onore, the autorosetting 
r eceptors on B lymphocytes were distinct from surface Ig and could develop in 
athymic (nude) mice . 
Chapter 4 
Autorosetting Receptors on Thymocytes 
Recognize Carbohydrate Structures on 
Erythrocytes 
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4 .1 Intr oduction 
In the preceding chapter , the autorosetting phenomenon ~as 
demonstrated to be mediated by H- 2- controlled receptors on thymocytes 
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and extra- thymic lymphocytes that primarily recognize self H-2L/H- 2D 
molecules on erythrocytes . Obviously this autorosetting system represents 
an ideal opportunity to chemically characterize the receptor and acceptor 
molecules involved in an H- 2- controlled interaction . This chapter describes 
preliminary attempts to characterize these molecules . On the basis of 
sugar inhibition studies and the sensitivity of the receptors and acceptors 
to protease and glycosidase treatments it appears th.at a protein receptor 
on thymocytes recognize a carbohydrate structure on er-1throcytes. 
4 . 2 Results 
4 . 2 .1 . Inhibition of Thymocyte Rosetting with Sugars 
The thirty monosaccharides and oligosaccharides listed in 
chapter 2 , Table 2 . 2 were tested for their ability to inhibit the rosetting 
of different strains of thymocytes with CBA/ H erythrocytes. The sugars 
tested for inhibitory activity represent the same haptens used previously 
to partially characterize Ia antigens (McKenzie et al 1977). It should be 
noted that it has previously been shown that erythrocytes from different 
mouse strains vary in their rosetting behaviour , a phenomenon dependent 
upon the genetic background rather than the H- 2 haplotype of the er-Jthrocytes 
(chapter J , section J . 2 .1) . Thus , in order to directly compare the sugar 
inhibition observed with different strains of thymocytes , all thymocytes 
were rosetted with CBA/H erythrocytes . 
The eight sugars that showed inhibitory activity are listed in 
Table 4 .1 . It was found that the monosaccharides D- galactosamine , D- mannose 
and N- acetylneuraminic acid and the oligosaccharides raffinose , maltose 
and mannan inhibited the rosetting of all mouse strains tested. Mannan , a 
' (j 
CV"\ 
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Sugar Inhibitor 
Monosaccarides: 
D-glucose 
D-galactose 
D-galactosamine 
D-mannose 
D-mannosamine 
N-acetyl-
neuraminic acid 
Oligosaccarides: 
raffinose 
maltose 
mannan 
Table 4.1 
Ability of Different Sugars to Inhibit the Rosetting of Different Thymocytes 
with CBA/H Erythrocytes 
a) 
Strain of Origin of Thymocytes 
CBA/H B10.BR DBA/1 B10.G DBA/2 BALB/c B10.D2 C57BL/6 C57BL/10 
( k) b) ( k) <.s) ( ~) ( d) (d) ( d) (b) ( b) 
- - -
- - - - - -
66±6.6 73±7.1 63±6.9 72±7.4 64 ±6. 9 70±6.9 71±5.7 61±6.7 70±7.1 
74±4.4 7 7 ±4. 6 79±5.l 68±4.J 76±3.6 71±5.5 67±4.8 74±3.9 75±4.1 
- - 52±6.2 60±7.5 
- - - 62±6.0 56±6.l 
66±6.5 67±5.2 54±4.7 66±6.5 59±4.5 67±6.2 65±4.2 70±5.8 65±5.5 
49±5 .7 51± 5. 2 48±5.6 47±4.8 57±5.4 53±4.9 49±5.l 41±6.4 43±4.9 
58± 6. 3 54±6.2 60± 6. 2 4 8± 5. 9 4 6± 5. 3 62±5.6 64±4.8 5 3± 5. 9 56±6.2 
84±4.6 87±6.5 87±4.9 82±5.3 85±6.2 89±4.5 79±5.2 81± 5. 7 84±4.6 
SJL/J B10.d2 
mutant 
( s) (dml) 
44±6.5c) 3 2 ±5. 4 
72±6.5 67±5.4 
70±6.2 66±4.6 
68±5.l 63±5.4 
52±4.6 52±5.3 
64±5.5 59±4.9 
86±5.4 81± 6. l 
a) Thymocytes preincubated for 60 min at 4°c with sugar (lOmg/ml) prior to rosetting with CBA/H erythrocytes. 
b) H-2 haplotype of mouse strains. 
c) 
Results expressed as% inhibition of rosetting± standard deviation of three determinations. A dash means no significant inhibition of rosetting. 
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polymer of mannose , was the most effective of these inhibitory sugars. On 
the other hand , at 10 mg/ml D- galactose and mannosamine exhibited strain 
specific inhibition . Thus , D- galactose only inhibited the rosetting of 
SJL/ J (H- 2s) and Bl0 .D2 mutant (H- 2dml) thymocytes , whereas D-mannosamine 
inhibited the rosetting of thymocytes from both H- 2Q (DBA/1 and BlO.G) and 
b H- 2 (C57BL/6 and C57BL/10) haplotypes . 
The effect of a range of sugar concentrations on the rosetting of 
DBA/ 1 and CBA/H thymocytes is depicted in Fig . 4 .1 . It can be seen that 
D- galactosamine and mannan inhibited the rosetting of both strains . In 
contrast , D- mannosamine strongly inhibited the rosetting of DBA/1 
thymocytes but , only at very high concentrations (i.e ., 20 mg/ml), showed 
slight inhibition of CBA/ H rosetting . The monosaccharides D- glucose and 
D- galactose were non- inhibitory at all concentrations used. 
Although previous studies have shown that rosetting is mediated 
by H- 2L/ H- 2D region controlled receptors on thymocytes (chapter J) , it was 
i mportant to confirm that the di fferences in sugar inhibition were H-2 
controlled . Certainl y , the data in Table 4 .1 suggested H- 2 involvement as 
different BlO congenic strains of mice exhibited different patterns of sugar 
i nhi bition , i . e ., mannosamine inhibited BlO .G (H - 2Q) and BlO (H- 2b) 
rosetting , but failed to block BlO . BR (H- 2k) and Bl0 .D2 (H- 2d) rosetting. 
Furthermore , comparable sugar inhibition was observed with thymocytes from 
mouse strains of the same H- 2 haplotype but of different genetic back-
ground , e .g . DBA/1 and BlO .G (H- 2q) . In addition , rosetting of Bl0.D2- H-2dml 
mutant thymocytes was inhibited by D- galactose , whereas the rosetting of 
wild- type Bl0 .D2 thymocytes was not inhibited by this sugar. Since this 
mutant has substantially modified H- 2L and H- 2D antigens (Morgan et al 
1978) this result suggests that the sugar inhibition is H- 2L/H- 2D region 
controlled . 
Further genetic analysis of the inhibition of rosetting by 
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SUGAR CONCENTRATION mg/ml 
Fig. 4. 1 Ability of different concentrations of sugars to 
inhibit the rosetting of either DBA / 1 ( left hand graph ) or 
CBA/H (right hand graph) thymocytes with CBA/H erythrocytes . 
The sugars used as inhibitors are listed on the right hand 
side of the figure ·. Vertical bars represent standard deviations 
of means. The rosetting of thymocytes, in absence of inhibitors, 
is indicated in the right hand margin of each graph. 
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D- mannosamine is presented in Table 4 .2 . Inhibition of autorosetting by 
D- mannosamine mapped to the D- end of the MHC for both .2. and b haplotypes. 
The critical recombinant :or the haplotype was Bl0 . A(2R) and for the .51. 
haplotype , Bl0 .T(6R) . Similarly , the inhibition of§. haplotype rosetting 
by D- galactose mapped to the D- region , in this case A.TH being the 
important recombinant strain . These data are consistent with the previously 
described D- region control of autorosetting in the b , .51. and§. haplotypes 
(chapter J) . 
Collectively , the sugar inhibition data suggests that H- 2 
controlled rosetting involves the recognition of carbohydrate moieties, 
subtle differences in tne structure of these carbohydrates occurring 
between different H- 2 haplotypes . 
4 . 2 . 2 Effect of Different Enzymic and Chemical Treatments on the 
Autorosetting of Thymocytes and Erythrocytes 
To further establish the nature of the autorosetting receptor 
on thymocytes and the acceptor structure on erythrocytes, initially thymocytes 
and erythrocytes from CBA/H mice were subjected to a range of enzymic and 
chemical treatments (Table 4 . J) . It was found that both the thymocyte 
receptor and the erythrocyte acceptor were almost completely abolished by 
the proteases bromelin , pronase and papain and partially destroyed by 
trypsin . In contrast , mixed glycosidases destroyed the erJthrocyte acceptor 
but had no effect on the thymocyte receptor . A nu.mber of selective exo-
glycosidases also partially destroyed the erythrocyte acceptor, namely 
8-galactosidase , neuraminidase and a- mannosidase, whereas the acceptor was 
resistant to a- galactosidase . None of these glycosidases affected the 
thymocyte receptor . Furthermore , the erythrocyte acceptor, but not the 
thymocyte receptor , was susceptible to oxidation by low concentration 
-4 (10 M) of periodate . Thus , the data ~n Table u.3 suggested that a nrotein 
sensitive receptor on thymocytes recognized a urotein- bou_nd carbohydrate 
g 
rl 
Table 4 . 2 
Ability of D-mannosamine and D-9alactose to Inhibit the Autorosetting of Different 
Congenic and Recombinant Strains of Thymocytes 
Thymocyte 
Strain a) 
Bl0 . 02 
BlO . G 
Bl0 .T( 6R ) 
Bl0 . A(2R) 
BlO 
SJL/J 
ATH 
BlO . BR 
Haplotype 
K 
I S G D ABJEC 
d ddddd d d d 
q qqqqq q q q 
q qqqqq q ? d 
k kkkkd d ? b 
b bbbbb b b b 
s sssss s s s 
s sssss s s d 
k kkkkk k k k 
% Rosette-Forming Cells a) 
Control D-mannosamine D-galactose 
60 + 2. 4 55 + 3. 3 57 + 3 . 7 
b) 
56 + 3.4 I 15 + 2 . 9 1 55 + 3 . 2 
55 + 2 . 9 54 + 2 . 8 52 + 2. 9 
55 + 3.8 I 1 7 + 4. 2 J 53 + 3 . 3 
49 + 2.9 I 18 + 2 . 2} 46 + 4.4 
20 + 1. 7 18 + 2 . 3 I 9 + 3 . ~[ 
39 + 2.8 35 + 4.0 36 ± 2 . 6 
61 + 3.8 54 + 4.6 59 + 3 . 9 
a) Thymocytes preincubated for 60 min at 4°c with sugar ( 20 mg/ml) prior to rosetting 
with a u tologous erythrocytes . 
b) Results expressed as% rosetting cells± standard deviation of three determinations. 
'n I." nclosed-
Table 4.J 
Effect of Different Enzymic or Chemical Treatments 
on the Ability of CBA/H Thymocytes and Erythrocytes 
Enzyme or 
Chemical 
to Autorosette 
Cells treated 
a) 
Erythrocytes Thymocytes 
b) 
Nil 31 + 3 . 1 33 + 2.8 
Trypsin 19 + 1 . 5 20 + 2.4 
Bromelin 2 + 1.1 2 + 1.2 
Pronase 3 ± 1 . 3 5 + 1.2 
Papain 2 + 1 . 2 6 + 1. 2 
a. - galactosidase 30 + 2 . 2 29 + 2 . 7 
S-gala ctosidase 10 + 2 . 7 28 + 3.1 
Neuraminidase 19 + 2.6 30 + 2 . 3 
a. - mannosidase 12 + 1.6 28 + 1.6 
Mixed glycosidases 3 + 1. 4 27 + 2.9 
Sodium Periodate (10- 4 M) 1 + 1. 2 31 + 2 . 5 
Sodium Per iodate (10 -S M) 31 + 2.4 32 + 2 . 9 
a) Erythrocytes or thymocytes were treated with the 
appropriate enzyme or chemical prior to rosetting with 
autologous thymocytes or erythrocytes. 
b) Results expressed as% autorosetting cells+ standard 
deviations of three determinations. 
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structure on erythrocytes . 
The sugar inhibition data in Table 4 .1 suggested subtle 
differences in the carbohydrate structure being recognized by thymocytes 
from mouse strains of different H-2 haplotype. As an extension of this 
study, the effect of different exoglycosidases on the rosetting behaviour 
of thymocytes and erythrocytes from five mouse strains was examined (Table 
4.4). None of the glycosidase treatments affected the autorosetting 
ability of thymocytes from the five strains. On the other hand , the 
glycosidases had strain-specific effects on the rosetting potential 
of the erythrocytes. Thus, S-galactosidase substantially reduced the 
rosetting of CBA/H (H-2k ) and BALB/c_ (H-2d) erythrocytes whereas a-~galacto-
sidase destroyed the acceptor of SJL/J (H-2s), BlO.G (H-2q) and C57JJL/6 
(H-2b) erythrocytes. Also, a-mannosidase had a selective effect on rosetting 
destroying the acceptor site on CBA/H (H-2k), BALB/c (H-2d) and C57BL/6 
(H-2b) erythrocytes. Neuraminidase was the least effective glycosidase, 
partially destroying acceptor sites on CBA/H (H-2k) ·, BALB/ c (H-2d) and 
SJL/J (H-2s) red cells. Although not shown in Table 4.4, the acceptor on 
erythrocytes from the Bl0.D2-H-2dml mutant strain was susceptible to the 
same glycosidases as the acceptor on wild-type Bl0.D2 (H-2d) erythrocytes 
even though the mutant exhibited a slightly different sugar inhibition 
behaviour (Table 4.1). It should be noted that the specificity of the 
glycosidases was confirmed by sugar blocking experiments. The effect of 
8-galactosidase on erythrocytes was blocked by lactose (4o mg/ml), the 
effect of a-galactosidase by melibiose (40 mg/ml) and the action of a-
mannosidase by mannose (40 mg/ml). 
As with the sugar inhibition studies, the genetic basis of the 
effects of the glycosidases was examined using erythrocytes from different 
H-2 congenic and recombinant mice (Table 4.5). It was found that the effects -
of the glycosidases mapped to the D-region of the MHC . Thus, with a-galacto-
("'I 
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Enzyme used 
Nil 
s-galactosidase 
s-galactosidase 
a-galactosidase 
a-galactosidase 
a-mannosidase 
a-mannosidase 
Neuraminidase 
Neuraminidase 
Table 4 . Li-
Effect of Different Glycosidase Treatments on Autoros etting of 
Thymocytes and Erythrocytes from Different Mouse Strains 
a) Mouse Strains 
Cells 
treated 
-
Erythrocytes 
Thymocytes 
Erythrocytes 
Thymocytes 
Erythrocytes 
Thymocytes 
Erythrocytes 
Thymocytes 
CBA/H 
( k) C) 
30 + 2.9 
17 
b) 
+ 2. ~I 
31 + 2.8 
28 + 3.1 
31 + 3. 1 
j 11 + 1. 7 J 
31 + 2.9 
J 2 0 + 2 . 6 1 
30 + 3.1 
BALB/c 
( d) 
42 + 4.7 
j 10 + 2. 5 1 
39 + 3 . 5 
36 + 2.9 
39 + 3. 3 
11 0 + 2 . 6 J 
37 + 4. 2 
J 31 + 2 . 8 ] 
40 + 3 . 2 
SJL/J 
( s ) 
18 + 2 . 2 
20 + 1.9 
19 + 1. 9 
I 3 + 1 . 91 
19 + 1.8 
18 + 2 . 3 
19 + 2.0 
_I 13 + 3 . 4 1 
20 + 2 . 2 
BlO.G 
( q) 
53 + 4.8 
48 + 3. 8 
50 + 3 . 2 
1 2 7 + 4. 71 
53 + 4.1 
55 + 5. 5 
53 + 5. 1 
48 + 4 . 7 
54 + 4.2 
C57BL/6 
( b) 
46 + 4.6 
42 + 4.6 
48 + 3.1 
I 29 + 3. 41 
47 + 3 . 9 
1 31 + 4. 11 
48 + 3. 2 
43 + 3. 6 
47 + 4.6 
a ) Erythrocytes or thymocytes were treated with the appropriate enzyme prior to rosetting 
with autologous thymocytes or erythrocytes . 
b) Results e xpress ed as% autorosetting ce lls ± standard deviations of three determinations. 
Values which represent significant effect are enclosed. 
3-
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Table L~.5 
Effect of Different Glycosidase Treatments on Autorosetting Ability of Erythrocytes from 
Different Mouse Strains 
Hap lo type . a) Glycosidase Treatment 
Strain I S G D K 
ABJEC Nil a.- galactosidase B-galactosidase a.-mannosidase 
Bl0 .D 2 d ddddd d d d 57 + 4. 3 52 + 2.6 [ 34 ± 4. ~b) 13 6 + 2 . 41 
BlO .G q qqqqq q q q 55 + 3 . 7 I 3 3 + 4 . 1 \ 56 + 3 . 6 50 + 3 . 5 
Bl0 .T( 6R ) q qqqqq q ? d 58 + 3.9 52 + 3 . 9 137 + 2. 8] 13 5 + 2 . 71 
Bl0.A(2R) k kkkkd d ? b 54 + 2 . 2 131 + 2 . 8 1 46 + 3 . 3 12 9 + 3 . 8 J 
BlO b bbbbb b b b 48 ± 2.9 12 5 + 3 . 2 I 45 + 3. 8 I 2 8 ± 3.4 
SJL/J s sssss s s s 18 + 2.1 1 6 + 2 . 6 1 21 + 1. 7 19 + 2 . 9 
ATH s sssss s s d 37 + 3 . 7 40 + 1. 7 14 + 2 . 21 l 6 + l. 9 1 
BlO . BR k kkkkk k k k 59 + 4.1 54 + 4.4 134 + 3. 6 1 136 + 3.9 1 
a) Erythrocytes were treated with the appropriate glycosidase for 30 min 7
0 . 
at 3 C prior to 
rosetting with autologous thymocytes. 
b) Results expressed as% autorosetting cells + standard deviation of three determinations . 
sidase the effect on erythrocytes from b , .9.. and ~ haplotypes was mapped 
to the D- end by the recombinants Bl0 .A(2R), Bl0 .T(6R) and A.TH, respectively. 
Similarly , the influence of ~galactosidase on the rosetting potential of 
d haplotype erythrocytes was mapped to the D region by the recombinants 
Bl0 .T(6R) , Bl0 . A(2R) and A. TH . Finally, the effect of a- mannosidase on 
d haploty:pe rosetting mapped to the D- region on the basis of the recom-
binants Bl0 .T(6R) and A.TH . There was insufficient information to map the 
effects of a- mannosidase on band k haplotypes and B- galactosidase on k 
haploty:pe to the D- region , although the data available was consistent with 
this possibility . 
4 . J Discussion 
The experiments described in this chapter attempted to analyse 
the chemical basis of the H- 2- controlled interaction between thymocytes 
and autologous erythrocytes . It was found that rosetting was inhibited, in 
a strain- specific manner , by a range of simple sugars (Table 4.1) , an 
observation that suggested that rosetting involved carbohydrate recognition. 
Subsequent treatment of either thymocytes or erythrocytes with specific 
exoglycosidases demonstrated that thymocytes , in fact , recognized a carbo-
hydrate structure on erythrocytes (Tables 4 . J and 4 . 4 ) . The extreme 
susceptibility of the erythrocyte acceptor to periodate oxidation (Table 
4 . J) was consistent with this conclusion . Furthermore , strain differences 
in the sugar inhibition and glycosidase effects mapped to the H- 2L/H- 2D 
region of the murine MHC (Tables 4 . 2 and 4 . 5) , confirming the H- 2 controlled 
............... 
nature of the roesetting phenomenon . On the other hand , both the thymocyte 
receptor and erythrocyte acceptor were destroyed by proteases (Table 4 ,J), 
a finding previously reported by Kolb (1978). This result suggests that the 
thymocyte receptor is probably a protein and, combined with the sugar 
inhibition and glycosidase findings , the target structure on erythrocytes 
146 
the carbohydrate portion of possibly a glycoprotein . 
It could be argued that the enzymic and chemical treatments 
that modified the rosetting behaviour of thymocytes and erythrocytes 
are indirectly , rather than directly , affecting cell surface structures, 
This could particularly be the case with periodate oxidation and neura-
minidase treatment where the charge on cells is modified . This possibility 
seems unlikely , however , as the sugar inhibition and glycosidase results 
complement each other and show H- 2- linked strain differences. It should 
also be noted that the specificity of the glycosidases was confirmed by 
sugar blocking experiments . The effect of S-galactosidase on er-Jthrocyte 
was blocked by lactose (40 mg/ ml) , the effect of a-galactosidase by 
melibiose (40 mg/ml) and the action of a- mannosidase by D-mannose (40 mg/ml). 
Table 4.6 summarises the sugars and glycosidases that affected 
the rosetting of different H- 2 haplotypes . Based on this information it is 
possible to propose a tentative structure of the carbohydrate moiety re-
cognized on erythrocytes . The monosaccharides D-galactosamine, D-mannose 
and N- aceyl - neuraminic acid inhibited the rosetting of all mouse strains 
tested . This result suggests that these sugars, or close analogues , play 
a prominent role in the acceptor structure. The glycosidase results support 
this contention as in all strains the target structure was susceptible to 
either a- or S- galactosidase and , in some strains , it was affected by a-
mannosidase and neuraminidase . Furthermore, since these glycosidases only 
cleave terminal monosaccharides , the carbohydrate acceptor must be a 
branched chain structure containing terminal D- galactose , D- mannose and 
sialic acid . On the other hand , differences in the linkage of these three 
monosaccharides occur between different haplotypes . Thus, the galactosidase 
results indicate that D- galactose is et-linked in .9.., ~ and b haplotypes and 
8- linked ink and d haplotypes . Similarly , D- mannose is a- linked ink , d 
and b haplotypes and may be S- linked in .9.. and~ haplotypes , although a 
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Table 4 .6 
Summary of sugar and glycosidase Treatments that Inhibit 
Rosetting of Thyrnocytes of Different Haplot y pe 
Hap lo type 
K d s b 
Sugar 
D- galactosarnine + + + + + 
D- galactose + 
D- mannose + + + + + 
D- rnannosarnine + + 
N- acetylneurarninic acid + + + + + 
raffinose + + + + + 
maltose + + + + + 
mannan + + + + + 
Glycosidase 
S - galactosidase + + 
a. - galactosidase + + + 
a. - mannosidase + + .i.. I 
neurarninidase + + .i.. I 
+ indicates a significant effect 
indicates no effect 
B-mannosidase was not available to test this possibility . Furthermore, 
the strain- specific blocking by D-galactose and D- mannosamine suggests 
that strains can differ not only in the aor S linkage but in the point 
of linkage in the carbon ring of these sugars , e .g ., only~ haplotype 
was inhibited by D- galactose even though the rosetting of s , q and b 
- - -
haplotypes was affected by a - galactosidase . 
Although the galactosidase studies implicate either a - or 
S- linked D- galactose in the acceptor site , D- galactosamine rather than 
D- galactose was usually the inhibitory sugar (Table 4 .1) . It is un-
likely that D- galactosamine is the terminating sugar as the a - and S 
galactosidase preparations are free of galactosaminidase . A more likely 
explanation is that , since the thymocyte receptor appears to accommodate 
several sugars , D- galactosamine more effectively masks the binding site 
of the receptor than D- galactose . Similarly , the inhibition of rosetting 
by raffinose (D-Gal -al - 6- D-Glu-al - 2- D- Fru) but not by stachyose 
(D-Gal - al - 6- D- Gal -al~ 6- D-Glu-al - 2- D- Fru) could be explained in this 
way . Finally , the blocking of rosetting by man.nan , a large mol . wt . 
polymer of D- mannose , supports D- mannose involvement in the acceptor. 
In contrast , blocking by maltose (D-Glu-al - 4- D-Glu) was unexpected, 
Presumably this disaccharide mimics the core of the b:r:anched chaLn 
structure being recognized . 
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Collectively , the sugar inhibition and glycosidase results 
indicate that autorosetting involves H- 2 controlled receptors on 
thymocytes recognizing terminal D-galactose , D- mannose and sialic acid 
residues on a branched chain carbohydrate structure on erythrocytes. 
Mouse strains of different H- 2 haplotypes express carbohydrate structures 
that differ in the linkage of these three terminal sugars. Until recently 
there was little evidence for carbohydrate H- 2 antigens , but recent 
studies with monoclonal anti - H- 2 antibodies now suggest that carbohydrate 
H- 2 antigenic specificities do indeed exist (O ' Neill et al 1981 , O' Neill 
and Parish 1981) . Such a conclusion has important theoretical implications 
and these will be discussed in detail in chapter 7 , 
Summary 
Rosetting between thymocytes and autologous erythrocytes is 
mediated by receptors on thymocytes that primarily recognize self H- 2L/ 
H- 2D molecules on erythrocytes . This chapter describes preliminary 
attempts to chemically characterize the receptor and acceptor molecules 
involved in this H- 2- controlled interaction . On the basis of sugar inhibition 
studies and the sensitivity of the receptors and acceptors to protease and 
glycosidase treatments it appears that a protein receptor on thymocytes 
recognizes the carbohydrate portion of a glycoprotein on erythrocytes. 
Furthermore , the thymocyte receptor appears to recognize terminal D-
galactose , D- mannose and sialic acid residues on a branched chain 
carbohydrate structure on erythrocytes, mouse strains of different H- 2 
haplotype expressing carbohydrate structures that differ in the linkage 
of these three terminal sugars . These findings indicate that H- 2- controlled 
carbohydrate-protein interactions can occur between cells , a conclusion 
wi th important theoretical implications . 
ChaJ?ter 5 
Ch.aracterisation of Receptors and Acceptors 
Involved in Autorosetting 
150 
5.1 
5.2 
5.J 
5.4 
Table of Contents 
Introduction 
Results 
5.2.1 
5.2.2 
5.2.J 
5.2.4 
5.2.5 
Detection of Haemagglutinin in Detergent Lysates of 
Lymphoid Cells 
Specificity of Thymocyte Haemagglutinin 
Strain Differences in Haemagglutinating Activity 
Analysis of Haemagglutinin in H- 2dm2 Mutant Mouse 
Sugar Inhibition of Thymocyte Haemagglutinin 
_51 
5.2.6 Inhibition of Haemagglutinin by Autorosetting Inhibition 
Factor (AIF) 
5.2.7 
5.2.8 
Detection of Haemagglutinin Acceptor in Detergent 
Lysates of Erythrocytes 
Chemical Characterization of Haemagglutinin and 
Haemagglutinin Acceptor 
Discussion 
Summary 
Introduction 
There are several re~orts that subpopulations of murine 
lymphocytes bind autologous erythrocytes , a phenomenon termed auto-
rosetting (Micklem and Asfi 1971 , Charriere and Bach 1975 , Kolb 1977, 
Steele and Cunningham 1980) . Recently three different laboratories 
demonstrated that this interaction is H- 2 controlled , lymphocytes 
preferentially binding H- 2 compatible erythrocytes (chapter J , Primi 
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et al 1979 , Charriere et al 1980) . Furthermore , detailed genetic analysis 
described in chapter J demonstrated that lymphocytes carry H- 2L/H- 2D 
region controlled receptors which preferentially recognize self H-21/H- 2D 
molecules on the erythrocyte surface . Based on these obse:r:vations , the 
autorosetting phenomenon represents an ideal opportunity to analyse the 
molecular nature of a MHC - controlled cell- cell interaction . 
Preliminary studies described in chapter 4 indicate that 
the autorosetting receptor is a protein which recognizes the carbohydrate 
portion of a glycoprotein on erythrocytes . This conclusion was based on 
two experimental approaches . First , certain monosaccharides and oligo-
saccharides inhibited autorosetting , the pattern of inhibitory sugars 
differing between H- 2 haploty:pes , an effect which mapped to the 
D- end of the H- 2 complex . Second , both the thymocyte receptor and 
erythrocyte acceptor were protease sensitive. However , the erythrocyte 
acceptor also was destroyed by certain exoglycosidases , the glycosidase 
susceptibility of the acceptor being dependent upon the H- 2 haploty:pe of 
the erythrocyte. Furthermore , as with the sugar inhibition studies, the 
differences in glycosidase susceptibility mapped to the D-end of the MHC. 
On the basis of these observations it was proposed that the thymocyte 
receptor recognizes terminal D- galactose , D- mannose and sialic acid residues 
of a branched chain carbohydrate structure on erythrocytes, mouse strains 
of different H- 2 haploty:pe expressing carbohydrate structures that differ in 
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the linkage of these three teTI!linal sugars . 
This chauter describes attempts to isolate and characterize 
the receutor and acceptor molecules from detergent _ysates of thymocytes 
and erythrocytes . The study supports the concept that autorosetting is 
mediated by a H- 2L/H- 2D region controlled lectin that recognizes a protein-
bound carbohydrate structure on er-Jthrocytes . 
5.2 Results 
5 , 2 .1 Detection of Haemagglutinin in Detergent Lysates of Lymphoid 
Cells 
Since there is ample evidence that murine thymocytes and 
peripheral T and B lymphocytes car-01 receptors for autologous erythrocytes, 
it seems possible that detergent lysates of lymphoid cells may contain 
haemagglutinating activity . To test this possibility , advantage was taken 
of the recent observation that NP - 40 lysates of lymphoid cells can be 
depleted of NP - 40 with detergent binding beads (Parish et al 1980). The 
resultant lysates contain enough residual detergent to keep membrane 
components in solution , but insufficient detergent to lyse intact cells. 
In fact , when NP- 40 lysates of BALB/c thymocytes were 
depleted of detergent in this manner , the lysates strongly haemagglutinated 
BALB/ c erythrocytes to a high dilution , i . e ., titre of 1/128 (Table 5.1). 
In contrast , spleen cell lysates had a much lower haemagglutinating 
activity (titre of 1/4) and no haemagglutinin could be detected in 
lymph node or bone marrow lysates . This result correlates with both the 
prevalence and avidity of the autorosetting cells in these different 
lymphoid organs , i . e ., the autorosetting frequency is thymus > spleen~ 
lymph node > bone marrow (Micklem and Asfi 1971, Charriere and Bach 197 5, 
chapter J) , and peripheral lymphocytes appear to bind fewer red cells 
then thymcoytes . It should be noted, however, that the cell lysates 
used could contain both membrane - associatedand cytoplasmic haemagglutinins, 
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However , when thymocytes were separated into cytoplasmic and microsomal 
fractions all haemagglutinating activity ~as recovered in the microsomal 
~ t ' rac ion , implying that the haemagglutinin is membrane - boLLnd (Table 5 .1). 
5,2.2 Specificity of Thymocyte Haemagglut1n1n 
The next series of experiments tested the ability of a 
BALB/c thymocyte lysate to haemagglutinate syngeneic, allogeneic and 
xenogeneic erythrocytes . It was found (Table 5.2) that the lysate 
haemagglutinated all mouse erythrocytes tested , Furthermore , the lysate 
agglutinated rat but not sheep or chicken erythrocytes . In fact , the 
lysate gave a higher haemagglutination titre on rat than on mouse red cells, 
i . e ., titre of 1/2048 compared with titre of 1/96 - 1/256 . This was a 
surprising result , even though murine lymphocytes can bind rat erythrocytes 
aPParently via the receptors that mediate autorosetting (chapter J) . The 
resul t could be due to either rat erythrocytes being intrinsically more 
readily haemagglutinated than mouse red cells or an additional haem-
agglutinin in the thymocyte lysate that is specific for rat red cells . 
Although red cells from all mouse strains tested were 
haemagglutinated by the BALB/c thymocyte lysate , it was noted that the 
lysate consistently gave slightly higher haemagglutination titres on some 
red cells than others , e .g ., the BALB/c lysate gave a titre of 1/96 on 
CBA/H and 1/256 on C57BL/ 6 red cells (Table 5 , 2) . An analysis of this 
effect is presented in more de tail in Table 5 . J . It can be seen that 
background (non- H- 2) genes influenced the ability of different erythrocytes 
to be haemagglutinated . For example , BlO. BR and CBA/H thymcocyte lysates 
gave higher haemagglutination titres on BlO. BR (1/192 - 1/256) than on 
CBA/H (1/64 - 1/96) red cells . It is noteworthy that these background 
effects correspond with the ability of different red cells to rosette 
with murine spleen cells and thymocytes (chapter J) . 
Table 5.1 
Distribution of Haemagglutinin in Lymphoid Organs of 
BALB/c Mice 
Lymphoid organ 
Thymus 
Spleen 
Lymph Node 
Bone Marrow 
Haemagglutination Titre 
on BALB/c erythrocytes 
128 + 9 c) 
4 + 2 
<2 
<2 
Thymocytes (cytoplasmic fraction) <2 
Thymocytes (microsomal fraction) 128 
c) Results expressed as haemagglutination titre+ 
standard errors of three determinations. 
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Table 5,2 
Ability of BALB/c Thymocyte Lysate to Haemagglutinate 
Different Erythrocytes 
Erythrocytes 
BALB/c 
DBA/2 
CBA/H 
BlO . BR 
SJL/J 
C57BL/6 
BlO.G 
Rat (Lewis) 
H- 2 haplotype 
d 
d 
k 
k 
s 
b 
q 
Haemagglutinati on 
Titre 
128 + 7 c) 
128 + 8 
9 6 + 6 
192 + 9 
128 + 9 
256 + 10 
192 + 7 
2048 + 14 
Sheep <2 
Chicken <2 
c) Results expressed as haemagglutination titre+ 
standard errors of three determinations . 
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Table 5.3 
Influence of Erythrocyte Background on Haemagglutinating 
Lysate 
Source 
B10.BR 
B10.BR 
CBA/H 
CBA/H 
B10.02 
Bl0.02 
BALB/c 
BALB /c 
B10.G 
B10.G 
DBA/1 
DBA/1 
c) 
Activity of Thymocyte Lysates 
k ( H- 2 ) 
(H-2k) 
d ( H - 2 ) 
(H - 2d) 
(H-2q) 
(H-2q) 
Erythrocyte 
Source 
B10.BR 
CBA/H 
CBA/H 
B10.BR 
B10 . 02 
BALB/c 
BALB/c 
B10.D2 
B10.G 
DBA/1 
DBA/1 
B10.G 
Haemagglutination 
Titre 
256 + 11 C ) 
96 + 7 
64 + 6 
19 2 + 9 
256 + 10 
96 + 5 
96 + 8 
19 2 + 9 
19 2 + 9 
96 + 8 
96 + 6 
256 + 8 
Results expressed as haemagglutination titre+ 
standard error of three determinations. 
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5.2.3 Strain Differences 1n Haemagglut1nat1ng Act1vity 
The data presented in Table 5.3 indicate that thymocyte 
lysates from six different mouse strains (i . e ., BlO . BR , CBA/H , Bl0 .D2, 
BALB/c , BlO .G and DBA/1) gave comparable haemagglutination titres when 
tested on BlO background erythrocytes . However , analysis of additional 
strains revealed that lysates of C57BL/6 thymocytes consistently gave low 
haemagglutinating titres . Table 5 .4 presents typical data in which a C57BL/6 
lysate gave a haemagglutination titre of 1/32 compared with titres of 1/192 -
1/256 for lysates from other strains . Furthermore, the C57BL/6 lysate gave 
low haemagglutination titres on autologous , syrrgeneic and allogeneic 
erythrocytes (data not shown) implying that this effect was a property of 
the thymocyte lysate rather than the red cells. 
It appears (Table 5 . 4) that the low haemagglutinating 
activity of C57BL/6 lysates is probably a property of the H- 2b haplotype 
as thymocyte lysates from strains with different H- 2 haplotypes but 
virtually the same genetic background as C57BL/6 exhibited high haem-
agglutination titres , i . e ., BlO .G (H- 2q) , Bl0 .D2 (H- 2d) and BlO . BR (H-2k). 
In fact , the effect was directly mapped to the D- end of the H- 2 complex 
by the two H- 2 recombinant strains BlO . A and Bl0 .A(2R), as BlO .A (Kk , Dd) 
lysates had high haemagglutinating activity (1/256), whereas Bl0 . A(2R) 
(Kk , Db) lysates exhibited low haemagglutination titres (1/ 24) (Table 5.4). 
Autorosetting receptors on lym~hocytes interact with a 
carbohydrate structure on erythrocytes that is destroyed by periodate 
(chapter 4) . It was thought , therefore , that if the autorosetting receptors 
and haemagglutinin are the same molecule , detergent lysis of lymphoid cells 
may release carbohydrate structures that neutral~se the haemagglutinin. To 
overcome this problem , thymocytes were periodate - treated prior to solubili-
sation with N1? - 40 . This treatment , in fact , restored the haemagglutinating 
activity of C57BL/6 and Bl0 . A(2R) _ysates to normal levels but d i d not 
Table 5. 4 
Haemagglutination Activity of Lysates from Untreated or 
Periodate-Treated Thymocytes 
Lysate 
Source 
C57BL/6 
B10.A(2R) 
B10.A(SgSn) 
B10.G 
Bl0 . D2 
B10.BR 
SJL/J 
H- 2 
haplotype 
b 
h2 
a 
q 
d 
k 
s 
Haemagglutination Titre 
Untreated Periodate - treated 
32 + 5 c) 256 + 10 
24 + 4 384 + 14 
256 + 14 384 + 11 
192 + 11 192 + 11 
256 + 10 192 + 14 
256 + 8 256 + 11 
192 + 7 256 + 12 
c) Results expressed as haemagglutination titre+ 
standard error of three determinations. All 
thyrnocyte lysates tested on C57BL / 6 eryth r o c y t e s. 
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augment the haemagglutination titres of thymocyte lysates from other 
strains (Table 5 .4) . The periodate treatment appeared to be modifying 
carbohydrate rather tnan protein stn1ctures on thymocytes as mixed 
glycosidase treatment of thymocytes also restored the haemagglutinating 
activity of C57BL/ 6 lysates (data not shown) . It should be noted , however, 
that periodate treatment did not augment the haemagglutination titres of 
spleen , lymph node and bone marrow lysates (Table 5 ,1) . 
5.2.4 Analysis of Haemagglutinin in H- 2dmZ Mutant Mouse 
In chapter J , it was demonstrated that lymphocytes from 
BALB/ c - H- 2dm2 t t · H 2L d 1 ' · ' · (MK · t 1 1 77 mu an mice , a - e e~ion s~rain I c enzie e a 9 , 
Hansen et al 1977) , were virtually unable to rosette with autologous , 
a llogeneic or xenogeneic erythrocytes . It was important, therefore, to 
assess the haemagglutinating potential of the thymocyte lysate from this 
mutant mouse (Table 5,5) . It was found that the mutant lysate had a much 
lower haemagglutination titre (1/12) than the thymocyte lysate prepared 
from the wild - type BALB/ c strain (titre of 1/96) . This result is certainly 
consistent with the haemagglutinin and autorosetting receptors being the 
same molecule . 
It is of interest to note that the mutant thymocytes were 
not completely devoid of haemagglutinat i ng activity . The residual 
activity may be derived from the residual population of autorosetting 
cells present in the thymus of this mutant (chapter J) . 
5.2.5 Sugar Tnh1bition of Thymocyte Haemagglutinin 
Earlier studies (chapter 4) demonstrated that the auto -
rosetting receptors on thymocytes recognize a carbohydrate stn1cture on 
erythrocytes. If the haemagglutinin described above represents the auto-
rosetting receptor, it would be expected that the same sugars that 
inhibit autorosetting would inhibit haemagglutination. 
Table 5,5 
drn2 Ability of BALB/c and BALB/c-H-2 Thyrnocyte Lysates 
to Agglutinate BALB/c Erythrocytes 
Thymocyte lysate 
BALB/c 
drn2 BALB/c-H-2 
Haemaagglutination Titre 
96 + 9 C) 
12 + 7 
c) Results expressed as haemagglutination titre+ 
standard errors of three determinations. 
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A total of thirty monosaccharides and oligosaccharides were 
tested for their ability to inhibit haemagglutination . These were the same 
thirty sugars that were previously tested for inhibition of autorosetting 
(chapter 4 ) . Of the thirty sugars screened , only eight inhibited haem-
agglutination , namely D- galactose , D- galactosamine , D- mannose , D- mannosamine, 
N- acetylneuraminic acid , maltose , raffinose and mannan (Table 5,6) . These 
were the same eight sugars that inhibited autorosetting (chapter 4) . 
Six of the eight inhibitory sugars were e~ually inhibitory 
for thyrnocyte lysates from six different mouse strains (Table 5.6). However, 
these six sugars varied in their inhibitory activity being mannan > 
D- mannosamine .> ~ - acetylneuraminic acid > mannose ;;,, maltose ;,, raffinose. This 
point is more clearly illustrated in Fig . 5 . 1 which depicts the effect 
of different concentrations of the inhibitory sugars on the haem-
agglutination titre of a C57BL/6 thyrnocyte lysate. 
It should be noted , however , that two of the inhibitory 
sugars , namely D-galactose and D- galactosamine, exhibited strain-
specific inhibition (Table 5 . 6) . Thus , D- galactose inhibited the haem-
agglutinin from SJL/J (H- 2s) mice , an effect that appears to map to the 
D- end of the H- 2 complex , as lysates from A. TH (Ks , Dd) mice were not 
- - - -
inhibited by D- galactose (data not shown) . Furthennore , D- galactose 
blocked haemagglutination by a lysate of Bl0 . D2 (M_504 ) mutant thyrnocytes, 
but did not inhibit a lysate from wild- type Bl0 .D2 (Table 5.6). Since 
the Bl0 .D2 (M504) strain represents a H- 2L/H- 2D mutant (Morgan et al 
1978) , this result is also consistent with the haemagglutinin being 
under H- 2L/ D region control. 
On the other hand D- galactosamine , although inhibiting the 
haemagglutinins of all mouse strains, was substantially less inhibitory 
for a C57BL/6 (H- 2b; lysate (Table 5,6). This difference is more clearly 
depicted in Fig. 5.2
1 
which shows the effect of different concentrations 
of D- galactosamine on haemagglutinating activity. Fig. 5 ,2 also maps 
('°'\ 
"° rl
Table 5.6 
Ability of Different Sugars to Inhibit the Haemagglutinating 
A c_:t_ i Vi t y of Different Thymocyte Lysate 
Strain of origin of thymocyte lysate a) 
Sugar inhibitor C57BL/6 B10.BR B10.G SJL/J B10.D2 B10.D2 
(M504) 
( b) b) ( k) ( q) ( s) ( d) (dml) 
- -
-
- --
Monosaccharides 
--
D-glucose 256 + 10 c) 192 + 9 256 + 10 192 + 7 256 + 12 256 + 13 
D-galactose 256 + 11 192 + 9 256 ± 11 64 + 12 256 + 10 96 + 9 
D-galactosamine 32 + 7 4 + 2 4 + 3 4 + 3 4 + 4 8 + 4 
D-mannose 64 + 6 64 + 8 48 + 7 64 + 7 48 + 5 64 + 7 
D-mannosamine 4 + 3 4 + 2 4 + 2 6 + 3 8 + 3 8 + 4 
N-acetyl-neuraminic 
acid 32 + 6 48 + 5 48 + 4 32 + 6 48 + 5 48 + 6 
Oligosaccharides 
maltose 64 + 6 96 + 8 64 + 5 48 + 6 64 + 7 96 ± 6 
raffinose 128 + 7 128 + 7 128 + 6 96 + 8 128 + 9 96 + 8 
man nan 2 + 2 2 + 2 2 + 1 2 + 1 2 + 1 2 + 2 
a) Thymocyte lysates preincubated with sugars (40 mg/ml) for 1 hr on ice prior to addition of 
C57BL/6 erythrocytes . 
b) 
c) 
H-2 haplotype of mouse strains . 
Results expressed as haemagglutination titre± standard error of three determinations. 
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Fig. 5.1 Ability of different sugars to inhibit the haem-
agglutination of C57BL/6 erythrocytes by a lysate of C57BL/6 
thymocytes. Sugar inhibitors are: rnannan ( 0 ) , D-rnannosamine ( * ) , N-acetyl-neuraminic acid ( _. ) , D-galactosamine ( Q ) , 
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166 
the difference to the D- end of tne n- 2 complex as C573~/6 (Xb , ~b) and 
Bl0 . A(2~) (Kk , Db) lysates were ir..hibited less ef:ect~vely than 310 . 5R 
(Kk , Dk) and Bl0 .D2 (Kd , Dd) lysates . 
Thus , the sugar inhibition data suggests that tne thymocyte 
haemagglutinin is under H- 21/D region control , and li~e autorosetting 
(chapter 4) , recognizes carbohydrate moieties on the ery-throcyte sur=ace ; 
subtle differences in the struc.1.ure o: these carbohydrates occuring betrleen 
different ~- 2 haplotypes . 
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human AIF to inhibit the haemagglutinating activity of a 
C57BL/6 thymocyte lysate. The haemagglutination titre of 
the thymocyte lysate in the absence of AIF, is shown by 
the dotted line. 
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constant amount of a thymocyte lysate . Using this approach (Table 5.7) it was 
possible to detect inhibitory material, presumably the haemagglutinin acceptor 
in detergent lysate of erythrocytes . Sub~equent studies revealed, however, 
that erythrocyte lysate lacked strain specificity in their inhibition, 
e .g ., lysates from BlO . BR (H- 2k) and BlO .G (H- 2q) red cells were equally 
effective at inhibiting haemagglutination by a BlO . BR thymocyte lysate 
(data not shown) . 
5 . 2 . 8 Chemical Characterization of Haemagglut1nin and Haem-
agglutin1n Acceptor 
The experimental protocol used to purify and characterize 
the thymocyte haemagglutinin was depicted in chapter 2 , Fig . 2 .1 . The 
protocol consisted of binding the haemagglutinin in a 125I - labelled 
lysate to glutaraldehyde fixed red cells, eluting the haemagglutinin 
from the red cells with D- galactosamine (20 mg/ml) and analysing the 
eluate by SDS- PAGE . In all experiments a control was included where the 
red cells were eluted with D- glucose (20 mg/ml) rather than D- galactosamine. 
Furthermore , a fraction of each eluate was depleted of sugar by dialysing 
and tested for the recovery of haemagglutinating activity . The same protocol 
125 
was used to isolate the haemagglutinin acceptor from I - labelled mouse 
erythrocytes , except that the erythrocyte lysate was bound to and eluted 
from thymocytes and recovery of haemagglutination- inhibition activity was 
determined . 
Table 5.8 presents typical elution data for the haemagglutinin 
and haemagglutinin acceptor in terms of recovery of radioactivity and 
biological activity. It can be seen that the D- glucose eluates contained 
little radioactivity and no biological activity , whereas the D- galacto-
samine eluates contained substantial radioactivity and good recovery-
(75 - 100%) of either the haemagglutinin or haemagglutinin acceptor. 
Table 5. 7 
Inhibition of Haernagglutinating Activity of BALB/c 
Thymocyte Lysate by BALB/c Erythrocyte Lysate 
Dilution 
of thymocyte 
lysate a) 
Inhibition titre 
of erythrocyte lysate 
1/4 
1/8 
1/16 
1/32 
a) 
c) 
6 + 2 C) 
16 + 4 
48 + 6 
64 + 6 
Thymocyte lysates tested on BALB/c erythrocytes. 
Haemagglutination titre of lysate was 1/128. 
Results expressed as inhibition titre+ 
standard error of three determinations. 
Table 5. 8 
Isolation of Haemagglutinin and Haemagglutinin Acceptor: 
Typical Elution Data 
a) Preparation 
Thymocyte lysate 
(Haemagglutinin) 
D- glucose eluate 
0 - galactosamine eluate 
E r ythrocyte lysate 
(Haemagglutinin 
a cceptor) 
D- glucose eluate 
D- galactosamine eluate 
125 
I 
c.p.m. 
3 , 201 
16,540 
2,107 
10,546 
Titre c) 
2 
96 ( 12 8) 
2 
16 ( 16) 
a) Lysate from BALB/c mice. Thymocyte lysate bound 
and eluted from BALB/c erythrocytes, whereas 
erythrocyte lysate bound and eluted from BALB/c 
thymocytes. 
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c) Haemagglutination titre in the case of the thymocyte 
lysate and haemagglutination-inhibition titre in the 
case of the erythrocyte lysate. Values in brackets 
represent titres of lysates before fractionation. 
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Figures 5 . 4 and 5.5 present SDS-PAGE analysis of the 
haemagglutinin and haemagglutinin acceptor , respectively . In the case 
of the haemagglutinin , under non- reducing conditions the D- galactosamine 
eluate gave a single radioactive peak of molecular weight 6J , OOO daltons 
( ~ 2000 daltons based on three determinations) whereas under reducing 
conditi ons two radioactive peaks were seen with molecular weights of 
54 , 000 ~ 1000 and 45 , 000 ~ 1000 daltons (Fig .5 . 4) . These radioactive 
peaks were not detected in the D- glucose eluate . On the other hand , with 
the haemagglutinin acceptor the D- galactosamine eluate gave a radio-
active peak of molecular weight 62 , 000 ~ 2000 daltons both under reducing 
and non- reducing conditions , a peak that was not observed in the D-
glucose eluate (Fig. 5.5) . 
5.3 Discussion 
This chapter describes attempts to isolate and characterize 
the cell surface st:r:uctures involved in the MHC - controlled interaction 
between autologous lymphocytes and erythrocytes . In initial attempts 
to isolate the autorosetting receptor(s) it was noted that NP - 40 
detergent lysates of thymocyte contained potent haemagglutinating 
activity for murine erythrocytes . Four lines of experimental evidence 
were obtained which suggested that this haemagglutinin was , indeed, 
the autorosetting receptor . First , the haemagglutinin had a similar 
lymphoid organ distribution to autorosetting cells , namely thymus > 
spleen~bone marrow , lymph node (Table 5 .1) . Furthermore, like autorosett-
ing cells , the haemagglutinin lacked strain specificity, reacting with 
autologous , syngeneic and allogeneic erythrocytes (Tables 5.2 - 5. 4 ). 
Second , the same eight sugars that inhibited autorosetting also inhibited 
the haemagglutinin (Table 5.6) . Third , purified human AIF, a potent 
inhibitor of autorosetting , also very effectively inhibited the haem-
agglutinin (Fig . 5.J) . Fourth , several results indicated that the 
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Fig. 5.4 SDS-polyacrylamide gel electrophoresis of 125 r-labelled 
BALB/c thymocyte receptor eluted from glutaraldehyde fixed BALB/c 
erythrocytes. The gel patterns represent (a) non-reduced 
D-galactosamine eluate, (b) reduced D-galactosamine eluate and 
(c) reduced D-glucose eluate. The migration distance of protein 
standards namely, IgG heavy chain (H) , ovalburnin (0) and IgG 
light chain (L) and the dye marker (D) are indicated in each gel. 
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Fig. 5. 5 SDS-polyacrylamide gel electrophoresis of 125 r-labelled 
BALB/c erythrocyte acceptor eluted from BALB/c thymocytes. The 
samples and protein standards are as in legend to Fig. 5. 
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haemagglutinin , like the autorosetting receptors , are controlled by the 
H- 2L/ D region of the H- 2 complex . 
The claim that the haemagglutinin is under H- 2L/D region 
control is based on several observations . The first indication was in 
the screening of thymocyte lysates from different mouse strains where 
it was noted that lysates of C57BL/6 thymocytes consistently gave much 
lower haemagglutination titres than lysates of other strains (Table 
5,4). By analysing lysates from H- 2 congenic and recombinant mouse strains 
this effect was shown to be controlled by the D- end of the H- 2 complex 
(Table 5 ,4) . Interestingly , the haemagglutinin could be recovered from 
C5?BL/ 6 (H- 2b) thymocytes if the thymocytes were periodate- treated 
before detergent lysis . 
Further support for the haemagglutinin being under MJ{C 
control was obtained from the sugar inhibition studies. The same thirty 
sugars that were tested for their ability to inhibit autorosetting in 
chapter 4 were used in this analysis . It was found that D- galactose 
and D- galactosamine inhibited the haemagglutinins in a strain- specific 
manner (Table 5.6) . Again , analysis of thyrnocyte lysates from H- 2 
recombinant mice mapped this difference to the D- end of H-2. However , 
perhaps the best evidence for the haemagglutinin being under H- 2L/D 
region control was obtained from the analysis of the H- 21/D mutant 
dml / dm2 dml 
strains of mice , namely Bl0 .D2 - H- 2 and BALB c- H-2 . The Bl0 ,D2 - H- 2 
mutant, which expressed modified H- 2L/D antigens (Morgan et a l 1978 ), 
also contains a thymo cyte haemagglutinin with modified binding specificit y , 
the mutant haemagglutinin , unlike _ the wild- type (B10 .D2) haemagglutinin , 
being in..hibited by D- galactose (Table 5.6) . Similarly, thymocytes from 
the H- 2L deletion mutant, PrALB/c-H- 2d.m2 , that virtually lack autorosetting 
receptors (chapter 3) , contained muqh less . haemagglutinin than wild-type 
(BALB/c) thymocytes (Table 5.5) .. This finding strongly supports the 
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notion that the autorosetting receptors and the haemagglutinin represent 
the same molecule . 
Although the same eight sugars inhibited the thymocyte 
haemagglutinin as inhibited autorosetting , there were some subtle 
differences between the two systems (summarised in Table 5.9) . It can 
be seen that D- galactose , D- mannose , l- acetylneuraminic acid , raffinose, 
maltose and mannan gave comparable inhibition of haemagglutination and 
rosetting . In contrast , D- galactosamine was less inhibitory for b 
haplotype haemagglutination than b haplotype autorosetting and 
D- mannosamine exhibited haplotype specific inhibition of autorosetting 
but was equally inhibitory for all haemagglutinins. The explanation 
for these differences is uncertain but it seems possible that cell 
bound and solubilized receptors could differ slightly in their 
interaction with target structures . 
As discussed in chapter 4 , it could be argued that the 
sugars inhibit the haemagglutinin in a non- specific manner due to 
osmotic effects or due to impurities in the sugar preparations . There 
ar e several points which indicate that this explanation is unlikely: 
(i) only eight of the thir ty sugars tested were inhibitory and these 
corresponded to the same sugars that inhibited autorosetting , (ii) the 
concentrations used to inhibit haemagglutination are similar to those 
used to establish the sugar specificity of numerous lectins in the 
past (Aswell and Morell 1977 , Kieda et al 1978) , and (iii) some sugars 
showed strain- specific inhibition that mapped to the H- 2L/H- 2D region. 
Another important point that warrants discussion is the fact 
that the haemagglutinin , like autorosetting , lacks strain specificity 
in its activity , agglutinating both syngeneic and allogeneic red cells. 
If the autorosetting receptor has highest affinity for self H- 2L/D 
molecules one might expect the detergent solubilised receptor 
\.0 
('.._ 
rl 
Table 5 _:2._ 
Comparison of Sugars which Inhibit Thymocyte Haemagglutinin and Thymocyte Autorosetting 
H-2 hap lo type of thymocytes 
--Sugar Inhibitor 
k d dml q s 
a) 
+ + - -D-galactose ( - ) b) ( - ) ( +) ( - ) ( +) 
++ ++ ++ ++ ++ D-galactosamine (++) (++) (++) (++) (++) 
+ + + + + D-mannose (++) (++) ( ++) (++) (++) 
D-mannosamine ++ ++ ++ ++ ++ ( - ) ( - ) ( - ) (++) ( - ) 
N-acetyl-neuraminic acid + + + + + 
( +) ( +) ( +) ( +) ( +) 
raffinose + + + + + ( +) ( +) ( +) ( +) ( +) 
+ + + + + maltose ( +) ( +) ( +) ( +) ( +) 
+++ +++ +++ +++ +++ mannan ( +++) (+++) (+++) (+++) ( +++) 
a) Inhibition of haemagglutinin . 
b) Inhibition of autorosetting (chapter 5) • 
+ designates strength of inhibition . 
indicates no inhibition . 
b 
( - ) 
+ 
(++) 
+ 
(++) 
++ 
(++) 
+ 
( +) 
+ 
( +) 
+ 
( +) 
+++ 
(+++) 
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(haemagglutinin) to most effectively agglutinate H- 2 compatible 
erythrocytes . However , gel filtration ~nalysis of the haemagglutinin 
in detergent depleted lysates revealed that the molecule has a 
molecular weight of approx . 500,000 daltons and, therefore, must 
represent an aggregate of autorosetting receptors (D. B. Rylatt , 
personal communication) . Thus the haemagglutinin could bind to red 
cells in a multipoint fashion and consequently similar to autorosett-
ing , haemagglutinate allogeneic and xenogeneic (rat) red cells . In this 
context , the well characterized galactose binding lectin of hepatocytes 
consists of two subunits of molecular weight 48 , 000 and 40 , 000 daltons 
that readily form aggregates of 500 ,000 dalton molecular weight 
(Aswell and Morell 1977) . 
This chapter also describes experiments which analysed 
the isolated thymocyte haemagglutinin (autorosetting receptor) and 
erythrocyte acceptor on SDS-PAGE . It was found that the haemagglutinin, 
under non- reducing conditions , had a molecular weight of 6J , OOO .±. 
2000 daltons . However , under reducing conditions the haemagglutinin 
gave two radioactive peaks of molecular weights 54 , 000 and 45 ,000 
daltons respectively (Fig . 5 . 4) . This result may reflect partial 
proteolytic cleavage of the molecule , reducing conditions releasing 
unlabelled fragments of molecular weight 9 , 000 and 18 , 000 . Another 
possibility is that the haemagglutinin consists of a 45 , 000 dalton 
polypeptide associated with two subunits of 9 , 000 mol. wt . This point 
will be considered further in chapter 7 , Whatever the explanation, it 
appears that only the unreduced haemagglutinin has binding activity as, 
following treatment with 2- mercaptoethanol , the haemagglutinin no 
longer interacted with e:0Jthrocytes as measured by uptake of radio-
activity and haemagglutinating activity (data not shown). 
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In contrast to the haemagglutinin, the erytnrocyte acceptor 
has a molecular weight of 62 ,000 daltons , both under reducing and non-
reducing conditions (Fig . 5,5) . This is an lLnusual molecular weight 
for H- 2 antigensr even though anti - H- 2L antibodies were found to block this 
acceptor (chapter J) . However , there is a recent report showing that a mono-
clonal anti - H- 2 antibody (11- 4 .1) can immuno- precipitate a 68 , 000 dalton 
molecular weight molecule from thymoma cells (HlLnter et al 1981) . 
Interestingly , th1s monoclonal antibody has been shown to be carbohydrate 
specific (O ' Neill et al 1981) . Whatever the explanation for the nature 
of the acceptor molecule , it is a glycoprotein (chapter 4) , and a 
carbohydrate moiety attached to this protein must be recognized by the 
haemagglutinin and autorosetting receptors . 
Collectively the results described in this chapter imply that 
the H- 2L/ D region of the murine MHC controls a family of lectins that 
recognize carbohydrate structures on murine erythrocytes . Previous studies 
indicate that the carbohydrate acceptors on erythrocytes are also lLnder 
H- 21/ D region control (chapters J & 4) , and can be blocked with anti -H- 2L 
antibodi es (chapter J) . In this context it should be noted that recent 
studies , using monoclonal antibodies , have defined carbohydrate H- 2Kk 
antigens (O ' Neill et al 1981) , and these carbohydrate antigens appear to be 
expressed as glycolipids in cell membranes . However , in the case of the 
erythroctye acceptor , attachment of a carbohydrate H- 21 antigen to a 
protein carrier may occur . On the other hand , whether the lectin is 
related to conventional H- 2 antigens remains to be determined . Certainly 
the molecular weight of the lectin does not resemble the conventional 
45 , 000 dalton protein H- 2 antigens , although the molecule contains a 45, 000 
dalton component. Furthermore , a polypeptide of about 12 ,000 daltons 
resembling S2 - microglobulin which is associated with H- 2L , H- 2K or 
H- 2D antigens has so far not been detected in receptor preparations, even 
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when highly cross- reactive gels (12% SDS) are run . The possibility that 
the _54 , 000 dalton polypeptide may represent a complex of the S2- micro-
globulin associated with the 45 , 000 dalton protein H- 2 antigen , however , 
can not be excluded . Preliminary studies i ndicate , however , that 
the BALB/c (H- 2d ) h.aemagglutinin can be removed from cell l ysates 
by a conventional anti - H- 2Ld serum ( AS 207- see chapter 2), but not by 
antisera raised against other regions of the H- 2 complex (i . e . , 
anti - H- 2Kd , anti - H- 2Dd and anti - lad sera) (data not shown) . Obviously, 
the i deal means of demonstrating the H- 2 nature of the haemagglutinin 
is to assess the ability of monoclonal anti - H- 2Ld and specific anti -
B2- microglobulin -sera to react with the purified haemagglutinin . 
Unfortunately , t here was i nsufficient time before thesis submission to 
attempt these experiments . 
Finally , it should be noted that there is one earlier 
report of lectins in the membranes of mouse lymphocytes (Kieda et al 
1978 ) . Whether the lectins described in this earlier study represent the 
same lectins discussed here is u..ncertain , as slightly different extraction 
procedures were used and a different panel of inhibitory sugars was tested. 
Summary 
Murine lym~hocytes bind autologous erythrocytes via H- 2L/H-2D 
region controlled recep~ors which appear to preferentially recognize 
self H- 21 molecules on the erythrocyte surface . This chapter describes 
attempts to isolate and characterize the cell surface molecules involved 
in this interaction . 
Initial studies revealed that detergent lysates of thymocytes 
contained potent haemagglutinating activity for murine erythrocytes . 
Several lines of experimental evidence indicated that this haemagglutinin 
was the autorosetting rece~tor , n.amely , (i) the 0.aemagglutinin had a 
similar lymphoid organ distribution to autorosetting cells ; (ii) the same 
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eight sugars that inhibited autorosetting also inhibited the haem-
agglutinin ; (iii) purified autorosette inhibi~ion facto~ 1ery ef:ectively 
inhibited the naemagglutinin ; (iv) thymocytes :rom the ~- 2L delet~on 
mouse strain , BALB/c- H- 2dmZ that r~rtua_ly lack autorosetting receptors, 
contained much less haemagglutinin than wild- type thymocytes and (v) 
additional genetic s~udies demonstra~ed that the _1aemagglutinin, like the 
autorosetting receptors , are contro_led by tne H- 21/ D region of t __ e 
H- 2 complex . 
P d d • d n • I • 125 roce ures were evise ror isola~ing - 1 - label_ed haem-
agglutinins (autorosetting receptors) and ery~nrocyte acceptors from 
detergent lysates of ce_ls . SDS- PAGE analysis revealed that the ~aem-
agg_utin~n _ias a mo_ecular weight of 6J , OOO daltons and may consist of 
2- J subunits , whereas the erythrocyte accentor represents a single poly-
peptide chain of 62 , 000 daltons . 
Chapter 6 
Isolation and Biological Properties of a 
Serum Factor that Blocks Autorosetting 
Re ceptors on Lymphocytes 
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6 . 1 Introduction 
Murine thymocytes and peripheral lymphocytes can 
spontaneously bind autologous and allogeneic erythrocytes (Micklem and 
Asfi 1971 , Charreire and Bach 1975 , Kolb 1977 and 1978) . Experiments 
described in chapter J demonstrated that thymocytes and peripheral 
lymphocytes bind autologous erythrocytes via receptors that primarily 
recognize self H- 2L/H- 2D molecules on the erythrocyte surface . Furthermore, 
on the basis of sugar- inhibition studies and the susceptibility of the 
autorosetting receptors and acceptors to protease and glycosidase 
treatments it appears that H- 2L/ H- 2D region controlled protein receptors 
on thymocytes recognize the carbohydrate portion of a glycoprotein on 
erythrocytes (chapter 4) . 
Several laboratories have reported that serum can inhibit 
autorosette formation (Micklem and Asfi 1971 , Charreire and Bach 1975 , 
Kolb 1977) . Recently Hsu et al (1980) presented evidence that the inhibitor-] 
activity (termed "autorosette inhibition factor" of AIF) was associated with 
the high density lipoproteins of mouse serum . In this chapter AIF is 
further analysed and the study demonstrates the presence of AIF in the sera 
of several species , its production by macrophages and its purification to 
homogeneity from human serum . 
6 .2 Results 
6 . 2 . 1 Detection of Autorosette Inhibition Factor (AIF) in Mouse Serum 
The ability of serial dilutions of BALB/c serum to inhibit the 
autorosetting of BALB/c thymocytes and spleen cells is depicted in Fig . 6 .1. 
It can be seen that the serum completely inhibited autorosette formation at a 
dilution of 1/8 - 1/16 and significant inhibition was obtained with dilutions 
as high as 1/128 . Comparable inhibition curves were obtained with both 
lymphoid populations even though spleen cells has a lower incidence of 
autorosetting cells than thymus (chapter J) . 
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SERUM 
NORMAL MOUSE SERUM DILUTION 
Fig. 6.1 Ability of BALB/c serum to inhibit the 
autorosetting of BALB/c thymocytes and spleen cells. 
Thymocytes ( .. ) or spleen cells ( 6.) were pre-
incubated with different concentrations of serum 
before rosetting. Vertical bars represent standard 
deviations of means. The rosetting of control thymocytes 
and spleen cells which were not preincubated with serum 
is indicated in the right hand margin of the figure. 
Sera from a range of mouse strains were t hen tested for their 
ability to inhibit the autorosetting of BALB/c thymocytes (Table 6 .1) . It was 
found that the sera of all strains tested were inhibitory , sera from both 
young and old CBA/H , BlO . BR , C57BL/6 , DBA/1 and SJL/J mice giving inhibition 
titres comparable to autologous BALB/c serum , i . e ., titre of 1/16 - 1/80. 
However , sera from four of the mouse s trains tested , namely dm2 , CBA/N , AKR 
and A/J, had significantly lower i nhibition titres than BALB/c serum . In the 
case of dm2 , A.KR and A/J mice , these lower inhibition titres were 
detected only in older mice, i . e ., 6 months of age . Although the 
explanation for these differences i s uncl ear it shoul d be noted that athymic 
nude mice and beige mice (C57BL/6 ' bg/ bg ') (Roder and Duwe 1979) had normal 
levels of AIF , a result suggesting that AIF production is independent of 
the thymus and functional NK cells . 
6 . 2 . 2 Inhibition of Autorosettlng by Sera from Different Species 
Sera from a range of different species were tested for their 
ability to inhibit the autorosetting of BALB/c thymocytes (Table 6 .2). All 
sera tested were inhibitory , the six mammalian sera (i . e ., human , mouse , rat, 
guinea pig , sheep and bat) giving comparable inhibition titres . Bird sera 
(i.e., goose and chicken) had inhibition titres approx . 2- 4 times higher than 
mammalian sera, whereas toad (African clawed toad) serum had a comparatively 
low inhibition titre , i . e ., 1/17 compared with 1/ 128 for mouse serum . 
6 . 2 . J Ontogeny of AJF in Mouse Serum 
Figure 6 .2 depicts the levels of AIF in the sera of foetal 
and new born mice . The 16- day foetus had approximately 16- 32 times less AIF 
in its serum than adult BALB/c mice . There was a gradual increase in the 
levels of AIF in .foetal serum with age , a mouse at birth having approximately 
1/4 - 1/2 the adult level . By 5-6 days after birth , adult levels of AIF in 
serum were detected . It is noteworthy that the ontogeny of serum AIF coincides 
with the ontogeny of autorosetting cells (Steele and Cunningham 1980) . 
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Table 6 .1 
Ability of Serum from Different Mouse Strains to Inhibit BALB/c 
Autorosetting 
Serum Donor 
BALB/c 
BALB/c athymic nude 
dm2 BALB/c-H-2 (C55) 
CBA/H 
CBA/H 
B10.BR 
NZB 
AKR 
C57BL/6 
C57BL/6 ("+/bg") 
C57BL/6 ("bg/bg") 
DBA/1 
SJL/J 
A/J 
H- 2 
Haplotype 
d 
d 
2 dm 
k 
k 
k 
k 
k 
b 
b 
b 
q 
s 
a 
Age 
(month) 
2-3 
6-7 
2-3 
2-3 
6 
2-3 
6-7 
2-3 
4-5 
2-3 
6 
9 
2-3 
6 
2-3 
6-7 
2-3 
2-3 
2-3 
5-6 
2-3 
6-8 
2-3 
5-7 
Serum 
a) 
Inhibitory Titre 
64 + 3 
72 + 4 
68 + 4 
58 + 4 
18 + 4 
80 + 4 
72 + 5 
30 + 4 
24 + 5 
78 + 4 
64 + 5 
88 + 4 
80 + 4 
16 + 4 
85 + 5 
70 + 4 
68 + 4 
62 + 5 
60 + 5 
74 + 4 
68 + 4 
76 + 5 
67 + 3 
22 + 5 
b) 
a) BALB /c thymocytes preincubated for 30 min at 4°c with serum 
from different mouse strains before rosetting with 
autologous erythrocytes. 
b) Results are expressed as the serum dilution required to inhibi t 
thymocyte autologous rosetting to 10% ± standard error of mean 
of three determinations. Values that represent inhibition 
titres significantly different from autologous BALB / c serum 
are enclosed . 
Table 6.2 
Ability of Serum from Different Species to Inhibit BALB /c 
Autorosetting 
Serum Donor 
Human 
Mouse 
Rat 
Guinea Pig 
Sheep 
Little Brown Bat 
Goose 
Chicken 
African Clawed Toad 
Serum 
Inhibitory titre 
80 + 4 
68 + 5 
64 + 4 
7 2 + 4 
6 8 + 5 
6 8 + 5 
2 5 6 + 6 
160 ± 5 
1 7 + 5 
Footnotes as in Table 6.1 
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Fig. 6.2 Level of AIF in the serum of foetal and new-born 
BALB/c mice. The normal level of the serum inhibitory 
factor in adult BALB/c mice is indicated as a dotted line . 
Arrow denotes day of birth. 
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6 .2 . 4 Absorption of AIF by Th.mocytes 
To establish whetner AIF .:..n serum binds directly to 
autorosetting receptors on tny:nocytes , advantage ~as ta~en of the early 
observation ~hat thymocytes =~o the ~- 2L deletion mutant mouse strain, 
BALB/c- H- 2dm2 (C55) lack autorosetting receptors (chapter J) . mhe 
experimental protocol was to measure the ability of varying numbers of 
either wild - type BALB/c or mutant BALB/c - H- 2dm2 thymocytes to absorb AIF 
from mouse serum . The complete absorpt.:..on data is de~icted 1_· _n_ F'i" g 6 J - . . . 
Using 10% fresh normal BALB/c serum for absor~tion , a~proximately 70% of 
the inhibitor] activity could be absorbed by 1 . 6 x 107 nALB/c ce_ls , 
whereas the same nw ber of mutant (C55) thymocytes failed to absorb the 
inhi bi to:ry .. a terial . Furthermore , i ~ should be noted tn.a t AIF ·..ras not 
absorbed by mouse erythrocytes (data not shown). These results suggest , 
therefore , that AIF binds d.:..rec~ly to the autorosetting receptors on 
thymoc;rrtes . 
6.2.5 ature of the Ce __ Prcducing AI? : ?2,diosens.:.. ti ·r.:.. ~l of 
Secreting Ce __ s 
mhe effect o~ ,.:..::erne~ aoses of y - .:..rradiation on tte 
levels of AIF in t.e serum of BA/H mice is shown in Fig . 6.L. A.n 
.:..rradiation dose of 250 rads hzci no effect o: A.IT leve_s w~e~eas tT.:..tn 
ose o: 500 ~ads and 700 rads , ~here ·tTas a 5Cf/a iec~ease .:..n ~:_e _2-rel 
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Fig. 6.J dm2 Ability of BALB/c and BALB /c -H-2 (CSS) thymocytes 
to absorb AIF from BALB/c serum. 100 µl of 10% fresh BALB/c 
serum was preincubated with 100 µl of varying number of 
BALB/c or CSS thymocytes before being used to inhibit the 
autorosetting of BALB/c thymocytes. Vertical bars represent 
standard deviations of means. The rosetting of control 
thymocytes is shown by the dotted line. 
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Fig. 6.4 Effect of different doses of y-irradiation 
(left hand graph) and Y-irradiation followed by bone 
marrow reconstitution (right hand graph} on the level 
of AIF in the serum of CBA/H mice. 
Left hand graph: Treatments were no irradiation ( i6,), 
250 (.), 500 ( • ) , 750 ( 0) and 900 ( 0) rads . 
Right hand graph: Treatments were 900 rad y-irradiated 
mice ( 0) or mice 900 rad y-irradiated and reconstituted 
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with 2 x 10 bone marrow cells ( *) . 
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sensitive cell that either resides in or is derived from bone marrow cells. 
6.2.6 Sens1t1v1ty of AIF Secret1on to Ant1 - _ acronhage Agents 
To detennine whether seru.m AIF was macro~hage dependent , mice 
were i ntravenously injected with anti - macrophage agents , i.e ., carrageenan 
and silica (see Fig . 6.5) . A significant decrease in the level of serum 
AIF was seen as early as 5 hours after carrageenan injection, and a 8-16 
fold decrease was seen after 24 hr . The maximum decrease (32 fold) was 
observed 2- 5 days after injection , after which AIF levels gradually increased, 
reaching nonnal levels 8 days post injection. Additional experiments 
demonstrated that carrageenan was not directly inactivating AIF as 
incubation of carrageenan (2 mg/ml) with serum had not effect on AIF 
activity (data not shown) . 
In order to establish the effect of different doses of 
carrageenan on seru.m AIF , varying doses of carrageenan were injected 
intravenously into mice (see Fig . 6.6) . Doses of 0 .25 mg/mouse 
significantly depressed serum AIF levels , there being a linear relation-
ship between the amount of carrageenan injected and the seri..un AIF level. 
Silica injection also depressed se:rum AiF levels but with 
very different kinetics to carrageenan (Fig . 6.5) . The level of serum 
AIF remained unaffected for two days after silica injection, decreased 
20- JO fold on day J , but returned to nonnal levels by day 4 . Such an effect 
was observed in five mice in two separate experiments . 
6.2.7 Secretion of AIF by Lymphoid Cells in vitro 
Studies reported in the preceding section with anti -
macrophage agents suggest that macrophages secret AIF. As a direct test 
of this possibility different populations of lymphoid cells from BALB/c 
mice were cultured in vitro for 6 hr and the inhibito:ry activity of the 
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Fig. 6.5 Time course of the ef feet of carrageenan ( e ) and 
silica ( 0) injections on the level of AIF in serum. Two mg 
of ca rrageenan or silica was injected, iv, into adult CBA/H 
mice. The level of AIF was assessed by inhibition of auto-
rosetting of CBA/H thymocytes. 
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/ 
Effect of varying doses of carrageenan on 
the levels of AIF in serume Carrageenan was injected , 
i.v., into adult CBA/H mice, and the levels of AIF 
we re assessed on day 3 post injection. 
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concentrated culture supeITiatants then assessed . It was f ound t hat cul t ure 
supeITiatants from thymus , spleen , bone marrow and lymph node were not 
inhibitory (Table 6.J) . In contrast , inhibitory supeITiatants were obtained 
from peritoneal cells , the inhibitory material being produced by the 
adherent population of peritoneal cells (Table 6.J) . 
6 . 2 . 8 Isola t-i on of AIF from H1-.unan Serum 
Attempts were made to isolate AIF from serwn . Preliminary 
studies with mouse serwn established that AIF was not precipitated by 5Cf/o 
saturated ammonium sulphate or 18% (w/v) sodium sulphate , but was 
precipitated by 50-8C% saturated ammonium sulphate . Such a result implies 
that AIF is not an immu_noglobulin . Since large volumes of mouse serwn 
were difficult to obtain , in subsequent experiments human serwn was used. 
After attempting a range of ion- exchange chromatography procedures it was 
found that AIF could be very readily purified to homogeneity on phospho-
cellulose columns . 
Figure 6,7 depicts a typical elution profile of human 
serum from phosphocellulose . The majority of human serum proteins were 
eluted from the column by 0 .8M salt , whereas when the column was eluted 
with a 0 . 8M to 2 . _5M salt gradient a major protein peak was eluted at 
approximately 1.6M salt (Fig . 6.7) . When column fractions were assayed 
for AIF , inhibitory activity was detected only in this protein veak. 72% 
of the AIF activity applied to the column was recovered by t his procedure. 
Fractions 50-70 were pooled and concentrated by vacuum 
dialysis . Analysis of the pooled fraction by SDS- polyacrylamide gel 
electronhoresis revealed that t he pre~arations contained only a single 
-" 
Coomassie Blue staining protein band of molecular weight 81, 000 daltons 
(Fig. 6 . 8) . 
Table 6.J 
Inhibitory Activity of Cell Culture Supernatants 
source of 
a) 
supernatant 
No. of cells 
cultured 
Volume 
( m 1) 
b) % autorosetting 
cells 
C ) 
Nil 44 + 4 . 5 
Thymus 10 8 5 40 + 6.1 
Lymph Node 10 8 5 39 + 4. 7 
Spleen 10 8 5 39 + 4.6 
Bone marrow 10 8 5 37 + 4.9 
Peritoneal cells 2 X 10 7 2 7 + 5.2 
No n - adherent 
10 7 peritoneal cells 1 39 + 5.5 
Adherent 
10 7 peritoneal cells 1 10 + 3 . 7 
a) Supernatants harvested and concentratred 15 fold from BALB/c 
cells cultured for 6 hr at 37°c in Fl5 medium. 
b) BALB/c thymocytes preincubated with undiluted supernatant 
for 30 min at 4°c before rosetting with autologous erythrocytes. 
c) Results expressed as% autorosetting thymocytes ± standard 
error of three determinations. Values that represent 
significant inhibition are enclosed in brackets. 
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Fig. 9.7 
Isolation of AIF by ion exchange chromatography on 
a phosphocellulose column. Human plasma in citrate buffer was 
applied to a column (3 X 20 cm) which had been precycled with 
BSA and then equilibrated with 0 . 8M NaCl, containing lmM EDTA; 
lmM DTT and 10 mM sodium phosphate, PH 7.4 (as described in 
Materials and Methods). The column was then eluted with a 
linear NaCl gradient from 0.8M to 2.SM (see upper graph). 
Fractions of 5 ml were coliected and tested for protein 
concentration ( e ) and AIF activity ( O). 
' 
1 2 
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D 
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F 
Fig.6.8. SDS-polyacrylamide gel electrophoresis 
of concentrated phosphocellulose column fractions 
nos. 50-75 from elution profile depicted in Fig.6~: 
(1) Molecular weight standards: A: Phosphorylase B 
(97,400) B: BSA (68,000) C: ovalbumin (43,000) 
D: Carbonic anhydrase (30,000) E: soybean trypsin 
inhibitor (21,000) F: lysozyme (14,000) (2) AIF 
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6 . J Discussion 
In the past ten years a number of laboratories have renorted 
that normal serum can effectively inhibit rosetting between lymphocytes 
and autologous erythrocytes (Micklem and Asfi 1971, Charreire and Bach 
1975 , Kolb 1977) . However , little is known about this autorosette inhibition 
factor (AIF) in serum , except that it lacks strain and species specificity 
(Charririre and Bach 1975 , Kolb 1977) , is not an immunoglobulin (Kolb 
1977) and in mouse serum fractionates with the high density lipoproteins 
(Hsu et al 1980) . This chapter describes attempts to determine the origin 
and nature of serum AIF . 
Initial studies confirmed that AIF lacks strain and species 
specificity (Tables 6 . 1 and 6 .2) , serum from all animals tested inhibiting 
the autorosetting of BALB/c thymocytes . Furthermore , AIF appears to 
directly interact with autorosetting receptors on lymphocytes as thymocytes 
/ dm2 from the BALB c- H- 2 mutant strain , which lacks autorosetting receptors, 
were unable to absorb the factor (Fig 6 .J) . However, mouse strains did 
vary in the levels of AIF in their serum , significantly lower inhibition 
titres being detected in 2- J month old CBA/ N mice and in old (6,Jnonths) 
but not young (2 - J months) BALB/c- H- 2dm2 , A.KR and A/J mice. The 
explanation for these differences is un_ki~own but it should be noted that 
lymphocytes from BALB/c - H- 2dm2mice , a H- 2L deletion mutant (Morgan et al 
1978) , almost completely lack autorosetting receptors (chapter J). It 
appears unlikely that the rt - 2L region directly controls AI~ synthesis 
as lymphocytes from both 2 month- old and 6 month- old mice lack autorosetting 
receptors whereas AIF levels are depressed only in older mutant mice . 
It is conceivable, owever, that expression of autorosetting receptors 
could indirectly effect AIF uroduction . On the other band , there must be 
another explanation for the lower levels of serum AIF in CBA/N , AKH and 
A/J mice as these strains contain normal pro~ortions of autorosetting cells 
in their lymphoid organs (data not shown). 
200 
An additional , interesting feature of these experiments flas 
that se:rum from old NZB mice , a strain that spontaneously develops a range 
of autoimmune diseases ( Staats 1980) , expressed normal levels of AIF. This 
result suggests that development of autoimmunity in this strain is not due 
to a lack of AIF , although low levels of AIF may be the cause of autoimmune 
disorders in other strains . However , analysis of human serum from patients 
with a range of autoimmune diseases (i . e ., rheumatoid arthritis, systemic 
lupus erythematosis , thyrotoxicosis and myasthenia gravis) revealed no 
change in se:rum levels of AIF (data not shown) . 
In this study a wider range of species was tested for serum 
AIF than previously reported. It is interesting to note that not only 
all mammalian sera , but bird (goose and chicken) and amphibia (toad) sera 
contained inhibitory activity . It could be argued that bird and amphibia 
sera contain "non- specific " inhibitory factors unrelated to mammalian AIF. 
However , the inhibitory molecule has been isolated from chicken se:rum and 
has similar properties to human AIF (D . B. Rylatt , personal communication). 
Several experimental approaches established the nature of the 
AIF secreting cells . First , the demonstration of normal levels of AIF in 
the serum of athymic nude mice and NK cell defective beige mice (Table 
6.1) suggested that AIF secretion is independent of T lymphocytes and NK 
cells . Second , total body i:rradiation experiments suggested that AIF 
production is dependent upon a comparatively radio- sensitive cell that is 
bone marrow derived (Fig . 6 .4) . Third , in vivo secretion of AIF was highly 
sensitive to the anti - macrophage agents , i . e. , carrageenan and silica 
6.5 & 6.6) . Fourth , in vitro culturing of different lymphoid cells revealed 
that AIF was secreted by an adherent population of ~eritoneal cells (Table 
6.J) , Collectively these data suggest that AIF is secreted by a population 
of short- lived , radiosensitive macrophages ( or monocytes ). 
An intriguing aspect of these experiments was that although 
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the two anti - macrophage agents carrageenan and silica profoundly 
depressed serum AIF levels they differed markedly in their kinetics of 
action (Fig . 6.5) . Carrageenan lowered AIF levels rapidly and for a 
prolonged period (days 1 - 7 after injection) wnereas silica only affected 
the serum AIF titre on the third day after injection . TI'-e explanation 
for this difference is uncertain but presumably reflects the target cell 
and mode of action of these anti - macrophage agents . For example , silica 
may delete a precursor of the AIF secreting cells (hence the delay in 
action) whereas carrageenan may directly inactivate the AIF producing 
cells . Whatever the explanation of these findings , the sudden fluctuations 
in AIF levels observed in these experiments suggest that there is a rapid 
turnover of AIF in serum . 
Thi s chapter also described a single step procedure using 
phosphocellulose ion- exchange chromatography for isolation of AIF from 
human serum (Fig . 6.7) . Precycling of the column with BSA and thorough 
washing of the column after absorption of human serum are essential 
steps i n the isolation of human AIF . Using this procedure pure AIF is 
obtained as judged by SDS- polyacrylamide gel electrophoresis (Fig. 6 .8). 
The i nhi bitory protein has a molecular weight of 81 , 000 daltons when 
electrophoresed under reducing conditions . ·Furthermore , gel chromatography 
on Sephacryl 3200 revealed a single species of molecular weight 79 , 000 
daltons , thus implying the active protein is a single polypeptide chain 
(D . B. Rylatt personal communication) . AIF appears to be present in serum 
at a concentration of the order of 50- 100 µg/ml of human serum . Further 
characterization of this protein and the analysis of its interaction with 
the lymphocyte receptor may lead to a role being assigned to this serum 
factor in vivo . 
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Summary 
Murine lymphocytes spontaneously bind autologous and allogeneic 
erythrocytes via receptors that primarily recognize self- H- 2L/H- 2D 
molecules on the erythrocyte surface . ormal mouse serum contains a 
factor , termed autorosette inhibition factor , (AIF) , that very effectively 
blocks autorosette formation . This report describes experiments that 
determine the origin and nature of serum AIF . 
It was found that AIF lacks strain and species specificity, serum 
from several mammalian and non- mammalian species inhibiting the auto -
rosetting of BALB/c thymocytes . However , mouse strains differed in the 
levels of AIF in their serum . Furthermore , AIF appears to directly 
interact with autorosetting receptors on lymphocytes as thymocytes from 
the BALB/c-H-2dm2 mutant strain , which lack autorosetting receptors, were 
unable to absorb the factor . 
Several lines of experimental evidence indicated that AIF is 
secreted by a population of short - lived , radiosensitive macrophages (or 
monocytes) . First , in vivo administration of the anti - macro~hage agents , i.e. , 
carrageenan and silica profoundly depressed AIF levels in serum . Second , 
in vitro culturing of different lymphoid cells revealed that AIF is 
secreted by an adherent population of peritoneal cell s. Third , total 
body irradiation experiments demonstrated that AIF production is 
dependent upon radiosensitive cells that are bone ma:rTow derived. 
Finally , a single step procedure was devised for purifying 
AIF to homogeneity from human serum . Purified AIF was found to be a single 
polypeptide chain ~ith a molecular weight of 81 , 000 daltons. 
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7.1 Introduction 
Substantial subpopulations of murine _ymphocytes can fonn 
rosettes with both autologous and allogeneic erythrocytes (Micklem and 
Asfi 1971 , Sandilands et al 1974, Charriere and Bach 1975, Braganza et al 
1975 , Kolb 1977) . Although this observation was first reported ten years 
ago there is still little known about the phenomenon . The studies described 
in this thesis attempted to correct this deficiency by analysing the 
autorosetting phenomenon at four levels : 
(1) The involvement of MHC gene products in the interaction 
(2) 
(J) 
The molecular basis of the interaction 
The manner in which autorosetting receptors are 
regulated in vivo . 
(4) The possible functional significance of the auto-
rosetting receptors in vivo 
This final discussion will surrunarise my experimental 
findings and discuss their overall biological significance. 
Involvement of~ Complex in Autorosetting 
There is increasing evidence that the MHC in mice (H-2 
complex) and other species is involved in various immune phenomena 
(reviewed in chapter 1). Thus , self H- 2K and H- 2L/D antigens are involved 
in the recognition of foreign antigens by cytotoxic T cells (Doherty et al 
1976 , Shearer 1976) whereas I - region controlled antigens are recognized 
in association with foreign antigen by the T lymphocytes that express 
help (Katz and Benacerraf 1975), delayed- type hypersensitivity (Miller 
et al 1976) , and antigen specific prolifer~tion i n vitro (Thomas et al 
1977 , Schwartz et al 1978) . Based on these observations it appeared 
possible that autorosetting may be mediated by an anti - self receptor that 
recognizes a MHC gene product on erythrocytes . 
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The experimental data presented in chapter J indicates that 
autorosetting is mediated by H- 2L/H- 2D region controlled receptors on 
thymocytes as well as peripheral T and B lymphocytes that preferentially 
recognize self H- 2L/ H- 2D region controlled molecules on the erythrocyte 
surface . This conclusion was based on three lines of evidence . First, 
by measuring the ability of erythrocyte sonicates from different mouse 
strains to inhibit rosette formation it was found that only sonicates 
from H- 2L/H- 2D region compatible strains were inhibitory. This result 
implied that the autorosetting receptors had h1ghest affinity for self 
H- 2L/ H- 2D region controlled structures on the eDJthrocytes . Second , 
anti- H- 2L sera were able to specifically block inhibition of autorosetting 
by erythrocyte sonicates , a result suggesting recognition of H- 2L antigens 
was involved . Third , it was found that H-2L/H-2D m~tant strains of 
. ( dml / dm2) mice Bl0 .D2-H- 2 and BALB c- H- 2 simultaneously expressed 
altered autorosetting receptors and acceptors , suggesting that the H- 2L/ H-2D 
region contr0ls autorosetting at both the thymocyte and erythrocyte level. 
At the same time that these investigations were being 
carried out two re~orts appeared in the literature which also 
demonstrated that autorosetting was under MHC control , i . e ., lymphocytes 
preferentially bound H- 2 compatible erythrocytes (Primi et al 1979, 
Charriere et al 1980) . However , in these two separate studies autorosetting 
was not mapped to the H- 2L/H- 2D region. By rosetting 24 hr cultured 
spleen cells with a variety of H- 2 congenic and recombinant strains of 
murine erythrocytes , Primi et al (1979) detected preferential binding of 
H- 2 compatible erythrocytes and mapped autorosetting to an undefined H-2 
locus , between H- 2G and H- 2L/H- 2D . Th1s is a surprising finding because 
uncultured spleen cells and thymocytes are found to rosette eQually well 
with autologous , allogeneic and xenogeneic erythrocytes (Micklem and 
Asfi 1971 , Sandilands et al 1974, Charriere and Bach 1975, braganza et al 
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1975 , Kolb 1977) . One possible explanation for these differences is that 
cultured spleen cells recognize different structures on erythrocytes than 
uncultured splenocytes , i . e ., culturing selects for a subpopulation of 
autorosetting cells . A.nother important uoint is that Primi et al 
a much lower proportion of autorosetting cells than in the studies presented 
in this thesis . This is probably due to the workers employing suboptimal 
autor osetting conditions (discussed in chapter 2) . Again this could result 
in a selected subpopulation of autorosetting cells being examined . 
In the second study Charriere et al (1980) used two 
approaches to assess H- 2 involvement in autorosetti~g . First , li~e 
Primi et al (1979) , they obse:rved preferential binding of H- 2 
compatible erythrocytes . In the second approach they assessed the ability 
of erythrocyte ghosts from different mouse strains to block autorosetting. 
Based on the data of one ~- 2 recombinant mouse strain BlO . A (Kk, Dd) , 
they concluded that both Kand D regions were involved in autorosetting. 
However , this study only examined one recombinant between k and d 
haplotypes , and the data in chapter J demonstrated that the autorosetting 
receptors of k and d haplotypes are completely cross reactive , i.e . , 
genetic mapping studies cannot be attempted between these haplotypes . 
Once autorosetting was shown to be H- 2L/ H- 2D region 
controlled ~twas im ortant to determine ~nether the specificity of 
the autorosetting rec 0 D.Lors - '-' _ L, _ ' · re 'ne sn_eci:i' ci t-.y- of H- 2 restricted _lK t, 
T cells (Zin~ernagel and Daher.Ly 1979) , was inTluenced by the thymic 
environment . 3y analysing lymphocytes from allogeneic and semi -
allogeneic cnineras (chapter J , section J .2 .10), i.L was found ~hat 
the raciiores~stant thymic eni.Lhe_ium of the chimeric mice did not 
modify the specif~city of the autorosetting recentors on ~he ioI'-or 
_ymphocytes . _his result i~nl~ed that .Lhe autorosetting recentors are 
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controlled in a different manner to the functional anti - self receptors 
on cytotoxic T lymphocytes , a Point which will be further discussed in 
section 7 .6 of this chapter . 
7 , J Nature of the Autorosett1ng Rece~tors and Acceptors 
Once autorosetting had been shown to be under H- 2L/H- 2D 
r egion control , it was important to determine the chemical nature of 
the autorosetting receptors and acceptors . Initial studies described in 
chapter J (section J . 2 .8) indicate that although the majority (80%) 
of autorosetting spleen cells are B lymphocytes , the autorosetting 
r eceptors are not immunoglobulin or iITLmunoglobulin- associated . This 
finding confirms similar experiments by Primi et al (1979) but is at 
variance with work by two other groups (Micklem and Asfi 1971 , 
Steele and Cunningham 1980) . However , the anti - lg reagents used by 
these two g roups were not immunoabsorbent purified and would have 
contai ned AIF , a potent blocker of autorosetting (cha~ter 6) . 
Chapters 4 and 5 are devoted to characterizing the 
autorosetting receptors and acceptors . Several lines of evidence 
indi cate that autorosetting is mediated by a protein receptor on 
lymphocytes (thymocytes) that interacts with a carbohydrate acceptor 
on erythrocytes . Briefly , this data is as follows : 
(1) A range of simple sugars could i nhibit autorosetting 
in a strain specific manner , t hese strain differences mappi ng to the 
H- 2L/ D region of the MHC (section 4 . 2 .1) . 
(2) The erythrocyte acceptor was destroyed by certain 
exoglycosidases whereas the thymocyte receptor was glycosidase ~esistant. 
Furthermore , difference in glycosidase susceptibility of the acceptor 
was noted between mouse strains , an effect again ma~ped to the H- 2L/ D 
region (section 4 .2 . 2) . 
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(J) Both the thymocyte receptor and erythrocyte acceptor 
were protease sensitive , a finding which suggested that the 
carbohydrate on erythrocytes was protein bound (section 4 .2.2). 
(4) The autorosetting receptor could be detected in detergent 
lysates of thymocytes and was characterized as a H- 2L/H- 2D region 
controlled lectin (chapter 5) . 
A combination of the data obtained suggested that the auto-
rosetting receptors on thymocytes recognize terminal D- galactose , 
D- mannose and sialic acid residues on a branched chain carbohydrate 
structure on erythrocytes , mouse strains of different H- 2 haplotype 
ex~ressing carbohydrate structures that differ in the linkage of these 
three terminal sugars . 
Based on the above findings procedures were devised for 
isolating the autorosetting receptors and acceptors from 125I - labelled 
detergent lysates of thymocytes and erythrocytes , respectively . SDS-
PAGE analysis revealed that the haemagglutinin has a molecular weight 
of 6J , OOO daltons and lLnder reducing conditions gives fragments of 
molecular weight 45 , 000 and 54 , 000 daltons . 
Three possible structures of the autorosetting receptor 
derived from these observations are depicted in the figure shown on 
the next page . It could be that the autorosetting receptor is a poly-
peptide chain of 6J , 000 daltons consisting of a 45 , 000 dalton poly-
peptide chain disulphide bonded to two subunits , each of molecular 
weight 9 , 000 daltons (Fig . A). If reduction was incomplete , components 
of 45 ,000 and _54 , 000 daltons would appear . The second possibility is · 
that the autorosetting receptor contains two proteolytic cleavage 
sites , each separated by a 9 , 000 dalton unit (Fig. B). As a result 
of proteolysis , one or two of these cleavage sites may be affected, thus 
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Possible Structures of the Autorosettirrg Receptor (Haemagglutinin) 
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releasing either 45 , 000 or 54 ,000 dalton fragments . The third possibility 
is that the receptor may consist of two classes of lectins : one of a 
45 , 000 daltons polypeptide chain disulphide bonded to a 18 , 000 dalton 
fragment ; the other a 54 , 000 dalton polypeptide disulphide bonded to 
a 9 , 000 dalton fragment (Fig . C) . Obviously these models assume the 
proposed 9 , 000/18 , 000 dalton fragments are not 125I - labelled . 
dhether the lectin is related to the conventional 
45 ,000 dalton protein H- 2 antigens remains to be determined . A poly-
pepti de similar in molecular size to 62- microglobulin (i . e ., 12 , 000 
daltons) ,which has been demonstrated to be associated with H-2K , H- 2D 
and H- 21 molecules , has so far not been detected in receptor preparations 
even when highly cross- linked gels (12%) were run . The possibility , 
however , may exist that the 54 ,000 dalton polypeptide may represent the 
45 , 000 dalton fragment complexed with the 12 , 000 dalton component . Studies 
employing the inhibition of BALB/c haemagglutinin by different anti - H-2 
ser a has so far revealed that it is blocked by conventional anti - H- 2Ld 
antibodies (AS 207) (data not shown) , but not antibodies raised against 
the other regions of the H- 2 complex (i . e ., anti -Kd , Dd , and lad) . 
Obviously , the ideal experiments to resolve the H- 2 nature of the 
haemagglutinin would be to react the purified haemagglutinin with 
different monoclonal anti - H- 2 sera. However, there was insufficient 
time to carried out these studies before thesis submission . 
SDS-PAGE analysis of the acceptor molecule has also 
revealed that it has an unusual molecular weight for H- 2 antigens 
(i . e., 62 , 000 daltons) even though the acceptor molecule Nas blocked 
by specific anti - H- 2L sera . However , Lhere was a recent report that a 
monoclonal anti - H- 2 antibody (11- 4 .1) could immuno- precipitate a 68, 000 
dalton molecular Neight molecule from thymoma cells (Hunter et al, 1981 ) . 
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Interestingly , this monoclonal antibody has been shown to be carbohydrate 
specific (O ' Neill et al 1981) . Whatever the relationship between the 
acceptor molecule and H- 2 it a~pears to be a glycoprotein (chapter 4) , 
the carbohydrate moiety attached to it being recognized by autorosetting 
receptors . 
7 ,4 Specificity of the Autorosetting Phenomenon 
At this point certain aspects of the specificity 
of the autorosetting receptors should be emphasized . First , it appears 
that autorosetting lymphocytes bind syngeneic, allogeneic and xenogeneic 
(rat) erythrocytes by the same receptor (chapter J). However, studies 
with erythrocyte sonicates revealed that the autorosetting receptor 
has highest affinity for H- 2L/H- 2D region compatible structures . In 
chapter J (section J . J) it was suggested that sonicates detected this 
"self preference " because (i) binding of intact red cells represents 
multi - point binding whereas the membrane vesicles generated by sonication 
would not bind in such a multi - point fashsion and (ii) unbound sonicates 
were washed away from lymphocytes whereas in rosetting assays unbound 
red cells were not removed . In this context , the ability of Primi et al 
(1979) and Charriere et al (1980) to detect preferential binding of 
intact red cells may be due to the very vigorous resuspension of rosettes 
by these workers (i . e ., vigorous mixing on a mechanical roller for 
JO - 60 sec) , wh1ch would favour highest affinity receptors. Perhaps a good 
demonstration that sonicate - inhibition highlights self preference was 
the observation that dm2 mutant erythrocytes (H-2L deletion), although 
rosetting normally with thymocytes of all mouse strains when intact, 
were unable to inhibit wild- type (H- 2d) autorosetting when used as a 
sonicate . This observation also indicates that the dm2 mutant has 
defective autorosetting receutors and acceptors. 
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Second , if one accepts that the autorosetting receptors 
have highest affinity for self H- 2L/H- 2D molecules but cross react 
with other H- 2 antigens , why is it that the detergent solubilised 
autorosetting receptors (h.aemagglutinin) described in chapter 5 
fail to show haplotype specificity in their haemagglutinating activity? 
The possible explanation for this paradox is that , following detergent 
depletion by XAD-8 beads the autorosetting receptors exist as high 
molecular weight aggregates rather than as separate molecules. 
Certainly gel filtration studies indicate that the haemagglutinin in these 
preparations has a molecular weight of approximately 500,000 daltons 
(D . B. Ryaltt , personal communication) . Thus the haemagglutinin would 
bind to the red cells in a multi - point fashion and consequently, 
similar to autorosetting , react with allogeneic and xenogeneic (rat) 
red cells . Whether the solubilised erythrocyte acceptor also exists 
as a high mol . wt . complex in detergent-depleted lysates has not been 
detennined. The report by Aswell and Morell (1977) that the galactose-
binding lectin of hepatocytes consists of two subunits of mol. wt. 
48 ,000 and 40 ,000 daltons that form high mol. wt. complexes of 500,000 
daltons is consistent with mammalian lectins fanning high mol. wt. 
aggregates . 
Finally , sonicate-inhibition studies revealed that 
Fl lymphocytes simultaneously express receptors against both parents 
(chapter J , section J . 2 . 9) . This conclusion was based on the 
observation that erythrocyte sonicates of either parent were potent 
inhibitors of Fl lymphocyte rosetting. Thus, this finding would seem 
to be a paradox as if there were separate receptors against each 
parental H- 2 haplotype one would only expect autorosette inhibition 
when er::;rthrocyte sonicates from both parents were present . However , it 
was suggested in chapter J (section J . J . J) that an explanation for this 
I 
i 
...... 
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paradox is that the erythrocyte sonicates represent membrane vesicles 
(i . e ., the vesicles that inhibit autorosetting are sedimented by 
5000 - 20 , 000 g centrifugation) and not solubilized membrane 
component . Thus , once lymphocyte receptors against one parental 
haplotype bound erythrocyte vesicles the receptors directed against 
the other parent would be sterically masked . 
7 ,5 Regulation of Autorosetting Receptors In Vivo 
Obviously the function of autorosetting receptors 
is not to interact with red cells in vivo . Autorosetting merely 
represents a convenient assay for detecting this family of anti -
self receptors. 
In support of th1s notion is the finding that serum 
contains a potent blocker of autorosetting receptor (termed auto-
rosette inhibition factor or AIF). As described in chapter 6 , human AIF 
was purified to homogeneity and shown to be a single polypeptide of mol. 
wt . 81 , 000 daltons and at a cqncentration of 50- 100 µg/ml of human seD.llll. 
An interesting feature of AIF is that it is active across species 
barriers , murine autorosetting being blocked by AIF from many species, 
e .g ., human , chicken and toad . This implies that AIF plays an 
important function in vivo and there are strong evolutionary pressures 
to conserve its structure. Certainly the blocking of lymphocyte 
receptors that potentially , can react against most self cells is an 
important function . Presumably autorosetting receptors are only 
functional in tissues where AIF is absent (see next section). 
Dr . D. B. Rylatt in this department recently has 
further characterized AIF from several species. He has found that 
human , mouse and bovine AIF ' s have mol. wt. of 81, 000 daltons and 
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almost identical amino acid compositions . In contrast, chicken AIF 
has a mol . wt of 160 , 000 daltons but its amino acid composition 
resembles mammalian AIF . An interesting feature of the AIF ' s is that 
they are rich in histidine and praline (approx . 15% of protein) and, 
in fact , resemble a protein of unknorrm function , termed histidine rich 
glycoprotein , isolated from human serum several years ago (Heimburger 
et al 1972) . Finally , it is intriguing to note that AIF is secreted 
by a population (populations?) of macrophages (chapter 6) . As 
macrophages are well documented to play an important role in regulating 
immune responses (Escobar and Friedman 1980) , the network whereby 
AIF regulates autorosetting receptors remains an exciting field of 
research . 
7 . 6 Functional Significance of Autorosetting Rece~tors 
As mentioned above , the autorosetting receptors on 
lymphocytes certainly do not function in vivo as receptors for self 
r ed cells . Also , it is unlikely that the autorosetting rece~tors 
represent the :postulated "anti- self receptors " involved in H- 2 
restricted recognition by T lymphocytes (Zinkernagel and Doherty 1979). 
This conclusion is based on the following observations : 
(1) The autorosetting receptors are restricted to 
the H- 21/ H- 2D region whereas cytotoxic T cells recognize self H- 2K , 
H- 21 and H- 2D structures . 
(2) In the periphery B lymphocytes are the predominant 
autorosetting cells . In fact , most data suggest that immature, rather 
than mature T cells , carry autorosetting receptors (Charreire and Bach 
1975 , chapter J) . 
(J) The specificity of the autorosetting receptors 
is unchanged in allogeneic and semi- allogeneic chimeras, i .e., the H- 2 
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specificity is the same as the donor cells (chapter J) . In contrast, 
the H- 2 specificity of cytotoxic T cells is changed in these chimeras 
(ZinkeTI1agel and Doherty 1979) . 
(4) Addition of purified human AIF to cultures at 
concentrations that block all autorosetting receptors failed to block 
a range of in vitro immune responses , such as generation and effector 
phases of H- 2 restricted virus- specific cytotoxic T cells , primary and 
secondary antibody responses , generation of virus specific delayed-
type hypersensitivity and mitogen responses (data not shown) . 
A likely flLnction of the autorosetting receptors is 
that they mediate a form of intercellular adhesion in which these 
MHC - controlled receptors recognize MHC - controlled structures on another 
cell . At this point it should be noted that there are several reports 
in the literature of MHC - controlled intercellular adhesions . The first 
description of this phenomenon was by Barlett and Edidin (1978) who 
observed that the rate of adhesion of mouse embryo fibroblasts to 
fibr oblast monolayers was related to the H- 2 haplotype of the fibroblast 
monolayer . That H- 2 antigens were involved in this interaction was 
suppor ted by the ability of anti - H- 2 sera to inhibit fibroblast -
fibroblast intercellular adhesion . 
Intercellular adhesion between mouse bone marrow and 
lymph node cells has been shown to be under H- 2 control, H-2 compatible 
cells adhering more effectively than allogeneic cells (Zeleny et al 
1978) . Similarly , Kand D- region compatibility between T and B cells was 
reported to be required for the secretion of certain factors that 
diminish the adhesiveness of the opposite cell type (Curtis 1978, 1979). 
Compatibility at the Kand D regions of the H- 2 complex was also shown 
to be necessary for controlling contact inhibition of movement of mouse 
epithelium outgrowths. Contact inhibition was greatly increased when 
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confronting epithelial outgrowths were histo- incompatible at these genetic 
regions (Curtis and Rooney 1979) . In a comletely different system H- 2 
antisera were shown to be capable of blocking the interaction between 
murine nepatocytes and metastasizing tumour cells (Schir..cmacher et al 
1980) . An interesting conclusion from this study 1.,,ras that this interaction 
is probably mediated by a galactose- specific lectin on the hepatocytes 
that results in liver metastasis . 
In a recent report , it was also shown that the optimal 
homing of T and 5 lymphocytes to lymph nodes reQuires identity at either 
the Kand/ or D- region of the murine MHC . Thus it is likely that lymphocytes 
interact ~ith endothelial cells via receptors that preferentially 
recogni ze self MHC antigens (Pincott and Bainbridge 1980) . 
Finally , the in vivo e:rythropoietic performance of 
mouse bone marrow cells has been demonstrated to be much lower in H- 2 
disparate than in H- 2 identical irradiated host (Lengerova et al 1977). 
Studies of several H- 2 recombinants and a H- 2 mutant indicated that the 
Kand D- regions of the H- 2 complex were involved . In addition , it was 
suggested that the recognition by the host of a carbohydrate H- 2 molecule 
on the donor cells determined e:rythropoietic performance . 
Nhether the autorosetting receptors mediate and AIF 
inhibits any of these other forms of intercellular adhesion is an 
interesting Question tnat deserves investigation . As mention above in 
section 7.5, a speculative fill1ction of the autorosetting receptors is 
that , in the in vivo absence of AIF , they may act as a lymphocyte "homing 11 
device . Conversely , W1ion of the recentor ~ith its acceptor could nrovide 
a differentiation signal . In th1s context , Dr . D. B. rtylatt has observed 
recently that AIF is highly sensitive to protease attack (~articularly by 
plasmin) and , therefore , the local activation or release of proteases 
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(such as in the case of tissue damage) could result in AIF destruction, 
exposure of the autorosetting receptors and consequent localisation of 
lymphocytes at that site . 
In conclusion , it should be emphasized tnat whatever 
the function of the autorosetting receptors may be, the autorosetting 
phenomenon appears to be under MHC control . This finding suggests t hat MHC 
not only controls the interaction of antigen- specific T lymphocytes with 
target cells but may play a much more fundamental role in cell- cell 
communication . 
7.7 Implications of Autorosetting be1ng a MHC - Controlled Proteln-
Carbohydrate Interaction 
In this final section , a speculative hypothesis will be 
proposed which considers the theoretical implications of autorosetting 
being mediated by a H- 2L/ H- 2D controlled lectin on lymphocytes that 
recognizes a H- 2L/ H- 2D region controlled carbohydrate structures on 
erythrocytes . An obvious implication is that the H- 2L/H- 2D region in some 
way codes for carbohydrate structures . Thls is not the first evidence 
for carbohyrate structures being controlled by the muiine MHC . 
Previous studies indicate that the .!_- region controls carbohydrate Ia 
antigens (McKenzie et al 1977 , Higgins et al 1980) and recent studies 
with monoclonal antibodies suggest that carbohydrate H-2Kk antigens 
exist (O ' Neill et al 1981) . Furthermore , these studies indicate that 
the carbohydrate H- 2 and Ia antigens are usually expressed as glycolipids 
on the cell surface and are different molecules to the conventional 
protein H- 2 and Ia antigens . 
The existence of carbohydrate H-2L/H-2D structures 
suggests that the H- 2L/H- 2D region codes for the glycosyltransferase 
enzymes tnat construct these molecules. The manner in which glycosyl-
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transferases catalyse the transfer of a monosaccharide residue from a 
sugar nucleotide (sugar donor) to the non- reducing tenninus of a specific 
sugar acceptor is depicted in Fig . 7 .1 . It should be emphasized that the 
attachment of each sugar in a carbohydrate chain re~uires a se~arate 
glycosyltransferase that has specficity for both the sugar acceptor and 
the sugar donor . Although the simplest model is that the H- 2L/H- 2D region 
directly codes for glycosyltransferases a more complex possibility is that 
the glycosyltransferases are coded for by genes located outside the 
MHC and the H- 2L/H- 2D region produces regulators of these enzymes . 
Once one considers glycosyltransferases as a gene 
product it is not difficult to envisage how one genetic region can 
control the expression of two separate classes of molecules on the 
cell surface. Thus the primary gene product of the H- 2L/H- 2D would be a 
family of glycosyltransferases that construct the carbohydrate H- 2~/H- ~D 
antigens, and both of these molecules could be expressed in the cell 
membrane as separate entities . Furthennore , it can be seen from Fig . 7.1 
that glycosyltransferases basically are lectins and , therefore, the auto-
rosetting receptors on lymphocytes could be H- 21/H-2D controlled glyco-
syltransferases. Such a model , in which glycosyltransferases on the 
surface of one cell recognize their carbohydrate substrate on another 
cell, has been proposed by Roseman (1970) to explain specific cell- cell 
communication. Fig . 7 . 2 depicts the way in which this model can be 
adapted to the autorosetting phenomenon , where a H- 2L/D region controlled 
glycosyltransferase (transferase J) is expressed on the surface of 
lymphocytes and interacts with its substrate , an incompletely glycosylated 
H- 2L/D carbohydrate , on erythrocytes . 
Is it possible to explain the modified autorosetting 
behaviour of H- 2L/H- 2D mutant mice by this model? In the case of the 
( dm2) h I h ' ' l ' 1 .-. I h H- 2L deletion mutant ~- 2 , w _ere Gere is a simu Ganeous _oss oI Ge 
Sugar acceptor reaction product 
enzyme 
+ + 
UDP/'v + UDP 
sugar donor free nucleotide 
GL Y COS YL TR,ANSFERASE REACTION 
Fig. 7,1. Glycosyltransferase reaction. Various monosaccharides 
are represented by circles, triangles, sq uares and diamonds . A 
trisaccharide sugar acceptor is depicted. linked at its reducing 
end to a protein or lipid moiety represented by the ~avy line. 
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The enzyme, usually in the presence of divalent metal ions, 
catalyzes the transfer of a monosaccharide from its uridine 
diphosphate donor to the nonreducing terminus of the sugar 
acceptor . The reaction products are a tetrasaccharide, represented 
here with a terminal ftdiamond" moiety, and the free nucleotide. 
From Shur and Roth ( 1975). 
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Postulated genetic basis of the autorosetting phenomenon . 
The H- 21/D region is depicted as coding for three different 
gl ycosyltransferase~ that sequentially attach three different 
sugars (depicted as diamonds , squares and circles) to a core 
structure (R) . Thus glycosyltransferase 1 catalyses the 
attachment to R of sugar <i) from its sugar nucleotide precursor, 
transferase 2 catalyses the attachment of sugar [ 2 ! to sugar <Q?>, 
etc . It is proposed that glycosyltransferase J is expressed on 
the surface of lymphocytes and acts as the autorosetting receptor. 
In contrast , transferase J is not produced by erythrocytes and, 
therefore , an incomplete carbohydrate structure (R~) 
is expressed on the surface of evJthrocytes and sev1es as the 
autorosetting acceptor . The model is derived from Roseman's 
generalised hypothesis for cell- cell recog.::.ition. 
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autorosetting receptor on thymocytes and acce~tor on eDJthrocytes , it 
could be proposed that there is a mutation in a H- 2L/H- 2D region regulatory 
gene resulting in no glycosyltransferases (receptors) or carbohydrate 
structures (acceptors) being synthesized by cells . On the other hand , 
the autorosetting receptors of the dml mutant , but _not the wild- tYJ;)e (B10 .D2) 
autorosetting receptors are inhibited by D- galactose (chapter J) . It could 
be proposed that in this Bl0 .D2- H- 2dml mutant strain, there 
is a mutation in a subterminal glycosyltransferase , say transferase 2 
(Fig . 7 ,2) , which results in an enzyme that can still bind , but cannot 
glycosylate its substrate , e .g ., the sugar nucleotide binding site of the 
transferase could be lost . Such a mutation would result in a modified 
erythrocyte acceptor (R-0instead of R~ and would require the 
mutant transferase 2 (not transferase J) to be the autorosetting receptor. 
Of course , for simplicity , Fig . 7 .2 only depicts transferase Jon the 
lymphocyte surface whereas all other transferases could be expressed. 
An important question arising from this model is 
whether conventional H- 2 protein antigens are , indeed, glycosyltransferases. 
The 6J , 000 dalton molecular weight of the autorosetting receptor (chapter 
5) does not , however , resemble the conventional 45 , 000 dalton protein 
H- 2 antigens , although the receptor appears to contain a 45 , 000 dalton 
component . Obviously , this question can only be answered by determining 
whether different anti - H- 2 sera , particularly monoclonal anti - H- 2L anti-
bodies , react with the purified autorosetting receptors. 
Another important question arising from these studies 
is whether H- 2 restricted cytotoxic T cells (Zinkernagel and Doherty 
1979) interact with target cells in a manner simi_ar to autorosetting 
cells . Are the target H- 2 antigens recognized by cytotoxic T cells 
carbohydrate and are the postulated anti - self receptors on these cells 
lectins? Currently there is no exuerimental evidence to discount these 
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questions but it should be possible to devise experiments to answer 
them . 
Appendix : 
Assaying Autorostting Thymocytes B-y 
The Coulter Counter 
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A microscope method has been used by different research 
groups to detect autorosetting _ymphocytes in the mouse and other 
species. Obviously , this microscope assay is subjective, tedious 
and time consuming . For these reasons , an automated procedure for 
counting autorosettes was devised using Coulter Counter , a machine 
which can determine the number and size of particles sus~ended 
in a electrically conductive liquid . The Coulter Counter achieves 
this by forcing the suspension to flow through a small aperture 
having an immersed electrode on either side . As a particle passes 
through the aperture , it changes the resistance between the 
electrodes . This produces a voltage pulse of short duration having 
a magnitude proportional to the particle size . The series of pulses 
is then electronically scaled and counted by the machine . In the 
case of autorosetting ~t would be anticipated that autorosettes 
would be larger than free red cells , and non- rosetting lymphocytes 
and , therefore , could be readily counted by this machine. 
In the experiments presented single cell suspensions 
of BALB/c thymocytes and erythrocytes were pre~ared as described 
6 in chapter 2 . Thymocytes were made up to 4 x 10 / ml and erythrocytes 
to 0.75% in HBSS containing 0.5% FCS . For calibrating the machine , 
200 µl of Lhe thymocyte sus~ension was mixed with 200 µ l of the 
0.75% erythrocyte suspension. Tne mixture was centrifuged at 
200 g for 1 min at 4°c . The cell pellet was allowed to incubate 
on ice for 1 hr before being resuspended gently using a short 
pasteur pipette . For Coulter Counter counting , the mixture was 
then gently pipetted into 20 ml of cold PBS and mixed gently . 
The counting profiles obtained for erythrocytes alone , autorosetting 
thymocytes , and autorosetting thymocytes in the presence of 10% 
I 
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autologous serum (sufficient seru..m to block autorosettes) at various 
threshold settings are depicted in the lower graph of Fig . 1. It 
can be seen that autorosetting thymocytes gave a different size 
distribution to non- rosetting (serum blocked) thymocytes , increasing 
lower threshold values representing increases in cell volwne . The 
optimal number of autorosetting thymocytes (23%) was obtained at a 
lower threshold setting of J6 (upper graph of Fig . 1). 
A parallel microscope assay detected 45% autorosetting 
cells in the sample . This discrepancy may be due to disruption of 
same autorosettes as they passed through the orifice . This is 
unlikely , however , as the machine also gives lower values for highly 
stable antibody- mediated rosettes . The discrepancy is probably due 
to autorosetting thymocytes having a wide size distribution , hence 
no one threshold setting can detect all autorosettes. 
In subsequent experiments a lower threshold setting 
of 40 was chosen as this setting detected a high proportion of 
autorosettes but few free thymocytes . For serum inh1bition of 
autorosetting , 200 µl of the thymocyte suspension 
6 (4 x 10 /ml) was 
incubated with 500 µl of neat , or serial two fold dilutions of 
BALB/ c serum for JO min on ice . 200 µl of a 0.75% autologous 
er-Jthrocyte susnension was then added for rosette fo:rmation. The 
percent autorosette fo:rming cells obtained at each serum dilution 
revealed that the inhibition profile of autorosetting by the 
different serum dilutions was comparable to that obtained with the 
microscope assay (Fig . 2) . This probably reflects differences in the 
minimwn size of autorosettes detected in the two assays. 
The results obtained in this study show that the 
Coulter Cou..nter assay can replace the microscope method as a non-
subjective method for quantitating autorosetting lymphocytes. 
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Fig. 1. Detection of autorosetting thymocytes by the 
Coulter Counter. The lower graph depicts the number of 
cells counted at each lower threshold setting, the curves 
depicting BALB/c mouse red cells alone ( Q ) , BALB/c 
thymocytes + BALB/c red cells rosetted in presence of 
20% BALB/c serum ( ) and BALB/c thymocytes + BALB/c 
red cells rosetted in the absence of mouse serum ( []) 
The upper graph depicts the percent rosette forming cells 
calculated at each lower threshold setting according ' to 
the formula: 
% RFC at lower 
threshold = 
setting X (LTX) 
No. cells in curve ( 
No. cells in curve ( 
D ) at LTX -
• ) at LT X 
Total no. thymocytes in sample 
For further details see text. 
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Fig. 2. Inhibition of autorosetting of BALB/c thymocytes 
by serial dilutions of BALB/c serum as detected by microscop ic 
assay ( 0 ) or by Coulter Counter assay ( • ) . 
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